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Dissertation Abstract 
Title: An Evaluation of Respiratory Exacerbation in New York City Given Current Trends in 
Climate Variability and Predictive Sociodemographic Factors 
Author: Sarah L. R. Kuril 
Advisor: Glen Johnson, PhD 
 
Background: Within the last century, the massive increase in emissions due to economic growth 
has made climate variability a major problem for many of the industrialized countries and an 
emerging problem for the rest of the world. With an increasing number of extreme weather 
events, such as heat waves, cold fronts, floods, heavy rain, and storms, individuals with Chronic 
Obstructive Pulmonary Disease (COPD) and asthma remain a vulnerable population, placing 
them at highest risk of respiratory exacerbation. This dissertation aims to contribute to our 
understanding of how climate variability, which can influence patterns of rainfall, temperature 
and other variables on a wide range of timescales, and sociodemographic factors impact 
respiratory disease exacerbation among New York City (NYC) residents.  
Methods: Outcome variables of asthma and COPD exacerbation occurring in the inpatient and 
outpatient medical settings are from the New York State Department of Health Statewide 
Planning and Research Cooperative System (SPARCS). Secondary outcome variables of hospital 
length of stay (LOS) and total charges for the third study are also from SPARCS. Additional 
datasets include products for climate (temperature, precipitation, wind, relative humidity, PM 
2.5) and socio-demographic potential predictor covariates (sex, age, race, income, poverty, 
educational attainment, and type of house heating fuel). The first study uses a space-time 
permutation model to determine spatial and temporal clusters of increased risk of respiratory 
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exacerbation episodes across NYC neighborhoods. The second study uses Poisson regression 
using a series of three models (general linear model (GLM), general linear mixed model 
(GLMM) and a Bayesian spatio-temporal model) to further quantify the complexity of factors 
such as overall climate and socioeconomic status (SES). The third study applies Bayesian spatio-
temporal modelling to predict the expected cases into the year 2039, total hospital charges and 
length of stay (inpatient setting only) based on Intergovernmental Panel on Climate Change 
(IPCC) predictive climatic factors and other predictive socio-demographic and SES factors.  
Results: The first study determined temporal and spatial variation of respiratory exacerbation 
episodes across NYC neighborhoods throughout the study period, with disproportionate 
increases in ZCTAs demonstrating geographic and hypothesized socioeconomic disparity. 
Results from the second study indicate the associations between respiratory exacerbation and 
predictive climate and sociodemographic factors vary according to location and are both positive 
and negative (increase and decrease risk). The third study found respiratory exacerbation, 
hospital length of stay and total hospital charges had a combination of positive (increase risk, 
increase LOS and increase total hospital costs), negative (decrease risk, LOS, cost) and zero 
associations into the year 2039 with increased temperature and precipitation projections by the 
IPCC well as predictive sociodemographic and SES factors.  
Conclusion: The studies in this dissertation provide additional evidence for the relationships 
between climate variability, sociodemographic factors and respiratory exacerbation in New York 
City. Spatio-temporal methods identify both time periods and spatial locations of increased risk 
and the role of predictive factors in certain neighborhoods. For example, the first and second 
studies determined neighborhoods in the south Bronx, upper Manhattan, eastern Brooklyn (as 
well as parts of north-western Brooklyn), north-central Queens (near LGA airport) and southern 
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Queens (near JFK airport) all presented with elevated risk. These neighborhoods are in proximity 
to major highways and/or airports and are known to have the highest rates of populations that are 
either in poverty or black regardless of ethnicity. Race and poverty were consistent risk factors 
throughout the second and third studies, whereas increased temperatures were protective 
suggesting cooler temperatures may potentially increase risk instead. The third study determined 
long-term implications of IPCC projected climatic trends and predictive factors: factors 
determining SES (black, poverty status) would be predictive of respiratory exacerbation into 
2039, and so would age for COPD outcomes; hospital LOS and total charges would be impacted 
by SES, age and IPCC projected precipitation increase, but for COPD outcomes only. 
The findings from this research support on-going respiratory management goals, which 
aim to improve disease management through underlying clinical components including proper 
medication reconciliation, follow-up on medication adherence, education on diagnosis/prognosis 
and access to resources to better track environmental conditions (e.g., weather, pollutant levels). 
The results also support adaptation measures, which are aimed at factors that are difficult to 
change in themselves, such as living in disadvantaged neighborhoods that are more vulnerable to 
the impacts of climate variability. The findings can further translate into pragmatic and practical 
measures to alleviate the variation observed in risk factors of respiratory exacerbation, including 
the promotion of increased annual primary care physician visits, increased access to specialty 
care within the outpatient setting, population health informatics tools to easily connect patients to 
medical resources, and coalitions with local environmental justice groups to help carry out these 
measures. Limitations, including spatial, temporal, and methodological issues with the data 
sources are discussed, as are suggestions for future research. 
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Chapter 1. Introduction 
This dissertation is concerned with environmental health through the facet of climate variability, 
and the impact it has on individuals with pre-existing respiratory disease. Although there are 
numerous diseases of the lung, this dissertation will be limiting the discussion of respiratory 
disease to two of the most prevalent: Asthma and Chronic Obstructive Pulmonary Disease 
(COPD). There are a multitude of factors affecting the prevalence of asthma and COPD 
exacerbation, yet the interplay of these components is not well understood. The population of 
interest are individuals pre-diagnosed with asthma and COPD in New York City (Figure 1.1). 
This region was chosen because it contains one of the largest and most diverse urban populations 
in the world1 and experiences the four seasons (Fall, Winter, Spring, Summer). Climate 
variability has been found associated with respiratory disease, but the extent of its current and 
future impacts are still being extensively studied, especially among vulnerable individuals.  
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Figure 1.1: Map of New York City Zip Code Tabulation Areas (ZCTAs) that make up the study area. Source: The Baruch College 
Geospatial Data Library, OpenStreetMap 
 
1.1 Respiratory (COPD and Asthma) Exacerbations 
Asthma accounts for 9.8 million doctor’s office visits, 188,968 discharges from hospital inpatient 
care and 1.8 million emergency department visits each year.2 Children are especially vulnerable 
as asthma is the leading chronic disease in children2 and is the third-ranking cause of 
hospitalization among children younger than 15.3 Asthma is the top reason for missed school 
days; in 2013 about 13.8 million missed school days were reported due to asthma.4  
Moreover, COPD stands as the third leading cause of death and second leading cause of 
disability in the United States (US).5,6 Almost 15.7 million Americans (6.4%) reported that they 
have been diagnosed with COPD.7 More than 50% of adults with low pulmonary function were 
not aware that they had COPD,8 so the actual number may be even higher. 
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The guidelines of the World Health Organization (WHO) and US National Heart Lung and 
Blood Institute Global Initiative for Chronic Obstructive Lung Disease (GOLD) define an 
exacerbation as “an event in the natural course of the disease characterized by a change in the 
patient's baseline dyspnea, cough, and/or sputum that is beyond normal day-to-day variations, is 
acute in onset, and may warrant a change in regular medication in a patient with underlying 
respiratory disease”.9 This is characterized by an acute worsening of respiratory symptoms (e.g., 
increased airway and systemic inflammation and physiological changes, such as airway edema, 
bronchospasm, and increased sputum production), leading to worsening airflow limitation.10,11 
 
Certain definitions for COPD exacerbation have also been suggested based on unscheduled 
physician visits, use of antibiotics or oral steroids at exacerbation, and hospital admissions.12 
However, many COPD and asthma exacerbations are not reported to health-care professionals 
and are either self-treated or left untreated altogether.13 Researchers have found that health-care 
use in COPD and asthma can vary depending on access, leading to substantial difficulty in the 
standardization of such a definition.14 Nonetheless, health-care use can still be implemented in 
defining the severity of an exacerbation (which GOLD considers an indicator of COPD disease 
stage), with higher frequency of exacerbations indicating an augmentation in severity of disease: 
mild if increases in regular inhaled medication are needed, moderate if courses of steroids or 
antibiotics are needed, and severe if the patient requires hospital admission.14,15 
 
Public health authorities are interested in reducing hospitalizations rates for several reasons: 
there is a need for improvement of the population's well-being, reducing healthcare costs and 
reducing consumption of resources.16 For instance, the New York State healthcare system spends 
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US$1.3 Billion dollars per year for asthma alone (second highest state in the US) and current 
asthma prevalence in adults living in New York City is 10.2%, higher than 9.3% of adults who 
live in the rest of the State.17 COPD also presents with its own burdens on morbidity, mortality 
and healthcare systems overall. Although there is limited research done on COPD in NYC, 
national studies have modelled the financial burden associated with COPD prevalence showing 
direct healthcare costs were found to range from US$1,681 for patients in stage I COPD (early 
stage), US$5,037 for patients in stage II (moderate stage) and US$10,812 for those in stage III 
(severe stage).18 
 
Effect of Respiratory Exacerbation on Human Health 
COPD and asthma exacerbations impose a substantial burden on health as they are a major cause 
of morbidity, mortality, and reduced health status.13 In a study of the time-course of community-
treated exacerbations, a proportion of patients never returned to baseline level and 14% of the 
patients still had not returned to baseline symptoms within 35 days (or 5 weeks) of onset.19 
Additionally, high exacerbation frequency suggests a higher risk of future exacerbations. 
According to the GOLD guidelines, patients with two or more exacerbations in the past 12 
months are at a high risk of future exacerbations compared to low-risk patients with one or zero 
exacerbations in the past 12 months.15 An audit of hospital admissions showed that around 30% 
of patients presenting with an index (first) exacerbation will be seen again and possibly 
readmitted with another (or recurrent) event within 8 weeks.20 In a cohort of patients with 
moderate to severe COPD followed-up after exacerbation, 22% had a recurrent event within 50 
days (or 7 weeks) of the first (index) exacerbation.21 Additionally, a retrospective cohort study 
utilizing data from a large US national health plan conducted from 2007 to 2012 showed 44.3% 
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had at least one exacerbation; 26.3%, 9.5%, and 8.5% had one, two, and ≥ three exacerbations in 
the 24-month follow-up period, respectively.22 
 
Repeated episodes of COPD and asthma exacerbations may lead to an accelerated rate of decline 
in pulmonary function, as measured by the forced expiratory volume (FEV1) test which measures 
how much air a person can exhale during the first second of a forced breath.23 Studies have found 
that patients with an FEV1 below 50% predicted (i.e., moderate-to-severe COPD) were reported 
to experience 1 to 2 exacerbations on a yearly basis.24 For example, Donaldson et al27 reported a 
mean of 2.92 exacerbations per year in COPD patients with moderate to very severe disease 
where mean FEV1 was 38% predicted. Furthermore, studies
25,26 have shown a prolonged return 
to baseline pulmonary function levels with higher rates of exacerbation per year. Celli et al28 
reported patients had a faster decline in FEV1 when they experienced a greater frequency of 
exacerbations during their 3-year study period. 
 
Patients with impaired lung tissue as a result of frequent exacerbations are more likely to 
experience a poorer quality of life as compared to patients with a history of less frequent 
exacerbations.11,29,30 A study by Connors Jr et al31 reported the quality of life outcomes in 
patients hospitalized with acute exacerbations of COPD: at 6 months about 54% of patients 
required assistance with at least one activity of daily living and 49% considered their health 
status to be either fair or poor. COPD exacerbations can also lead to a significant reduction in 
physical activity and overall exercise tolerance.32 Additional investigations have further found 
inpatient mortality rates associated with COPD exacerbations to occur at a rate of anywhere 
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between 2.5% and 10%, with increases up to 40% in 1 year.15 In patients older than 65 years of 
age, the 1-year mortality rate was observed to be as high as 59%.33 
 
1.2 Climate Variability and Respiratory Exacerbation 
Climate variability is formally defined by the World Meteorological Organization as “variations 
in the mean state and other statistics of the climate on all temporal and spatial scales, beyond 
individual weather events.”34 The fluctuations comprising climate variability can influence 
patterns of rainfall, temperature and other variables on timescales anywhere from a few weeks to 
a few decades.35 Variability may be due to natural internal processes within the climate system 
(internal variability), or to variations in natural or anthropogenic external factors (external 
variability).34 
 
Within the last century, massive increases in emissions associated with population and economic 
growth has made climate variability a major challenge for countries throughout the world.36 
Increased concentrations of greenhouse gases in the earth’s atmosphere have substantially 
warmed the planet, affecting the biosphere and causing more severe and prolonged heat waves, 
temperature variability, heavy rainfall, storms, air pollution, forest fires, droughts, and floods.36-
38 One of the best indicators of the impacts of climate variability on societies is human health and 
well-being.39 The European Respiratory Society (ERS) provided a position statement 
highlighting climate-related health impacts, which included a growing toll of deaths and 
morbidity due to climate extremes.40,41 Unfavorable changes in climate can specifically impact 
air quality and pose a quantifiable threat towards an increased frequency of respiratory disease 
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requiring hospital care. Such episodes can permanently affect the overall function of the 
respiratory system, causing COPD to progress faster or asthmatic disease to worsen.42 
 
The Influence of Temperature and other Meteorological Factors 
The earth’s atmosphere has been warming since 1880, which is the first year of temperature 
record in NASA Goddard Institute for Space Studies (GISS). Currently, average annual global 
temperatures have increased by about 0.8° Celsius (1.4° Fahrenheit).43 Two-thirds of the 
warming has occurred since 1975 at a rate of roughly 0.15-0.20°C per decade,43 with 16 of the 17 
warmest years on record having occurred since 2001.44 According to NASA GISS and National 
Oceanic and Atmospheric Administration (NOAA), the warmest year on record to date is 2016 
with temperature anomalies at 0.95°C and 1.71°F (Figure 1.2).45 
 
 
Figure 1.2: Ten Warmest Years (1880–2018) The above table lists the global combined land and ocean annually-averaged 
temperature rank and anomaly for each of the 10 warmest years on record. Source: NOAA 
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Evidence of increased mortality and acute morbidity among respiratory patients as a result of 
heat waves makes COPD and asthma patients extremely vulnerable to respiratory illness during 
the summer season.46 During a period of extremely high temperatures, each degree Celsius (C) 
above the threshold of the temperature-health effect curve (29°C–36°C) was associated with a 
2.7% – 3.1% increase in same-day hospitalizations due to respiratory diseases.47 There was also 
an increased risk of premature death up to six times higher among respiratory patients than in the 
rest of the population.38 COPD patients have also been reported to experience more frequent 
exacerbation of their disease and were found to have higher hospitalization and morbidity rates 
during the winter season.48,49 The winter season is also associated with an increased prevalence 
in respiratory viral infections.50,51 
 
Although COPD and asthma exacerbations are more frequent in the winter and summer seasons, 
it is currently unclear which combination of meteorological factors exert the greatest influence 
on respiratory exacerbations, and whether or not time and/or space plays a role.52 The 
temperatures experienced locally and in short periods can fluctuate significantly due to 
predictable cyclical events (night and day, summer and winter) and hard-to-predict wind and 
precipitation patterns, whereas the global temperature are long-term averages of daily weather 
and mainly depends on how much energy the planet receives from the Sun and how much it 
radiates back into space—quantities that are supposed to change very little.53 Therefore, critical 
barriers to general understanding of the relationship between global climate change and 
respiratory exacerbation include meteorological factors, such as regional temperature, rainfall, 
humidity, wind speed, and particulate matter (PM 2.5), which tend to vary with different seasons 
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and across different locations. This is especially true in regions experiencing all four seasons 
such as in NYC. 
 
Rainfall, Humidity and Wind on Respiratory Health 
While asthma in children and young adults have been less common in areas with colder winters 
and lower humidity than along the wetter coastal areas, more severe rainfall and storms could 
increase this risk.54 Studies were done to determine the effects of fluctuations in climatic factors 
(temperature, humidity, and barometric pressure) on pediatric asthma exacerbations, and found 
emergency department visits for pediatric asthma occurred 1 to 2 days after fluctuations in 
humidity and temperature.55 In another study56 looking at respiratory disease and climatic 
seasonality in children under 15 years old in a town in the Brazilian Amazon, results showed 
peaks in number of visits due to respiratory disease during the months of March and August 
(being more accentuated during March and April, which is the wet season in the region). The 
number of hospital visits declined thereafter until another peak in August that was accompanied 
with a lower relative humidity of air.56 Out of the 3-year time period analyzed in this dissertation, 
NYC experienced higher than normal precipitation in 2018 with nearly 57 inches.57 (Figure 1.3) 
 
Recent epidemic thunderstorm asthma has been reported about a dozen times in the past 35 
years; the threshold for reporting seems to be an increase of at least five to ten times in asthma 
presentations to emergency departments over a short period of time.58 Nevertheless, many 
individuals are affected by these events but do not seek acute medical care.59 This emerging 
phenomenon is accompanied with periods of heavy rainfall and intense wind, which are believed 
to increase extreme exposure to allergens, predominantly grass pollen, in susceptible allergic 
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individuals.60 Wind speed, air turbulence, and mixing depth all affect how pollutants disperse 
within a region or possibly spread out from an area.61  
 
 
Figure 1.3: Precipitation (in) to Date for New York (LaGuardia), N.Y. The 3 wettest periods since 1940 (showcased in green) are 
2011, 1983 and 1975. Source: NOAA. The three driest periods (showcased in brown) are 1965, 1970 and 1964. The normal 
precipitation periods (underlaid in dark gray) reflect baseline normal for 1981-2010. The most recent precipitation period was in 
2018, with nearly 57 inches. 
 
Poor Air Quality, as a result of PM 2.5, on Respiratory Health 
In modern society, people spend 80 to 90% of their time indoors where the quality of air is 
driven by pollutant source and loss mechanisms.62  This includes indoor emission sources in 
close proximity to occupants, and outdoor pollutants that are transported indoors via ventilation 
and infiltration, pollutant deposition to indoor surfaces, and filtration, among others.62  
 
Fuel oil/kerosene, coal/coke, wood and utility gas with improper ventilation systems are all 
sources of indoor particulate matter (PM). Although NYC has mandated cleaner burning oil in 
recent years through the NYC Clean Heat program created in 2010, the remaining residual oil 
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boilers in buildings that have yet to convert to cleaner oil can still emit PM, especially when 
fuels are incompletely burned.63 Residual fuel oil #4, which won’t be banned until 2030, 
continued to be burned by 3,253 residential buildings, despite the city’s efforts to educate and 
incentivize owners to switch to cleaner fuels.64 Of these buildings, studies found 1,724 or 53 
percent were clustered in Manhattan north of 110th Street and the Bronx— portraying the role of 
space as these neighborhoods are disproportionately higher than the area’s population (only one-
fifth of city residents live in these neighborhoods).65 
 
Aforementioned, Indoor Air Quality (IAQ) is also challenged by outdoor air pollution entering 
indoors through ventilation and infiltration and by indoor emission sources.62  Studies found that 
approximately 62% of the 2 million annual DALYs of indoor exposure was caused by the 
transport of outdoor PM2.5 to the indoor environment via ventilation and 16% by indoor 
sources.66 Nevertheless, air pollution can be reduced by periods of heavy rainfall which also has 
the potential to “wash” PM pollutants out of the atmosphere.67 Wind speed can have a similar 
effect on fine particulate matter as fine PM 2.5 concentrations have been found to decrease 
gradually with the increase of wind speed, whereas coarse PM 10 concentrations can increase 
due to dust resuspension under strong wind.68  
 
PM 2.5 levels have declined from 2016 through 2018 (Figure 1.4), however, levels remained 
relatively higher throughout much of Manhattan and in areas of higher traffic density, building 
density and industrial areas in the outer boroughs.69 Additional driving factors of poor IAQ 
include occupant density, pets, pests, smoking and cooking.70 Acute exposure to particulate air 
pollution has been found to be associated with increases in the rates of daily asthma attacks, the 
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rate of respiratory exacerbations due to respiratory infections, hospital admissions, and 
mortality.46,71  
 
Respiratory disorders may be also exacerbated by warming-induced increases in the frequency of 
particulate air pollution matter by fostering conditions favorable to forest fires and, in some arid 
parts of the world, promoting sand storms.72 The association of PM with wildfire smoke is 
influenced by increased wind erosion, which can increase levels of particulate air pollution 
extending over great distances.73 Such exposures to wildfires can lead to an increase in 
respiratory and cardiovascular hospital admissions and emergency room visits.74,75 
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Figure 1.4: Annual comparison of PM 2.5 levels, shown with a ZCTA overlay, 2016-2018. Source: New York City Community Air 
Survey (NYCCAS), 2020 
 
1.3 The Effect of Socio-demographic Factors  
Of further concern, studies have consistently shown the impact an individual’s social or 
economic standing, measured by an individual's or family's social or economic position or rank 
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in a social group,76 has on morbidity, mortality, and access to health care with regards to 
respiratory health.77-79 Research addressing low SES among individuals diagnosed with COPD 
and asthma is associated with disproportionate access to respiratory health care; SES has an 
inverse relationship with COPD prevalence, mortality, health utilization costs and health-related 
quality of life (HRQoL), and asthma has shown an increased severity and hospitalizations in 
relationship to a lower SES.79 As COPD and asthmatic events are often triggered by 
environmental irritants, and can be augmented by certain socioeconomic conditions, climate 
variability can alter air quality and pose a quantifiable threat by permanently affecting the overall 
function of an individual’s respiratory system, causing COPD to progress faster or asthmatic 
disease to worsen. 
 
Figure 1.5 is a conceptual framework showing the relationships between the individual, the 
community and the environment, all placing an individual vulnerable (measured by exposure, 
sensitivity and resilience) to adverse health outcomes. Global climate change serves as the 
overarching contextual hazard that transgresses into exposure determined by regional weather 
variability (e.g., extreme temperature (high, low), rainfall/humidity, wind patterns and PM 2.5). 
The exposures transcending into a system’s sensitivity to climate variability as a result of climate 
change is mitigated by factors such as resilient housing and infrastructure as well as emission 
reduction. Mediating influences and negative moderators to how a system can withstand 
variations in climate include neighborhood-level (e.g., proximity to highways, toxic waste sites) 
and individual-level (socioeconomic, pediatric, elderly, pre-existing medical condition) 
variables. Collectively, these influences determine which societies or communities are resilient 
and adaptive to climate variability and change. Potential outcomes include adverse health effects 
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in communities that are less resilient, whereas adaptive capacities such as air condition use can 
support a system’s resiliency.  
 
 
Figure 1.5: The conceptual framework informing this research proposal integrates theories of the Social Ecological Model 
(SEM), and the Climate-Related Illness Vulnerability framework (CRIV). 
The SEM is a theory-based framework for understanding the multifaceted and interactive effects of individual and 
environmental factors. It was originally developed by Bronfenbrenner, who illustrated nesting circles that place the 
individual in the center surrounded by various systems.80 The CRIV conceptual framework provides broad classes of 
components and linkages that comprise a coupled system's vulnerability to hazards. It aims to determine 
populations vulnerable to environmental variability (exposure), how the consequences of these changes are either 
attenuated or amplified by different human and environmental conditions, and methods that can be implemented to 
reduce vulnerability to change (i.e., responses such as coping, impacts, adjustments, adaptations).81 
 
1.4 Overall Goal of the Dissertation 
Though substantial progress has been made in defining the etiology of exacerbations in COPD 
and asthma in the context of extreme high temperatures or extreme cold temperatures leading to 
respiratory exacerbations and in some instances mortality,46,47,52 there are still many gaps in the 
understanding of how time and space play a role combined with the effect of climate and 
sociodemographic predictor variables. For example, there are inconclusive findings between 
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studies detecting evidence that increasing temperature modifies the effect of air pollution 
exposure leading to respiratory disease and studies detecting interactive effects only.82-88 In 
addition, studies77-79 addressing the effect of an individual’s social or economic standing on 
respiratory exacerbation lack inclusion of climatic co-variables. Furthermore, very few studies 
have provided a spatio-temporal analysis of the future burden COPD and asthma exacerbation 
poses on morbidity and the healthcare system as a whole. 
  
The goal of this dissertation is to address these gaps and contribute to our understanding of how  
climate variability and sociodemographic factors impact respiratory disease among NYC 
residents. Therefore, this dissertation will focus solely on respiratory disease as a function of 
space and time, given an individual’s community-level contextual factors and climatic variation. 
One aim examines spatial-temporal patterns of respiratory exacerbation hospital discharges 
across NYC ZCTAs from 2016 to 2018. Using a space-time permutation model, this study uses 
geo-spatial techniques to determine whether there is temporal and/or spatial variation of 
respiratory exacerbation episodes across NYC ZCTAs throughout the study period and identify 
statistically significant space-time clusters of elevated risk. Another aim examines the 
associations between climatic variation, sociodemographic composition and respiratory disease 
across the whole study area, which comprises of 214 ZCTAs across New York City from 2016 to 
2018. This study uses Poisson regression using a series of 3 models (general linear model 
(GLM), general linear mixed model (GLMM) and a Bayesian spatio-temporal model) to 1) 
determine whether there is spatio-temporal variation in the associations between respiratory 
disease, climatic and sociodemographic covariates, 2) determine regions of elevated risk after 
controlling for climatic and sociodemographic covariates, and 3) determine whether the relative 
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risk of COPD and asthma exacerbation rates will increase within both the inpatient and 
outpatient settings. The third aim seeks to estimate the spatio-temporal association between 
respiratory-related exacerbations across New York City as a whole given predictive temperature 
and precipitation covariates provided by the Intergovernmental Panel on Climate Change (IPCC) 
and certain predictive socio-demographic and socio-economic factors. The secondary outcomes 
that were also analyzed included 1) total charges per stay and 2) length of stay (for the inpatient 
medical settings only). 
 
This dissertation draws upon the epidemiologic and medical understanding of COPD and asthma 
exacerbation, along with components of climate variability such as variation in temperature, 
rainfall, humidity, wind, and air pollution [as measured by PM 2.5]. Poisson regression models 
have the potential to forecast patterns and simulate the interaction of the different climate 
variables on the burden of COPD and Asthma, especially given the potential of model instability 
caused by the relatively small number of reported cases. In addition, geographic information 
sciences (GISc) coupled with space-time scan statistics provides an analysis of spatial and 
temporal relationships between variables of interest. Using these methods collectively, the 
findings from this dissertation may lend new perspectives to current understandings of 
respiratory exacerbation across time and space within NYC and support decision-making with 
the potential to reduce the future burden. 
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1.5 Specific Aims and Hypotheses 
Specific Aim 1: To analyze spatio-temporal patterns of COPD and asthma exacerbation hospital 
discharges across NYC ZIP code tabulation areas (ZCTAs) by month during the period 2016-
2018, including identification of statistically significant space-time clusters of elevated risk. 
 
Hypotheses: It is hypothesized rates of COPD and asthma exacerbation will vary across NYC 
ZCTAs and throughout the duration of the study period in a non-random manner. 
 
Specific Aim 2: To estimate the association of COPD and asthma exacerbation hospital 
discharges across NYC ZIP code tabulated areas (ZCTAs), after adjusting  for sociodemographic 
predictive factors (sex, age, race, income, poverty, educational attainment, and type of house 
heating fuel) and climatic predictive factors (temperature, precipitation, wind, relative humidity, 
and PM 2.5). This will be accomplished through a series of three Poisson regression models: the 
first is a general linear model (GLM), the second is a general linear mixed model (GLMM) with 
adjustment for temporal autocorrelation, and the third is a Bayesian spatio-temporal model with 
adjustment for spatio-temporal random effects variances.  
 
Hypotheses: It is hypothesized Poisson regression results will be best fitted after utilizing the 
Bayesian spatio-temporal approach to adjust for spatio-temporal autocorrelation. We further 
hypothesize results from our Bayesian spatio-temporal model will suggest sociodemographic 
predictive factors (including sex, age, race, income, poverty, educational attainment, and type of 
house heating fuel) and climatic predictive factors (including temperature, precipitation, wind, 
relative humidity, and PM 2.5) will increase the relative risk of COPD and asthma exacerbation 
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rates within both the inpatient and outpatient settings. We also hypothesize there will be spatio-
temporal variation in the associations between respiratory disease, climatic and 
sociodemographic covariates, and certain regions within NYC will have elevated risk relative to 
other regions. 
 
Specific Aim 3: To estimate the future burden of COPD and asthma-related hospital discharges 
across the entire city of New York with IPCC predicted temperature and precipitation measures, 
as well as predictive factors that are socio-demographic (age) and socio-economic (race and 
poverty) in nature. The sub-aims entail looking at similar associations using the following 
secondary outcomes: 1) Total charges and 2) Length of stay (LOS) (for inpatient settings only). 
The aims will be carried out using Bayesian spatio-temporal modelling to adjust for spatio-
temporal autocorrelation, which can lead to case observations from geographically close areal 
units and temporally close time periods to have more similar values than units and time periods 
that are further apart.89 
 
Hypotheses: We hypothesize the number of cases of respiratory-related hospitalizations (primary 
outcome), number of total charges (secondary outcome), and length of stay [for inpatient settings 
only] (secondary outcome) will increase into the year 2039 across New York City as a whole, 
given the IPCC predicted temperature and precipitation values, as well as the socio-economic 
and socio-demographic predictive covariates. 
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Chapter 2. The spatio-temporal distribution of Chronic Obstructive 
Pulmonary Disease and Asthmatic exacerbation across New York 
City from 2016 to 2018: A cluster analysis using space-time 
permutation modelling  
 
2.1 Introduction 
Individuals diagnosed with pre-existing respiratory disease remain vulnerable in regions most 
prone to a changing climate, and are susceptible to a respiratory exacerbation during periods of 
climate variability.1 Specifically, asthma and chronic obstructive pulmonary disease (COPD) are 
both known to decrease lung function into adulthood.2 As asthma and COPD are both 
incurable,3,4 and COPD stands as the third leading cause of death and second leading cause of 
disability in the United States,4,5 exacerbations of COPD and asthma determine a full range of 
difficulties.6 
 
The Role of Time and Space in Respiratory Exacerbation 
Despite progress in understanding spatial variation in population-based rates of COPD and 
asthma cases across NYC, there are few published studies assessing the manner with which these 
rates change over both space and time. In fact, little to no studies have either detected or have 
used statistical software that automatically adjusts for the location of both purely spatial and 
purely temporal clusters of COPD and asthma exacerbations across NYC and have evaluated 
their statistical significance. 
 
The aim of this study is to analyze spatial-temporal patterns of COPD and asthma exacerbation 
hospital discharges across NYC ZIP code tabulation areas (ZCTAs) (Figure 2.1) during the 
period 2016-2018, including identification of statistically significant clusters of elevated risk. 
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New York City was selected as the study area since this socioeconomically diverse city has a 
high burden of respiratory disease.29-31 An estimated 5% of adults aged 18 years or older in New 
York City (335,000 adults) report being told by a health care provider that they have COPD.32 
Furthermore, the current asthma prevalence for NYC adults is 7.1%.33 New York City children 
had an even higher prevalence of asthma (9.7%), compared to children residing in the rest of the 
state (7.4%) and adults in general.33 Due to its latitude position on the globe, New York City also 
has a varied climate with all four seasons. The availability of hospital discharge data within a 
reasonable timeframe was also a consideration when selecting the study time period. 
 
 
Figure 2.1: Map of New York City Zip Code Tabulation Areas (ZCTAs) that make up the study area 
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Hypotheses 
It is hypothesized rates of COPD and asthma exacerbation will vary across NYC ZCTAs and 
throughout the duration of the study period in a non-random manner.  
 
2.2 Methods 
Data 
This study combines health and spatial data from a variety of sources. The outcome of interest – 
hospital discharges related to COPD and asthma exacerbation episodes – are provided by the 
New York State (NYS) Statewide Planning and Research Cooperative System (SPARCS), after a 
limited dataset application, entailing a data use agreement, which does not contain any direct 
identifiers under HIPAA34,35. SPARCS consists of two geocoded datasets – an inpatient dataset 
of hospital discharges (including emergency department (ED) visits that subsequently result in a 
hospital admission) and an outpatient dataset that includes “treat and release” visits to the ED 
and visits to health care facilities certified under Article 28 of the New York State Public Health 
Law (NYSPHL)35. Article 28 facilities are hospitals, diagnostic and treatment centers (also called 
clinics), and nursing homes.35 In-hospital deaths from asthma or COPD are also included in this 
study. Due to data availability issues for hospital discharge information prior to 2016, only 
hospital discharge data from 2016-2018 are used as part of this study. NYC spatial designations 
are derived from specialized products described below. 
 
The NYS SPARCS hospital discharge data only provides patient-level address information as a 
5-digit United States Postal Service (USPS) ZIP code. However, USPS ZIP codes do not have 
specific geographic boundaries since they are simply assigned to ranges of addresses associated 
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with street segments. A ZIP code tabulation area, otherwise known as a ZCTA, is an 
approximate area representation of USPS five-digit ZIP Code service areas that the Census 
Bureau creates using whole blocks to present statistical data from censuses and the American 
Community Survey (ACS).36 Blocks that do not contain addresses but are completely surrounded 
by a single ZCTA (enclaves) are assigned to the surrounding ZCTA; those surrounded by 
multiple ZCTAs will be added to a single ZCTA based on limited buffering performed between 
multiple ZCTAs.36 ZCTAs are also defined by a 5-digit numeric code as well. There are some 
non-geographical ZIP Codes for which there are no corresponding ZCTAs. In NYC there are 
several small ZCTAs that cover nonresidential office buildings or public facilities, primarily in 
Midtown Manhattan.37 ZCTAs may also cross borough and/or county boundaries; in particular 
ZCTAs 11001, 11003, and 11040 are partially located in Queens, but a large majority of the land 
area and population are in Nassau County.37 
 
In order to convert residence postal ZIP codes from the NYS SPARCS hospital discharge data to 
ZCTAs, a crosswalk Microsoft Excel file was used, provided by the Geospatial Data Library at 
the City University of New York (CUNY) Baruch College.38 This file crosswalks all USPS ZIP 
Codes in the five boroughs of New York City to 2010 ZIP Code Tabulation Areas (ZCTAs) 
created by the US Census Bureau. This enables users working with address-based data to 
aggregate ZIP Codes to ZCTAs, in order to associate their data with census data published at the 
ZCTA level, and to map their data using ZCTA boundaries.39 It is a subset of the ZIP to ZCTA 
Crosswalk 2010 file provided by the Missouri Census Data Center40 and originally sourced from 
the Uniform Data System (UDS) mapper41. 
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The Baruch College Geospatial Data Library also provides a NYC Geodatabase37 with metadata 
for the individual layers and tables in the NYC Geodatabase (‘nyc_gdb’), for mapping and 
analyzing city-level features and data in GIS. The geodatabase is made available on a Spatialite 
version 4.1.1 format built on SQLite version 3.8.8.2 that can be used in an open source software 
like QGIS version 3.10.2. The individual geodatabase layer used for this study was ‘a_zctas’, 
which is a multi-polygon layer representing ZCTAs. It is a subset of the U.S. Census TIGER 
ZCTA file, re-projected to local state plane and modified by subtracting a subset of the U.S. 
Census TIGER water layer (a_water_coastal) to create land-based boundaries.37 
 
COPD and/or Asthma Exacerbation 
The outcome of interest was obtained from NYS SPARCS, which was measured by 
International Classification of Diseases 10th Revision Codes (ICD-10CM)42,43 pertaining to 
either a COPD exacerbation: 
J44.1 for “Chronic obstructive pulmonary disease with acute exacerbation, unspecified,” 
Or an asthma exacerbation: 
J45.21 for “Mild intermittent asthma with [acute] exacerbation,” 
J45.31 for “Mild persistent asthma with [acute] exacerbation,”  
J45.41 for “Moderate persistent asthma with [acute] exacerbation,” 
J45.51 for “Severe persistent asthma with [acute] exacerbation,”   
J45.901 for “Unspecified asthma with [acute] exacerbation.” 
 
 
 
30 
 
Type of Diagnosis Code 
Data on the type of diagnosis code was obtained from NYS SPARCS, which indicates whether a 
diagnosis was “PR” Principal; “OT” Other; “EX” External Cause of Injury; “AD” Admitting; 
“RV” Reason for Visit.35 For this study, only ‘Admitting Diagnosis (AD)’ was used for the 
inpatient dataset as it more accurately represents reason for patient admission into the hospital 
after assessment by a physician, as compared to ‘Principal Diagnosis’ which may simply reflect 
suspected cause of presentation to the hospital. Only ‘Reason for Visit (RV)’ was used for the 
outpatient dataset.  
 
Discharge Date 
Discharge data for each patient record was provided by the NYS SPARCS hospital discharge 
dataset. Discharge data was provided for each patient record in month and year format, between 
January 2016 through December 2018. 
 
Population Data 
Population data in NYC for the 3-year time period 2016 - 2018 was collected for computation of 
COPD and asthma-related discharge rates per NYC neighborhood per year. This data was be 
derived from U.S. Census Bureau population estimates from the 2010 U.S. Census.  
 
NYC Spatial Designation 
The NYC spatial designation was derived from the CUNY Baruch College NYC Geodatabase, 
which contained an individual database layer for NYC ZCTAs. The spatial designation was used 
to assign each patient hospital record to a specific ZCTA within NYC, after cross-walking NYC 
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ZIP codes to ZCTAs. ZCTAs were also linked to their corresponding latitude and longitudinal 
coordinates using data obtained from the US Census Gazetteer44 files.  
 
Analyses 
Data Preparation 
NYS SPARCS Hospital discharge data information was prepared using SAS version 9.4, as per 
NYS SPARCS data usage guideline recommendations35. Data was provided in a total of six (6) 
datasets organized by year of discharge (2016, 2017 and 2018) and by inpatient/outpatient status: 
2016 Inpatient (2016 IP) 
2016 Outpatient (2016 OP) 
2017 Inpatient (2017 IP) 
2017 Outpatient (2017 OP) 
2018 Inpatient (2018 IP) 
2018 Outpatient (2018 OP) 
The 6 SPARCS hospital discharge datasets were also provided using SAS format consisting of 
14 relational tables. For the purposes of this study, only the following 3 relational tables were 
kept: 
Location 
Diagnosis 
Claim 
For each dataset, patient records were linked across tables by the Claim Transaction ID variable 
(clm_trans_ID). Within SAS, discharge data was filtered by “Diagnosis Code” using the ‘Query’ 
function to filter for COPD and asthma exacerbation ICD-10 diagnosis codes42,43: ‘J441’ for 
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COPD with acute exacerbation, unspecified, ‘J4521’ for mild intermittent asthma with [acute] 
exacerbation, ‘J4531’ for mild persistent asthma with [acute] exacerbation, ‘J4541’ for moderate 
persistent asthma with [acute] exacerbation, ‘J4551’ for severe persistent asthma with [acute] 
exacerbation, and ‘J45901’ for unspecified asthma with [acute] exacerbation. Discharge data was 
then filtered by “Diagnosis Type Code” using the ‘Query’ function to filter for ‘Admitting 
Diagnosis (AD)’ (inpatient dataset) and ‘Reason for Visit (RV)’ (outpatient dataset). Rows with 
missing information on any of the 4 final variables were omitted from the final 6 datasets to be 
used for analysis.  
 
The final 6 datasets were imported into R Studio version 1.2.5033 using the R ‘Haven’ library 
package. Using the R ‘Dplyr’ library package, the datasets were converted into R data frames for 
easier data manipulation and only the following three (3) variables were retained: 
Patient 5-digit ZIP code (pat_address_zip 5) 
ICD-10 diagnosis code (dx_cd) 
Discharge date (disch_dt) 
ICD-10 diagnosis codes were extracted from each of the 6 data frames using the ‘subset’ 
function within R, where a new dataset was created for each diagnosis (COPD, asthma) and each 
year (2016, 2017, 2018). The following data frames resulted: COPD 16 IP, COPD 16 OP, COPD 
17 IP, COPD OP, COPD 18 IP, COPD 18 OP, Asthma 16 IP, Asthma 16 OP, Asthma 17 IP, 
Asthma 17 OP, Asthma 18 IP, and Asthma 18 OP. These data frames were then condensed into 
the final 4 data frames using the ‘rbind’ function in R, in order to distinguish between overall 
‘disease-medical facility setting’: 
COPD Exacerbation Inpatient (COPD IP) 
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COPD Exacerbation Outpatient (COPD OP) 
Asthma Exacerbation Inpatient (Asthma IP) 
Asthma Exacerbation Outpatient (Asthma OP) 
 
Cross-walking NYS SPARCS discharge data from ZIP codes to ZCTAs 
The Microsoft Office Excel crosswalk file provided by the Baruch College geospatial library, 
‘zip_to_zcta10_nyc_revised’, was imported into R Studio. In addition, the US Census provides 
the US Gazetteer Files that makes available all geographic areas for selected geographic area 
types including representative latitude and longitude coordinates.44 A comma separated value 
(CSV) file that lists all NYC ZCTAs and their corresponding latitude and longitudinal 
coordinates (‘2013_Gaz_zcta_national’) was obtained from the US Gazetteer files and imported 
into R Studio.  
 
Both imported files, ‘zip_to_zcta10_nyc_revised’ and ‘zipcode_coordinates’, were then merged 
to create a final ZIP code to ZCTA crosswalk dataset with corresponding latitude and 
longitudinal coordinates. This crosswalk dataset was then merged with each of the final 4 patient 
record data frames by ZIP code, resulting in cross-walked ZCTAs for each ZIP code linked to a 
patient record. Corresponding latitude and longitudinal coordinates were also kept. Unmatched 
ZIP code data were removed because it revealed patient ZIP codes that did not fall within the 
NYC region (e.g., if a patient record had a ZIP code of ‘00602’, it was not included into the 
merged data frame because this represents an instance where a patient was seen at a  NYC 
medical facility but their place of legal residence lies outside of NYC). Each data frame was then 
cleaned to remove the ZIP code variable. 
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Counting Number of Discharges per ZCTA 
Using the ‘arrange’ function within R ‘dplyr’ library package, each of the final 4 data frames 
were sorted by ZCTA and then by discharge month. Next, using the ‘count’ function within the 
same library package, the number of discharges were counted based on ZCTA primarily, and 
then by discharge date secondarily. The results from the ‘arrange’ and ‘count’ functions were 
saved into a new data frame and converted into a CSV file. This was done for each of the final 4 
data frames. 
 
Spatial and Temporal Adjusted Cluster Detection and Evaluation 
Statistically significant spatio-temporal clusters of COPD and asthma exacerbation events were 
detected in the study area through the space-time scan statistic, as encoded in SaTScan software 
version 9.6.45 This method evaluates many possible clusters due to space-time interaction in the 
form of cylindrical windows on the map, where the size of the circular base represents the 
geographic area depending on the number of contiguous circles, and the height of the cylindrical 
window reflects the time period of potential clusters. For the space-time permutation model, the 
analysis automatically adjusts for both temporal trends and temporal clusters. If there is an 
increasing temporal trend in the data, then the space-time scan statistics will pick up that trend by 
assigning a cluster during the end of the study period. If there is a decreasing trend, it will instead 
pick up a cluster at the beginning of the time period.45 This method automatically adjusts for 
spatial clusters as well by adjusting the expected count separately for each location, removing all 
purely spatial clusters, then stratifying by location ID to ensure that each location has the same 
number of events in the real and random data sets.45  
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A space-time permutation model is used to search for increases in COPD and asthma 
exacerbation episodes across the study area during the three-year study period. This cluster 
search was retrospective, with the space unit represented by ZCTAs and the time unit 
represented by months. Using this model, a cylindrical window is moved in space and time so 
that for each possible geographical location and size, each possible time period is also visited.45 
The number of observed and expected observations inside the window at each location is noted 
in order to evaluate the potential clusters in a geographical area during a specific time period, 
and to compare whether or not these clusters have a higher proportion of its cases in that time 
period relative to the remaining geographical areas. For each potential cluster with risk that is 
elevated relative to everywhere in the study area outside of the cluster in that time period, the 
null hypothesis is tested whereby the elevated cluster is assumed to have occurred from random 
chance alone.46  
 
Statistical significance of the clusters was established by comparing the observed likelihood ratio 
of each cluster to the null distribution generated from 999 Monte Carlo replications 47 of the 
maximum likelihood ratio, where cases are randomly distributed across space and time.48 A 
statistically significant cluster was identified if there was no more than a 5% chance of 
incorrectly rejecting the null hypothesis that a cluster with elevated risk was from random 
variation (p ≤ 0.05). 
 
Analyses were conducted separately for each diagnosis-medical facility setting within the study 
time period: COPD exacerbation inpatient (COPD IP), COPD exacerbation outpatient (COPD 
OP), asthma exacerbation inpatient (asthma IP) and asthma exacerbation outpatient (asthma OP). 
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In running the four models, the maximum cluster size was designated as up to 50% of the 
population at risk (the maximum), p-values were based on 999 iterations (results were the same 
for 9,999 iterations), and there was no geographic overlap among clusters.45,46 All the clusters 
with a p-value of ≤ 0.05 were mapped in qGIS version 3.10 by convex polygons, bounded by 
latitude and longitudinal coordinates.  
 
2.3 Results 
Table 2.1 presents a description of the study population by diagnosis, medical facility setting and 
diagnosis-medical facility setting. Of the 300 745 total respiratory (asthma and COPD) 
exacerbation cases included in the study across the 214 NYC ZCTAs during the 2016 – 2018 
period, 243 336 cases (80.91%) were asthma-related and 57 409 cases (19.09%) were COPD-
related. Respiratory exacerbation cases occurring in the inpatient medical facility setting made 
up 21.18% (63 686 cases) of the total population, while cases occurring in the outpatient setting 
made up 78.82% (237 059 cases). Of the asthma exacerbation episodes, 10.25% (30 828 cases) 
occurred in the inpatient medical facility setting and 70.66% (212, 508 cases) were outpatient. Of 
the COPD exacerbation episodes, 10.93% (32, 858 cases) occurred in the inpatient medical 
facility setting and 8.16% (24, 551 cases) were outpatient. 
 
The distribution of respiratory exacerbation cases by diagnosis and medical facility setting at the 
level of NYC neighborhood is summarized in Table 2.2. Due to NYS DOH SPARCS small-cell 
regulations, all cells less than 6 must be suppressed. Therefore, Table 2.2 summarizes case 
counts and population-based rates (per 1000 individuals) for each NYC neighborhood (as 
opposed to NYC ZCTAs) as per the DOH definitions of NYC neighborhoods by ZIP codes 
cross-walked to ZCTAs.49 The highest population-based rates for ‘asthma-inpatient’ could be 
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seen in the Hunts Point and Mott Haven neighborhoods of the Bronx (12.79 per 1000 
individuals), and for ‘asthma-outpatient’ could be seen in the East Harlem neighborhood of 
Manhattan (93.61 per 1000 individuals). The highest population-based rates for ‘COPD-
inpatient’ and ‘COPD-outpatient’ could both be seen in the Battery Park neighborhood of 
Manhattan with rates 293.33 and 175.41 per 1000 individuals, respectively. 
 
Type of Respiratory 
Exacerbation 
Diagnosis 
Medical Facility 
Setting 
Case Counts 
  
Number of 
ZCTAs 
Percent 
  
Asthma   243,336 80.91 214 
COPD   57,409 19.09 214 
  Inpatient 63,686 21.18 214 
  Outpatient 237,059 78.82 214 
Asthma Inpatient 30,828 10.25 214 
Asthma Outpatient 212,508 70.66 214 
COPD Inpatient 32,858 10.93 214 
COPD Outpatient 24,551 8.16 214 
Total   300,745   214 
Table 2.1: Description of the study population with case counts and corresponding percent respiratory (Asthma and COPD) 
exacerbation episodes by: diagnosis, medical facility setting and diagnosis-medical facility setting. 
 
Space-time permutation cluster analysis 
The asthma exacerbation cluster search with the space-time permutation approach detected ten 
statistically significant clusters during the study period for ‘Asthma-Inpatient’ and four 
statistically significant clusters during the study period for ‘Asthma-Outpatient’ (Table 2.3). The 
COPD exacerbation cluster search with the space-time permutation approach detected three 
statistically significant clusters during the study period for ‘COPD-Inpatient’ and nine 
statistically significant clusters during the study period for ‘COPD -Outpatient’ (Table 2.3).
 
1 
A temporal description, as measured in seasons, of the timeframe for each statistically significant 
cluster is also presented in Table 2.3. For asthma exacerbation episodes across both medical 
facility settings, Summer 2018 appeared in the most statistically significant clusters for a total of 
8 clusters. Spring 2018 and Autumn 2018 followed, each appearing in a total of 6 statistically 
significant clusters. Winter 2017 was also among the top seasons, appearing in 4 statistically 
significant clusters. For COPD exacerbation episodes across both medical facility settings, 
Summer 2016 appeared in the most statistically significant clusters for a total of 5 clusters. Other 
seasons appearing in exactly four of the statistically significant COPD exacerbation clusters 
included Winter 2016, Spring 2016, Autumn 2017, Winter 2017, Spring 2018 and Summer 2018. 
Across total respiratory (asthma and COPD) exacerbation, Summer 2018 notably appeared in 12 
statistically significant clusters across total respiratory exacerbations and Spring 2018 appeared 
in 10 statistically significant clusters. 
 
The distribution of ‘Asthma-Inpatient’ exacerbation episodes at the ZCTA level is presented in 
Figures 2.2 - 2.5. Most of the significant asthma exacerbation inpatient clusters occurred in the 
second half of the study period, indicating increased inpatient hospitalizations for asthma 
exacerbation diagnoses throughout the five boroughs of NYC beginning with Lower Manhattan 
(Wall Street, Tribeca), as well as other neighborhoods in Manhattan including Chelsea, Clinton, 
Gramercy Park, Murray Hill, Meatpacking District, Garment District, East Village, City Hall and 
Lower East Side (Figure 2.2). The borough of Queens also saw increased inpatient 
hospitalizations for asthma exacerbation diagnoses with patients residing in Bayside, Central 
Queens, North Queens, Rego Park, West Queens, Maspeth, Ridgewood, West Central Queens 
and Woodhaven. Within Brooklyn, increased asthma exacerbation inpatient hospitalizations 
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occurred in East New York, Bay Ridge, Southwest Brooklyn, Bedford Stuyvesant, Bushwick and 
Williamsburg, Crown Heights, Northwest Brooklyn, Prospect Heights and Prospect Leffert. 
Staten Island saw increased hospitalizations in Stapleton and St. George, and Bronx within the 
neighborhoods of Bronx Park, Fordham, Central Bronx, Northeast Bronx, Riverdale and 
Southeast Bronx. One cluster was identified in Queens within the first half of the study period 
(March through August 2017). The neighborhoods part of this cluster were Central Queens, 
Douglaston, Jamaica, Oakland, Southeast Queens, and Utopia. This area was the only one with 
increased asthma exacerbation inpatient hospitalizations in the first half of the study period. 
 
 
Figure 2.2: Location of statistically significant (p ≤ 0.05) asthma exacerbation inpatient clusters by order of statistical 
significance, New York City, 2016–2018, for space-time permutation cluster search. 
 
Most of the significant asthma exacerbation outpatient clusters occurred in the second half of the 
study period, indicating increased outpatient visits for asthma exacerbation diagnoses throughout 
 
3 
the five boroughs of NYC beginning with Northwest Staten Island (Figure 2.3). The boroughs of 
Bronx and Manhattan also saw increased outpatient hospitalizations for asthma exacerbation 
diagnoses with patients residing throughout majority of Bronx and within the Manhattan 
neighborhoods of Inwood, Washington Heights, Lower Manhattan and Midtown. Within 
Queens, increased asthma exacerbation outpatient hospitalizations occurred in Hunter’s Point. 
One cluster was identified spanning across Brooklyn and Queens within the first half of the study 
period (March through August 2016). The neighborhoods part of this cluster were Eastern 
Brooklyn, Central Queens, and Southwest Queens. This area was the only one with increased 
asthma exacerbation outpatient hospitalizations in the first half of the study period. 
 
 
Figure 2.3: Location of statistically significant (p ≤ 0.05) asthma exacerbation outpatient clusters by order of statistical 
significance, New York City, 2016–2018, for space-time permutation cluster search. 
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Most of the significant COPD exacerbation inpatient clusters occurred in the first half of the 
study period, indicating increased inpatient hospitalizations for COPD exacerbation diagnoses in 
Clinton and Midtown West (Manhattan) as well as Silver Lake and West Brighton (Staten 
Island) (Figure 2.4). One cluster spanning across neighborhoods within Bronx and Manhattan 
was identified in the second half of the study period (September 2017 through May 2018). The 
neighborhoods part of this cluster included Melrose and Highbridge (Bronx), as well as 
Washington Heights (Manhattan). This area was the only one with increased COPD exacerbation 
inpatient hospitalizations in the second half of the study period. 
 
 
Figure 2.4: Location of statistically significant (p ≤ 0.05) COPD exacerbation inpatient clusters by order of statistical 
significance, New York City, 2016–2018, for space-time permutation cluster search. 
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The significant COPD exacerbation outpatient clusters occurred throughout the entire study 
period (Figure 2.5). The significant clusters in the first half of the study period were in 
Bensonhurst, Brooklyn (February 2017 through April 2017), NoHo and SoHo, Manhattan 
(November 2016 through January 2017), West Central Queens (January 2016 through July 
2016), Northeast Brooklyn (January 2016 through July 2016), Bathgate Bronx (June 2016 
through November 2016), and other neighborhoods of the Bronx including Mott Haven, Melrose 
and Longwood (February 2016 through April 2017). The significant clusters of COPD 
exacerbation outpatient visits in the second half of the study period included the entire borough 
of Staten Island, as well as Southwest Brooklyn and Richmond Hill in Queens (December 2017 
through November 2018). Another significant cluster in the second half of the study period 
(August 2017 through March 2018) included Inwood and Washington Heights neighborhoods of 
Manhattan, as well as Mid-West Bronx. An additional significant cluster during the second half 
of the study period (April 2018 through August 2018) spanned Long Island City and Steinway 
within Queens, and Upper West Side within Manhattan. The neighborhoods of Rockaway Park 
and Belle Harbor within Queens saw a significant cluster in the second half of the study period 
(April 2018 through July 2018) as well. 
 
The average number of cases included in the asthma exacerbation inpatient clusters was 154.3 
cases. The cluster including the largest number of asthma exacerbation inpatient hospitalization 
was located within border neighborhoods of Brooklyn (Bedford Stuyvesant, Bushwick and 
Williamsburg, Crown Heights, Northwest Brooklyn, Prospect Heights, and Prospect Leffert) and 
Manhattan (City Hall and Lower East Side), with 395 cases. This cluster spanned from October 
through December 2018. The average duration of the asthma exacerbation inpatient clusters was 
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2.8 months. The clusters with the longest duration were in Manhattan (Chelsea and Clinton, 
Meatpacking District, Garment District, and East Village) and Queens (Central Queens, 
Douglaston, Jamaica, Oakland, Southeast Queens, and Utopia), each with 6 months (Table 2.3). 
 
Figure 2.5: Location of statistically significant (p ≤ 0.05) COPD exacerbation outpatient clusters by order of statistical 
significance, New York City, 2016–2018, for space-time permutation cluster search. 
 
The average number of cases included in the asthma exacerbation outpatient clusters was 4,896 
cases. The cluster including the largest number of asthma exacerbation outpatient hospitalization 
was located within border neighborhoods of Bronx (Northeast Bronx, Southeast Bronx, Central 
Bronx, Hunts Point and Mott Haven, Bronx Park and Fordham, Kingsbridge and Riverdale) and 
Manhattan (Inwood and Washington Heights), with 8,555 cases. This cluster spanned from 
September through December 2018. The average duration of the asthma exacerbation outpatient 
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clusters was 7.5 months. The cluster with the longest duration was in Northwest Staten Island 
(Port Richmond, Silver Lake, Bull's Head, and Grymes Hill) with 12 months (Table 2.3). 
 
The average number of cases included in the COPD exacerbation inpatient clusters was 212 
cases. The cluster including the largest number of COPD exacerbation inpatient hospitalization 
was located within border neighborhoods of Bronx (Melrose and Highbridge) and Manhattan 
(Washington Heights), with 481 cases. This cluster spanned from September 2017 through May 
2018. The average duration of the COPD exacerbation inpatient clusters was 5.7 months. The 
cluster with the longest duration was located within neighborhoods of Bronx (Melrose and 
Highbridge) and Manhattan (Washington Heights) with 9 months (Table 2.3). 
 
The average number of cases included in the COPD exacerbation outpatient clusters was 345.4 
cases. The cluster including the largest number of COPD exacerbation outpatient hospitalization 
was located within border neighborhoods of Queens (Elmhurst, Maspeth, Ozone Park, West 
Central Queens, Woodhaven, and Woodside) and Brooklyn (Bushwick and Williamsburg, 
Brownsville, Crown Heights, East New York, Ocean Hill, City Line), with 964 cases. This 
cluster spanned from January through July 2016. The average duration of the COPD 
exacerbation outpatient clusters was 7.2 months. The cluster with the longest duration was in 
South Bronx (Mott Haven, Melrose, and Longwood) with 15 months (Table 2.3). 
 
The statistically significant clusters for respiratory exacerbation medical visits by ‘diagnosis-
setting’ are summarized with their respective timeline in Figures 2.6 and 2.7, followed by a 
temporal summary of observed and expected counts over time in Figures 2.8, 2.9, 2.10 and 2.11. 
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There were a few neighborhoods in each borough that appeared in both statistically significant 
asthma exacerbation clusters for clusters with the longest duration within both the inpatient and 
outpatient settings. In Manhattan, they include: Chelsea & Clinton (appearing in 2 asthma IP 
clusters for 6 months & 1 month respectively, and 7 months for OP), and City Hall & Lower East 
Side (3 months IP, 7 months OP for each); then in Queens: West Central Queens (predominantly 
Maspeth) (1 month IP, 6 months OP), and Jamaica (6 months IP, 6 months OP); In Brooklyn: 
Bushwick, Williamsburg & Prospect Leffert (3 months IP, 6 months OP); in Staten Island: Silver 
Lake, Stapleton & St. George/Silver Lake (4 months IP, 12 months OP); and finally in the 
Bronx: Bronx Park & Fordham, Kingsbridge & Riverdale, Northeast & Southeast Bronx, and 
Central Bronx (all 1 month IP, 4 months OP). 
 
The Melrose neighborhood within the Bronx appeared in both statistically significant COPD 
exacerbation clusters for clusters with the longest duration within both inpatient and outpatient 
settings (Figure 2.7). The persistence of the Melrose, Bronx cluster can also be seen in the 
timeline summary of observed and expected counts over time (Figures 2.10 and 2.11). No other 
areas had persistent and significant clusters in the same location for an average of 12 months (9 
months for inpatient and 15 months for outpatient) of the study period (Figures 2.6, 2.7, 2.8, 2.9, 
2.10 and 2.11). 
 
The Silver Lake (part of Stapleton and St. George), Staten Island ZCTA neighborhood appeared 
across all statistically significant respiratory (asthma and COPD) exacerbation clusters within 
both the inpatient and outpatient settings. No other ZCTA was persistent and significant across 
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all four ‘diagnosis-settings’ (asthma inpatient, asthma outpatient, COPD inpatient and COPD 
outpatient) for all three years of the study period (Tables 2.4 and 2.5).  
 
 
Figure 2.6: Statistically significant asthma exacerbation neighborhood clusters, New York, 2016-2018, by spatial-temporal 
analysis. 
 
 
Figure 2.7: Statistically significant COPD exacerbation neighborhood clusters, New York, 2016-2018, by spatial-temporal 
analysis. 
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Borough 
Matching COPD 
ZCTAs Neighborhood 
Manhattan 10032 Washington Heights 
Manhattan 10033 Washington Heights 
Staten Island 10301 Silver Lake (Stapleton and St. George) 
Staten Island 10302 West Brighton 
Staten Island 10310 West Brighton 
Bronx 10452 Highbridge 
Bronx 10456 Melrose 
Table 2.2: Statistically significant ZCTA’s with corresponding neighborhoods appearing within both inpatient and outpatient 
settings for space-time permutation COPD exacerbation cluster search, New York City, 2016-2018. 
 
There were a couple of ZCTA neighborhoods appearing in statistically significant asthma 
exacerbation clusters across both the inpatient and outpatient settings (Table 2.4). Within 
Manhattan, the ZCTA neighborhoods of Chelsea, City Hall, East Village, Lower East Side, 
Meatpacking District, Midtown West, Theatre District, Tribeca, Turtle Bay, and Upper West 
Side all appeared. Within Staten Island, there were the ZCTA neighborhoods of Silver Lake and 
Grymes Hill. Within Bronx, the ZCTA neighborhoods of Bathgate, Belmont, Bronx Park South, 
Coop City, Eastchester Bay, Jerome Park, Morris Heights, North Baychester, Pelham Gardens, 
Riverdale, Soundview Bruckner, Southeast Bronx, Van Cortlandt Park, Van Nest, Wakefield, 
and Westchester Square all appeared. Within the borough of Brooklyn, the neighborhoods of 
Bushwick, Prospect Heights, Prospect Leffert, and Ridgewood were included. Within the 
borough of Queens, the neighborhoods of Elmhurst, Glendale, Jamaica Hills, Kew Garden Hills, 
Maspeth, Middle Village, Rego Park, St. Albans, and Woodhaven all appeared across both 
inpatient and outpatient asthma exacerbation settings. 
 
A few ZCTA neighborhoods appeared in statistically significant COPD exacerbation clusters 
across both the inpatient and outpatient settings (Table 2.5). They included Melrose and 
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Highbridge ZCTAs within Bronx, Brighton and Silver Lake within Staten Island, and 
Washington Heights within Manhattan. 
 
The Highbridge ZCTA neighborhood within the Bronx appeared in statistically significant 
asthma outpatient, COPD inpatient and COPD outpatient exacerbation clusters. However, it did 
not appear in statistically significant asthma inpatient clusters. 
 
There were no persistent ZCTAs that appeared across all statistically significant inpatient 
respiratory (asthma and COPD) exacerbation cluster searches. However, there were several 
ZCTA neighborhoods that appeared across all statistically significant outpatient respiratory 
(asthma and COPD) exacerbation cluster searches (Table 2.6). They included neighborhoods 
within all five NYC boroughs: Manhattan (NoHo/SoHo, Inwood, Upper West Side and 
Washington Heights), Staten Island (Grymes Hill, Mariners Park, Silver Lake – part of Stapleton 
and St. George, and West Brighton), Bronx (Bathpage, Highbridge, Jerome Park, Longwood, 
Melrose, Morris Heights, and Mott Haven), Brooklyn (Brownsville, Bushwick, City Line, Crown 
Heights, East New York, Ocean Hill and Williamsburg), and Queens (Elmhurst, Forest Hills, 
Glendale, Maspeth, Middle Village, Ozone Park, Richmond Hill, Ridgewood, Rego Park, and 
Woodhaven). 
 
2.4 Discussion 
In the present study, the analyses identified statistically significant clusters of asthma and COPD 
exacerbation medical visits in specific ZCTAs of New York City from 2016 to 2018. Those 
clusters were persistent in the Silver Lake ZCTA, part of the Staten Island neighborhood of 
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Stapleton and St. George, across all four ‘diagnosis-setting’ space-time permutation analyses. 
This finding is similar to a recent study which found higher positive relation between obesity and 
asthma hospitalizations in all New York City, with high significance value in northern Staten 
Island.51    
 
The Melrose ZCTA part of the South Bronx borough was persistent for the longest duration of 
the study period in both COPD inpatient and outpatient exacerbation space-time permutation 
analyses. The Melrose neighborhood of the South Bronx, as well as the Inwood and Washington 
Heights neighborhoods of Northern Manhattan, were also statistically significant across three of 
the space-time permutation analyses (Asthma inpatient, COPD inpatient, and COPD outpatient). 
Although there is limited COPD research within this region, the research findings within this 
study are consistent with the available research on spatio-temporal asthma hospitalizations 
within NYC. There is a high percentage of urban populations residing near major roadways and 
the high prevalence of urban asthma.52 The literature shows an average of 45% of children 
residing in Manhattan and the Bronx live within 400-480 m of a state or county highway and 
zones of elevated concentrations of traffic-related pollutants.53 These children presented with 
wheeze, asthma and high levels of immunoglobulin (Ig) E.53,54  
 
Another study assessing asthma hospitalizations within New York City found the Bronx, East 
Harlem and some neighborhoods in North/Central Brooklyn close to some of the biggest 
highways of the city (e.g., Brooklyn-Queens Expressway, Long Island Expressway) and having 
the highest hospitalization rates of the whole city, together with the highest pollution level of all 
the neighborhoods excluding the wealthiest areas of Manhattan.51 They further found those areas 
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with the highest hospitalization rates also had the highest poverty rate as well as the lowest 
percentage of insured people in the city.51  
 
This study also identified statistically significant outpatient respiratory (asthma and COPD) 
exacerbation clusters across all five NYC boroughs: Manhattan (NoHo/SoHo, Inwood, Upper 
West Side and Washington Heights), Staten Island (Grymes Hill, Mariners Park, Silver Lake – 
part of Stapleton and St. George, and West Brighton), Bronx (Bathpage, Highbridge, Jerome 
Park, Longwood, Melrose, Morris Heights, and Mott Haven), Brooklyn (Brownsville, Bushwick, 
City Line, Crown Heights, East New York, Ocean Hill and Williamsburg), and Queens 
(Elmhurst, Forest Hills, Glendale, Maspeth, Middle Village, Ozone Park, Richmond Hill, 
Ridgewood, Rego Park, and Woodhaven). These findings align with the current research which 
shows race seemed to play a role on asthma exacerbation hospitalizations, where the highest 
percentage of the NYC population identifying as black reside in the Bronx, in Harlem and East 
Harlem, Southeast Queens and East Brooklyn, especially Crown Heights, Flatbush and 
Brownsville.51  
 
Each statistically significant cluster was presented temporally by season in Table 2.3. There was 
a consistent amount of Spring 2018 and Autumn 2018 timeframes appearing in statistically 
significant clusters across total respiratory exacerbations. The population strata may help explain 
temporal clusters, where the sociodemographic makeup may explain some of the variation of 
clusters across time. For example, the population is aging over time leading to age, period and 
cohort (APC) as different sources of health-related change. First, individuals can age, meaning 
that they change as they progress through their life course. Second, change can occur over time 
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due to differences between cohort groups, whereby as new cohorts replace old cohorts, the social 
composition (and thus the health) of society as a whole can change. Third, and finally, change 
can occur as a result of period effects, whereby passage through time results in a change in 
health, regardless of the age of the individual.55 
  
Meteorological conditions may have also played a role on the seasonal rates of respiratory 
exacerbation, where the National Oceanic and Atmospheric Administration (NOAA) stated New 
York set/tied their all-time warmest minimum temperature records for October 2018, falling 
under the Autumn 2018 timeframe.56 Low temperatures ranged from 70 degrees F (21 degrees C) 
to 72 degrees F (22 degrees C) throughout New York on October 9, 2018.56 It was also the 
coldest Thanksgiving Day on record for New York, with temperature lows in NYC ranging from 
38.1 degrees F (3.4 degrees C) to 40.5 degrees F (4.7 degrees F).56 In addition, a nor’easter 
moved through NYC on March 21, 2018, contributing to Kennedy Airport, New York City 
having their snowiest spring on record.56 This storm brought along the greatest snowfall totals 
reported in New York to date, causing schools to close throughout NYC and more than 5,000 
flights to be cancelled. A late Autumn storm also moved through New York from November 15 
to 16, 2018 and dropped mixed precipitation and up to 18 inches (46 cm) of snow on the 
region.56 Kennedy Airport in New York City had their greatest 1-day snowfall for November, 
with 6.4 inches (16 cm) and 4.8 inches (12 cm), respectively.56 The storm also made it Kennedy 
Airport's snowiest November on record.56 For Central Park in New York City, it was the earliest 
6+ inch (15 cm) snowstorm on record.56  
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A strength of this study is the analysis of space-time permutation for respiratory exacerbation 
across New York City at the level of the ZCTA. USPS ZIP Codes lack a pre-defined geographic 
area so the USPS assigns ZIPs to ranges of addresses associated with street segments. However, 
the ZCTA is composed of aggregated census blocks where most addresses have the same ZIP 
Code. In addition, the research shows there is substantially more spatial variability at the 
neighborhood than at the county level for asthma-related emergency department (ED) visits 
within New York City.57 One study found neighborhood variability was especially notable for 
asthma-related ED visits where county-level rates vary four-fold, with highest rates in the 
Bronx.57 They further found hospitalizations for respiratory causes varied by eight-fold across 
United Hospital Fund (UHF) neighborhood, with highest rates in the Bronx and Northern 
Manhattan while rates only vary by 1.8-fold at the county level.57 
 
Clustering in the outpatient analyses were more sporadic. Outpatient medical visits tend to be 
less severe, where patients are usually admitted into a hospital to treat more serious forms of the 
condition. Furthermore, SPARCS data is unable to capture visits at the local level such as within 
medical provider clinics, unless the case is serious enough to require immediate referral to a 
hospital. These findings emphasize the importance of inpatient hospitalizations as a clearer 
indicator of population-level health impacts. Additionally, the space-time cluster analysis 
demonstrated increased asthma exacerbation episodes in the second half of the study, whereas 
there were increased COPD exacerbation episodes in the first half of the study. Further studies 
may be carried out to analyze climatic events (e.g., heat waves, hurricanes, blizzards) within 
these time periods which may have contributed to the temporal associations with respiratory 
exacerbation determined in this study. This can also include analyses to include climatic 
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variables such as temperature and precipitation maximums, as well as wind and relative humidity 
averages. 
 
2.5 Conclusion 
In summary, this study addresses important problems in the fields of public health, 
environmental health, climate science, health care, and sociology. In particular, it addresses the 
need for focused studies in major cities such as New York City, where there are diverse 
sociodemographic classes residing in different geographic regions who experience adverse health 
effects from climate patterns in varying ways.  
 
The results from this study largely agree with the original hypothesis. Rates of COPD and 
asthma exacerbation varied across NYC ZCTAs and throughout the study period. Aligning with 
current research,54,58 our study found the difference in COPD and asthma exacerbation rates were 
highest in areas appearing close in proximity to major highways and facilities with pollutant 
emissions. The literature also cites those areas with the highest hospitalization rates also have the 
highest positive association between obesity and asthma16, the highest poverty rate as well as the 
lowest percentage of insured people in New York City 51  
 
‘Summer 2018’ and ‘Spring 2018’ appeared in the most amount of statistically significant 
clusters across total respiratory exacerbation episodes, indicating that seasonal allergies may 
have played a role. Furthermore, the summer and winter seasons were among the most persistent. 
For example, ‘Summer 2018’ appeared in the most statistically significant asthma exacerbation 
episodes across both medical facility settings for a total of 8 clusters. ‘Winter 2017’ was also 
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among the top seasons, appearing in 4 statistically significant clusters. For COPD exacerbation 
episodes across both medical facility settings, ‘Summer 2016’ appeared in the most statistically 
significant clusters for a total of 5 clusters.  
 
This study has several limitations, including the 3-year time period. Traditionally, scientists have 
defined a ‘Climate Normal’ as an average over a recent 30-year period simply because it is the 
accepted convention.59  In addition, this may have affected the inconsistency of statistically 
significant clusters of high respiratory exacerbation rates witnessed over time and season.  
However, the results of this study can be used to inform future research with the capability of 
accessing respiratory exacerbation for a longer period of time.  
 
Misclassification of case location could have also occurred, because addresses and geocoded 
coordinates can be subject to errors.60 In addition, cases may spend a majority of their time 
outside of their place of residence such as work and/or school, so the ZCTAs recorded for the 
cases may not represent the locations where they may have highest exposure to risk factors for a 
respiratory exacerbation. However, respiratory exacerbation is usually an emergency so patients 
are sent to the hospital or article 28 medical facility nearest their current location, which may 
very likely be work or home. Further, these limitations are hypothetical in nature and there is no 
available evidence that these potential location errors are systematic. Therefore, they should be 
minimized by the use of ZCTAs as the unit of analysis, as done in this study, rather than the 
specific geocoded address points.48  
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Another limitation is the lack of primary care or pediatrician visits captured by SPARCS.35 Many 
patients go to their Primary Care Physician (PCP) once they experience a symptom of 
COPD/Asthma, prior to heading to their nearest hospital or medical facilities certified under 
Article 28 of the Public Health Law35 where they fear experiencing long waiting periods. 
Nevertheless, the findings from this study can guide future studies for analyses at the level of the 
PCP. 
 
Although our results determined respiratory exacerbation rates were highest in clusters appearing 
closest in proximity to major highways and facilities with high emissions of toxic pollutants, our 
study was methodologically limited in providing a systematic analysis to confirm this 
association. Future research may measure the distance to major highways and toxic release 
inventory sites (TRIs) within spatio-temporal clusters presenting with high rates of respiratory 
exacerbation, and then compare to clusters with low rates. Studies can further assess climatic and 
sociodemographic factors that may drive the spatio-temporal differences found between clusters, 
such as obesity, seasonal allergies, and SES status, factors that have been associated with 
increased respiratory hospitalizations.61,62 
 
The findings from this study can be generalizable to other individuals living within NYC that are 
pre-diagnosed with asthma and COPD but were not included in this research, as well as to 
individuals in other urban areas diagnosed with a chronic health condition (e.g., cardiac), that 
may be also experience health inequities. The New York State SPARCS hospital discharge data 
includes outcomes from a representative sample of an urban area (New York City) within the 
NYS population and includes individuals who were discharged from a NYS hospital or article 28 
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medical facility, regardless of age, sex, race/ethnicity and socioeconomic status. Therefore, this 
study could also be transportable to other diverse urban populations within the U.S. with a 
similar population structure, where there is a disproportionate burden of chronic health disease 
(e.g., respiratory, cardiac) among disadvantaged populations. Given our findings in NYC, 
research can focus on similar racial and socioeconomic disparities that are expected in other 
large cities with a similar population makeup across the United States.  
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2.7 Appendix 
Table 2.2: Case counts and population-based rates of respiratory (Asthma and COPD) 
exacerbation episodes by ‘diagnosis-medical facility setting’ in 43 neighborhoods within New 
York City, 2016-2018 
 
Borough Neighborhood Asthma Inpatient Asthma Outpatient COPD Inpatient COPD Outpatient 
  
Count 
Population-
Based Rate 
(per 1000 
people) 
Count 
Population-
Based Rate 
(per 1000 
people) 
Count 
Population-
Based Rate 
(per 1000 
people) 
Count 
Population-
Based Rate 
(per 1000 
people) 
Bronx 
Bronx Park and 
Fordham 1576 6.24 12847 50.85 1527 6.04 954 3.78 
Bronx Central Bronx 1584 7.68 13740 66.66 824 4.00 448 2.17 
Bronx 
High Bridge 
and Morrisania 2272 10.94 16119 77.63 576 2.77 343 1.65 
Bronx 
Hunts Point 
and Mott 
Haven 1747 12.79 11428 83.67 370 2.71 270 1.98 
Bronx 
Kingsbridge 
and Riverdale 314 3.45 2055 22.61 352 3.87 527 5.80 
Bronx 
Northeast 
Bronx 916 4.80 6700 35.14 551 2.89 694 3.64 
Bronx 
Southeast 
Bronx 1547 5.19 9652 32.40 212 0.71 48 0.16 
Brooklyn Borough Park 323 0.97 2373 7.15 1320 3.98 1069 3.22 
Brooklyn 
Bushwick and 
Williamsburg 910 4.32 9121 43.34 1046 4.97 733 3.48 
Brooklyn 
Canarsie and 
Flatlands 455 2.33 4544 23.30 527 2.70 181 0.93 
Brooklyn 
Central 
Brooklyn 1451 4.55 14497 45.46 1600 5.02 970 3.04 
Brooklyn 
East New York 
and New Lots 1129 6.01 8893 47.34 1146 6.10 980 5.22 
Brooklyn Flatbush 759 2.56 8615 29.05 864 2.91 770 2.60 
Brooklyn Greenpoint 287 2.26 1261 9.93 739 5.82 524 4.12 
Brooklyn 
Northwest 
Brooklyn 1113 4.96 4201 18.74 314 1.40 261 1.16 
Brooklyn 
Southern 
Brooklyn 606 2.12 3905 13.68 993 3.48 746 2.61 
Brooklyn 
Southwest 
Brooklyn 258 1.29 1329 6.67 950 4.77 264 1.32 
Brooklyn Sunset Park 222 1.74 1949 15.24 1207 9.44 482 3.77 
Manhattan Battery Park 0 0.00 31 6.48 1403 293.33 839 175.41 
Manhattan Central Harlem 1099 6.76 11877 73.02 723 4.45 529 3.25 
Manhattan 
Chelsea and 
Clinton 866 5.98 1562 10.78 906 6.25 681 4.70 
Manhattan East Harlem 741 6.74 10294 93.61 1640 14.91 1614 14.68 
Manhattan 
Gramercy Park 
and Murray 
Hill 560 4.16 944 7.02 216 1.61 160 1.19 
Manhattan 
Greenwich 
Village and 
Soho 57 0.68 345 4.12 1376 16.43 867 10.35 
Manhattan 
Inwood and 
Washington 
Heights 844 3.40 8589 34.56 26 0.10 7 0.03 
Manhattan 
Lower East 
Side 494 2.49 3215 16.17 676 3.40 1087 5.47 
Manhattan 
Lower 
Manhattan 428 8.85 819 16.93 210 4.34 308 6.37 
Manhattan 
Upper East 
Side 184 0.84 1223 5.58 390 1.78 156 0.71 
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Manhattan 
Upper West 
Side 360 1.68 3339 15.54 423 1.97 317 1.48 
Queens Central Queens 204 2.11 1000 10.33 957 9.88 1029 10.63 
Queens Jamaica 1393 4.82 6332 21.90 824 2.85 1583 5.48 
Queens North Queens 518 1.99 1677 6.46 1069 4.12 830 3.20 
Queens 
Northeast 
Queens 97 1.81 299 5.58 98 1.83 99 1.85 
Queens 
Northwest 
Queens 435 2.16 3272 16.26 469 2.33 607 3.02 
Queens Rockaways 490 4.26 3428 29.81 1147 9.98 586 5.10 
Queens 
Southeast 
Queens 666 3.52 3200 16.92 749 3.96 798 4.22 
Queens 
Southwest 
Queens 624 2.34 3835 14.40 843 3.17 467 1.75 
Queens 
West Central 
Queens 724 2.95 2126 8.65 1012 4.12 414 1.68 
Queens West Queens 1068 2.22 6699 13.94 736 1.53 488 1.02 
Staten 
Island Mid-Island 332 3.88 528 6.17 114 1.33 170 1.99 
Staten 
Island Port Richmond 430 6.11 1673 23.77 261 3.71 98 1.39 
Staten 
Island South Shore 268 1.42 839 4.43 742 3.92 293 1.55 
Staten 
Island 
Stapleton and 
St. George 477 3.86 2133 17.25 730 5.90 260 2.10 
Total  30828 3.79 212508 26.16 32858 4.04 24551 3.02 
Table 2.3: Case counts and population-based rates of respiratory (Asthma and COPD) exacerbation episodes by ‘diagnosis-
medical facility setting’ in 43 neighborhoods within the study area, New York City, 2016-2018. Source: New York State SPARCS, 
U.S. Census 
 
Table 2.3: Location of statistically significant COPD and asthma clusters, New York City, 2016-
2018. 
Disease 
Exacerbation 
Type-Setting 
Cluster Location (NYC 
Neighborhood) 
Time Frame 
Cases 
Observed 
Maximum 
Likelihood 
Ratio Test 
Statistic 
p-value 
Asthma - 
Inpatient 
Wall Street, Lower Manhattan 
09/2018 
(Summer/Autumn 2018) 
22 44.74 <0.0001 
 Chelsea and Clinton, Gramercy Park 
and Murray Hill; Manhattan; NY 
06/2018 
(Spring/Summer 2018) 
34 27.09 <0.0001 
  Tribeca, Lower Manhattan 
12/2017 - 01/2018 
(Autumn 2017/Winter 
2018) 
16 25.8 <0.0001 
  
Chelsea and Clinton, Meatpacking 
District, Garment District, East Village 
03/2018 - 08/2018 
(Winter 2017/Spring 
2018/Summer 2018) 
155 21.62 <0.0001 
  
Bayside, Central Queens, North Queens, 
Rego Park, West Queens 
04/2018 - 07/2018 
(Spring/Summer 2018) 
235 17.4 0.0001 
  
East New York, Brooklyn; Maspeth, 
Ridgewood, West Central Queens & 
Woodhaven, Queens 
03/2018  
(Winter 2017/Spring 
2018) 
74 12.2 0.013 
  
Bay Ridge and Southwest Brooklyn, 
Brooklyn; Stapleton and St. George, 
Staten Island 
08/2018 - 11/2018 
(Summer/Autumn 2018) 
107 12.03 0.016 
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Bronx Park and Fordham, Central 
Bronx, Northeast Bronx, Riverdale, 
Southeast Bronx; Bronx 
11/2018  
(Autumn 2018) 
216 11.96 0.017 
  
Central Queens, Douglaston, Jamaica, 
Oakland, Southeast Queens, Utopia 
03/2017 - 08/2017 
(Winter/Spring/ 
Summer 2017) 
289 11.71 0.023 
  
Bedford Stuyvesant, Bushwick and 
Williamsburg, Crown Heights, 
Northwest Brooklyn, Prospect Heights, 
Prospect Leffert, Brooklyn; City Hall & 
Lower East Side, Manhattan 
10/2018 - 12/2018 
(Autumn 2018) 
395 10.87 0.05 
Asthma - 
Outpatient 
Port Richmond, Silver Lake, Bull's 
Head, Grymes Hill; Staten Island; NY 
01/2018 - 12/2018 
(Winter/Spring/Summer 
/Autumn 2018) 
1564 105.07 <0.0001 
  
Northeast Bronx, Southeast Bronx, 
Central Bronx, Hunts Point and Mott 
Haven; Bronx Park and Fordham, 
Kingsbridge and Riverdale; Bronx; NY / 
Inwood and Washington Heights; 
Manhattan; NY 
09/2018 - 12/2018 
(Summer/Autumn 2018) 
8555 50.3 <0.0001 
  
Chelsea and Clinton, Midtown West, 
Upper West Side, Upper East Side, 
Gramercy Park and Murray Hill, 
Theatre District, Greenwich Village and 
SoHo, Lower East Side, City Hall, 
Battery Park City, Tribeca; Manhattan; 
NY / Hunters Point; Queens; NY 
03/2018 - 09/2018 
(Winter/Spring/Summer 
2018) 
1347 36.55 <0.0001 
  
East New York and New Lots, Canarsie 
and Flatlands, Central Brooklyn, 
Bushwick and Williamsburg, Flatbush, 
Prospect Leffert; Brooklyn; NY / 
Southwest Queens, West Central 
Queens, Forest Hills, Jamaica, Maspeth, 
Kew Garden Hills, Elmhurst; Queens; 
NY 
03/2016 - 08-2016 
(Spring/Summer 2016) 
8118 28.14 <0.0001 
COPD - 
Inpatient 
Clinton - Midtown West; Manhattan; 
NY 
09/2016 - 11/2016 
(Summer/Autumn 2016) 
28 18.46 <0.0001 
 Silver Lake, West Brighton; Staten 
Island; NY 
01/2016 - 05/2016 
(Winter/Spring/Summer 
2016) 
127 13.18 0.0057 
  
Melrose, Highbridge; Bronx / 
Washington Heights; Manhattan; NY 
09/2017 - 05/2018 
(Summer 2017/Autumn 
2017/Winter 
2017/Spring 2018) 
481 12.25 0.013 
COPD - 
Outpatient 
Sunset Park, Southwest Brooklyn; 
Brooklyn; NY /Richmond Hill; Queens; 
NY / Bloomfield, South Bloomfield, 
Mid-Island, Port Richmond, South 
Shore, Silver Lake, Rosebank; Staten 
Island; NY 
12/2017 - 11/2018 
(Autumn 2017/Winter 
2017/Spring 
2018/Summer 
2018/Autumn 2018) 
805 40.12 <0.0001 
  Bensonhurst; Brooklyn; NY 
02/2017 - 04/2017 
(Winter/Spring 2017) 
42 25.4 <0.0001 
  NoHo, SoHo; Manhattan; NY 
11/2016 - 01/2017 
(Autumn 2016/Winter 
2017) 
26 22.96 <0.0001 
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Elmhurst, Maspeth, Ozone Park, West 
Central Queens, Woodhaven, Woodside; 
Queens; NY / Bushwick and 
Williamsburg, Brownsville, Crown 
Heights, East New York, Ocean Hill, 
City Line; Brooklyn; NY 
01/2016 - 07/2016 
(Winter/Spring/Summer 
2016) 
964 22.22 <0.0001 
  
Inwood and Washington Heights; 
Manhattan; NY / Morris Heights, 
Highbridge, Jerome Park; Bronx; NY 
08/2017 - 03/2018 
(Autumn 2017/Winter 
2017/Spring 2018) 
345 17.18 <0.0001 
  Bathgate; Bronx; NY 
06/2016 - 11/2016 
(Spring/Summer/Autumn 
2016) 
115 16.95 0.0001 
  
Long Island City, Steinway; Queens; 
NY/ Upper West Side; Manhattan; NY 
02/2018 - 08/2018 
(Winter/Spring/Summer 
2018) 
153 14.79 0.001 
  
Rockaway Park, Belle Harbor; Queens; 
NY 
04/2018 - 07/2018 
(Spring/Summer 2018) 
32 12.56 0.01 
  
Mott Haven, Melrose, Longwood; 
Bronx; NY 
02/2016 - 04/2017 
(Winter 2016/Spring 
2016/Summer 
2016/Autumn 
2016/Winter 
2016/Spring 2017 
627 11.77 0.025 
Table 2.4: Location of statistically significant (p ≤ 0.05) COPD and asthma clusters, New York City, 2016-2018, for space-time 
permutation cluster search. 
 
Figure 2.8: Observed and expected case counts for statistically significant asthma exacerbation 
inpatient clusters, New York City, 2016-2018. 
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Figure 2.8: Observed and expected case counts for statistically significant (p ≤ 0.05) asthma exacerbation inpatient clusters, 
New York City, 2016-2018 (blue bars represent statistically significant clusters, and orange bars represent observed case counts 
within those clusters over a period of time): (a) Wall Street, Lower Manhattan, (b) Chelsea, Clinton, Gramercy Park & Murray 
Hill, Manhattan, (c) Tribeca, Lower Manhattan, (d) Chelsea, Clinton, Meatpacking District, Garment District & East Village, 
Manhattan, (e) Bayside, Central Queens, North Queens, Rego Park & West Central Queens, (f) East New York, Brooklyn; 
Maspeth, Ridgwood, West Central Queens & Woodhaven, Queens, (g) Bay Ridge & Southwest Brooklyn; Stapleton & St. George, 
Staten Island, (h) Bronx Park & Fordham, Central Bronx, Northeast Bronx, Riverdale, Southeast Bronx, (i) Central Queens, 
Douglaston, Jamaica, Oakland, Southeast Queens, Utopia, Queens, (j) Bedford Stuyvesant, Bushwick & Williamsburg, 
Northwest Brooklyn; City Hall & Lower East Side, Manhattan. 
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Figure 2.9: Observed and expected case counts for statistically significant asthma exacerbation 
outpatient clusters, New York City, 2016-2018. 
 
 
Figure 2.9: Observed and expected case counts for statistically significant (p ≤ 0.05) asthma exacerbation outpatient clusters, 
New York City, 2016-2018(blue bars represent statistically significant clusters, and orange bars represent observed case counts 
within those clusters over a period of time): (a) Northwest Staten Island, (b) West Bronx; Inwood & Washington Heights, (c) 
Lower & Midtown Manhattan; Hunter’s Point, and (d) Eastern Brooklyn; Southwest & Central Queens. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10: Observed and expected case counts for statistically significant COPD exacerbation 
inpatient clusters, New York City, 2016-2018. 
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Figure 2.10: Observed and expected case counts for statistically significant (p ≤ 0.05) COPD exacerbation inpatient clusters, 
New York City, 2016-2018 (blue bars represent statistically significant clusters, and orange bars represent observed case counts 
within those clusters over a period of time): (a) Clinton & Midtown West, (b) Silver Lake & West Brighton, Staten Island, and (c) 
Melrose & Highbridge, Bronx; Washington Heights, Manhattan. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Observed and expected case counts for statistically significant COPD exacerbation 
outpatient clusters, New York City, 2016-2018. 
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Figure 2.11: Observed and expected case counts for statistically significant (p ≤ 0.05) COPD exacerbation outpatient clusters, 
New York City, 2016-2018 (blue bars represent statistically significant clusters, and orange bars represent observed case counts 
within those clusters over a period of time): (a) Staten Island; Southwest Brooklyn; Richmond Hill, Queens, (b) Bensonhurst, 
Brooklyn, (c) NoHo & SoHo, Manhattan, (d) West Central Queens; Northeast Brooklyn, (e) Inwood & Washington Heights, 
Manhattan; Mid-West Bronx, (f) Bathgate, Bronx, (g) Long Island City & Steinway, Queens; Upper West Side, Manhattan, (h) 
Rockaway Park & Belle Harbor, and (i) Mott Haven, Melrose & Longwood, Bronx. 
 
Table 2.4: Statistically significant ZCTA’s with corresponding neighborhoods appearing within 
both inpatient and outpatient settings for space-time permutation asthma exacerbation cluster 
search, New York City, 2016-2018. 
 
Borough 
Matching Asthma 
ZCTAs Neighborhood 
Manhattan 10001 Chelsea 
Manhattan 10002 Lowest East Side 
Manhattan 10003 East Village 
Manhattan 10007 Tribeca 
Manhattan 10011 Chelsea 
Manhattan 10014 Meatpacking District 
Manhattan 10019 Upper West Side 
Manhattan 10020 Theatre District 
Manhattan 10022 Turtle Bay 
Manhattan 10038 City Hall 
Manhattan 10103 Midtown West 
Manhattan 10110 Midtown West 
Manhattan 10111 Midtown West 
Manhattan 10112 Theatre District 
Manhattan 10119 Midtown West 
Manhattan 10152 Midtown West 
Manhattan 10153 Midtown West 
Manhattan 10154 Midtown West 
Manhattan 10165 Upper West Side 
Manhattan 10167 Midtown West 
Manhattan 10169 Upper West Side 
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Manhattan 10170 Upper West Side 
Manhattan 10171 Midtown West 
Manhattan 10172 Upper West Side 
Manhattan 10173 Upper West Side 
Manhattan 10177 Upper West Side 
Manhattan 10199 Chelsea 
Staten Island 10301 Silver Lake (Stapleton & St. George) 
Staten Island 10304 Grymes Hill 
Bronx 10453 Morris Heights 
Bronx 10457 Bathgate 
Bronx 10458 Belmont 
Bronx 10460 Bronx Park South 
Bronx 10461 Westchester Square 
Bronx 10462 Van Nest 
Bronx 10463 Riverdale 
Bronx 10464 Southeast Bronx 
Bronx 10465 Eastchester Bay 
Bronx 10466 North Baychester 
Bronx 10467 Van Cortlandt Park 
Bronx 10468 Jerome Park 
Bronx 10469 Pelham Gardens 
Bronx 10470 Wakefield 
Bronx 10472 Soundview Bruckner 
Bronx 10473 Soundview 
Bronx 10475 Coop City 
Brooklyn 11206 Williamsburg 
Brooklyn 11207 East New York 
Brooklyn 11211 Williamsburg 
Brooklyn 11213 Crown Heights 
Brooklyn 11216 Bedford Stuyvesant 
Brooklyn 11221 Bushwick 
Brooklyn 11225 Prospect Leffert 
Brooklyn 11237 Ridgewood 
Brooklyn 11238 Prospect Heights 
Queens 11367 Kew Garden Hills 
Queens 11373 Elmhurst 
Queens 11374 Rego Park 
Queens 11378 Maspeth 
Queens 11379 Middle Village 
Queens 11385 Glendale 
Queens 11421 Woodhaven 
Queens 11432 Jamaica Hills 
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Queens 11433 St. Albans 
Table 2.5: Statistically significant ZCTA’s with corresponding neighborhoods appearing within both inpatient and outpatient 
settings for space-time permutation asthma exacerbation cluster search, New York City, 2016-2018. 
 
Table 2.6: Statistically significant ZCTA’s with corresponding neighborhoods appearing across 
outpatient settings for space-time permutation respiratory (asthma and COPD) exacerbation 
cluster search, New York City, 2016-2018. 
 
Borough 
Matching 
Outpatient 
ZCTAs Neighborhood 
Manhattan 10012 NoHo/SoHo 
Manhattan 10032 Washington Heights 
Manhattan 10033 Washington Heights 
Manhattan 10034 Inwood 
Manhattan 10040 Washington Heights 
Manhattan 10162 Upper West Side 
Staten 
Island 10301 Silver Lake (Stapleton and St. George) 
Staten 
Island 10302 West Brighton  
Staten 
Island 10303 Mariners Park 
Staten 
Island 10304 Grymes Hill 
Staten 
Island 10310 West Brighton  
Staten 
Island 10314 Bull's Head 
Bronx 10451 Melrose 
Bronx 10452 Highbridge 
Bronx 10453 Morris Heights 
Bronx 10454 Mott Haven 
Bronx 10455 Mott Haven 
Bronx 10456 Melrose 
Bronx 10457 Bathgate 
Bronx 10459 Longwood 
Bronx 10468 Jerome Park 
Brooklyn 11206 Williamsburg 
Brooklyn 11207 East New York 
Brooklyn 11208 City Line 
Brooklyn 11212 Brownsville 
Brooklyn 11213 Crown Heights 
Brooklyn 11221 Bushwick 
Brooklyn 11233 Ocean Hill 
Queens 11237 Ridgewood 
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Queens 11373 Elmhurst 
Queens 11374 Rego Park 
Queens 11375 Forest Hills 
Queens 11378 Maspeth 
Queens 11379 Middle Village 
Queens 11385 Glendale 
Queens 11416 Woodhaven 
Queens 11417 Ozone Park 
Queens 11418 Richmond Hill 
Queens 11421 Woodhaven 
Table 2.6: Statistically significant ZCTA’s with corresponding neighborhoods appearing across outpatient settings for space-
time permutation respiratory (asthma and COPD) exacerbation cluster search, New York City, 2016-2018. 
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Chapter 3. Associations between Respiratory (Chronic Obstructive 
Pulmonary Disease and Asthma) Exacerbations, Socio-demographic 
and Climatic Predictive Factors in New York City: A Poisson 
Regression Approach  
 
3.1 Introduction 
Individuals with Chronic Obstructive Pulmonary Disease (COPD) and asthma remain a 
vulnerable population during periods of adverse climatic events.1 As asthma has been identified 
as a known risk factor for development of reduced lung function and chronic obstructive 
pulmonary disease (COPD) in adults,2 and COPD and asthma are both incurable,3,4 impacts will 
not only affect individuals with existing respiratory diseases but will likely increase the 
incidence and prevalence of respiratory conditions overall. Exacerbations of COPD and asthma 
determine a full range of difficulties including disease-associated morbidity, mortality, resource 
burden and healthcare costs.5 
 
Variations in Climate and Respiratory Illness 
Climate variability is formally defined by the World Meteorological Organization as “variations 
in the mean state and other statistics of the climate on all temporal and spatial scales, beyond 
individual weather events.”6 The fluctuations comprising climate variability can influence 
patterns of rainfall, temperature and other variables on timescales anywhere from a few weeks to 
a few decades.7 Variability may be due to natural internal processes within the climate system 
(internal variability), or to variations in natural or anthropogenic external factors (external 
variability).6 The European Respiratory Society (ERS) provided a position statement 
highlighting climate-related health impacts, which included deaths and morbidity.8 Increased 
concentrations of greenhouse gases, and especially CO₂, in the earth's atmosphere have already 
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warmed the planet substantially. This has caused more severe and prolonged heat waves, 
temperature variability, air pollution, forest fires, heavy rain, storms, droughts, and floods, all of 
which put respiratory health at risk.9 
 
Although COPD and asthma exacerbations are more frequent during periods of extreme heat and 
cold, it is currently unclear which combination of meteorological factors exert the greatest 
influence on respiratory exacerbations, and whether or not time and/or space play a role.10 The 
dynamic qualities of climate are regulated by meteorological factors, such as regional 
temperature, humidity, wind speed, rainfall and particulate matter (PM 2.5), which tend to vary 
with different seasons and across different locations.  
 
This is especially true in regions experiencing all four seasons such as in NYC. For example, 
LaGuardia Airport (LGA) located in northern Queens recorded the warmest year on record in 
2016, as well as the warmest autumn to date.11,12 NYC also experienced its coldest Thanksgiving 
Day on record in 2018 with temperature lows ranging from 38.1 degrees F (3.4 degrees C) to 
40.5 degrees F (4.7 degrees F).13 In addition, John F. Kennedy Airport (JFK) located in southern 
Queens record their snowiest spring when a nor’easter moved through the city in March of 
2018.13  
 
Climate variability leaves the most vulnerable individuals of a population, including COPD and 
asthmatic patients, susceptible to augmented chronic health outcomes. Asthma is already 
understood to be the leading chronic disease in children14 and is the third-ranking cause of 
hospitalization among children younger than 15 years old.15 Moreover, it is known that COPD 
 
37 
stands as the third leading cause of death and second leading cause of disability in the United 
States.4,16 During the winter season, COPD patients have been reported to experience more 
frequent exacerbation of their disease and were found to have higher hospitalization and 
morbidity rates.17,18 The winter season is also associated with an increased prevalence in 
respiratory viral infections.19,20 Evidence of increased mortality and acute morbidity among 
respiratory patients as a result of heat waves makes COPD and asthma patients extremely 
vulnerable to respiratory illness during the summer season as well.21 During a period of 
extremely high temperatures, each degree Celsius (C) above the threshold of the temperature-
health effect curve (29°C–36°C) was associated with a 2.7%–3.1% increase in same-day 
hospitalizations due to respiratory diseases.22 There is also an increased risk of premature death 
up to six times higher among respiratory patients than in the rest of the population.23 
 
Not only does temperature affect respiratory health outcomes, but studies have also shown 
increases in relative humidity are related to decreased lung function.24 Studies were done to 
determine the effects of fluctuations in climatic factors (temperature, humidity, and barometric 
pressure) on pediatric asthma exacerbations, and found emergency department visits for pediatric 
asthma occurred 1 to 2 days after fluctuations in humidity and temperature.25 Humidity can be 
further affected by heavy rainfall events, which could alter the humidity in the environment and 
contribute to changes in airflow within the pulmonary system that could further exacerbate 
respiratory disease. 25-27  
 
With the overall increase of global temperatures, many climate models have predicted a general 
increase in atmospheric water vapor accompanied by an increase in the intensity of heavy rainfall 
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events.28-30 Changes in temperature, air pressure, and most importantly precipitation patterns 
affect the probability of storms and floods. Heavy rain and flooding may cause water damage on 
buildings, leading to an increase in mold exposure. Although mold allergy is rare, there is a clear 
relationship between damp houses and respiratory diseases such as asthma.31 Other studies 
carried out in the Brazilian Amazon have even found peaks in the number of hospital visits due 
to respiratory disease during the wet seasons (between the months of March and April), which 
may of had an association with relative humidity in the air.32  
 
Recent epidemic thunderstorm asthma has been reported about a dozen times in the past 35 
years; the threshold for reporting seems to be an increase of at least five to ten times in asthma 
presentations to emergency departments over a short time.33 Nevertheless, many individuals are 
affected by these events but do not seek acute medical care.34 This emerging phenomenon is 
accompanied with periods of heavy rainfall and intense wind, which are believed to increase 
extreme exposure to allergens, predominantly grass pollen, in susceptible allergic individuals .35 
However, wind can also have the reverse effect and move allergens outside of the region.  
 
Acute exposure to particulate air pollution has also been found associated with increases in the 
rates of daily asthma attacks, the rate of respiratory exacerbations due to respiratory infections, 
respiratory-related hospital admissions and mortality.21,36 Fuel oil/kerosene, coal/coke, wood and 
utility gas with improper ventilation systems are all sources of  particulate matter (PM), which 
can be directly emitted from remaining residual oil boilers in buildings or released when fuels 
are incompletely burned.37 Although NYC has mandated cleaner burning oil in recent years 
through the NYC Clean Heat program created in 2010, the remaining residual oil boilers in 
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buildings that have yet to convert to cleaner oil can still emit PM, especially when fuels are 
incompletely burned.37 Residual fuel oil #4, which won’t be banned until 2030, continued to be 
burned by 3,253 residential buildings, despite the city’s efforts to educate and incentivize owners 
to switch to cleaner fuels.38 Space appears to play a role as studies found 1,724 or 53 percent of 
remaining residual oil boilers post-NYC Clean Heat program were clustered in Manhattan north 
of 110th Street and the Bronx—disproportionately higher than the area’s population (only one-
fifth of city residents live in these neighborhoods).39  
 
Outdoor air pollutants can also be transported indoors via ventilation and infiltration, pollutant 
deposition to indoor surfaces, and filtration, among others.40 Studies have shown approximately 
62% of the 2 million annual DALYs of indoor exposure was caused by the transport of outdoor 
PM2.5 to the indoor environment via ventilation and 16% by indoor sources.
41   
 
Nevertheless, air pollution can be reduced by the climatic variables aforementioned. For 
example, periods of heavy rainfall can decrease air pollution levels by “washing” PM pollutants 
out of the atmosphere.42 Wind speed can also have a similar effect on fine particulate matter as 
fine PM 2.5 concentrations have been found to decrease gradually with the increase of wind 
speed, whereas coarse PM 10 concentrations can increase due to dust resuspension under strong 
wind.43 Overall, there is limited research on the effects of air pollution exposure on respiratory 
disease management. Most studies that were carried out on respiratory disease-air pollution were 
mostly carried out among the asthmatic population and children.44  
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The Role of Socioeconomic Conditions on the Relationship Between Climate Variability and 
Respiratory Exacerbation 
Research has consistently shown the impact an individual’s social or economic standing, 
measured by an individual's or family's social or economic position or rank in a social group,45 
has on morbidity, mortality, and access to health care with regards to respiratory health.46-48 
Studies addressing low SES among individuals diagnosed with COPD and asthma have found an 
association with disproportionate access to respiratory health care. For instance, there is an 
inverse relationship between SES and COPD prevalence associated with mortality, health 
utilization costs and health-related quality of life (HRQoL).48 There is also a relationship 
between lower SES and increased severity of asthma leading to subsequent hospitalization.48 
These findings are relevant to our study as there is over 8 million people currently residing in 
NYC49 and the five boroughs that make up this city house a diverse sociodemographic 
population with individuals in different socioeconomic classes experiencing adverse health 
effects from climate change in varying ways. 
 
Specific Aims 
The aim of this ecological study is to estimate the association of COPD and asthma exacerbation 
hospital discharges across NYC ZIP code tabulated areas (ZCTAs) (Figure 3.1), after adjusting  
for sociodemographic predictive factors (sex, age, race, income, poverty, educational attainment, 
and type of house heating fuel) and climatic predictive factors (temperature, precipitation, wind, 
relative humidity, and PM 2.5). The aims will be carried out through a series of three Poisson 
regression models: the first is a general linear model (GLM), the second is a general linear mixed 
 
41 
model (GLMM) with adjustment for temporal autocorrelation, and the third is a Bayesian spatio-
temporal model with adjustment for spatio-temporal random effects variances.  
 
 
Figure 3.1: Map of New York City ZIP Code Tabulation Areas (ZCTAs) that make up the study area. Source: Geospatial Data 
Library at CUNY Baruch College. 
 
Hypotheses 
We believe Poisson regression results will be best fitted after utilizing the Bayesian spatio-
temporal modelling approach to adjust for spatio-temporal autocorrelation. Our outcomes and 
potential predictive covariates vary significantly across time (36 time periods to include monthly 
discharge data from 2016 to 2018) and space (214 ZCTAs across NYC). We further hypothesize 
results from our Bayesian spatio-temporal model will suggest sociodemographic predictive 
factors (including sex, age, race, income, poverty, educational attainment, and type of house 
heating fuel) and climatic predictive factors (including temperature, precipitation, wind, relative 
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humidity, and PM 2.5) will increase the relative risk of COPD and asthma exacerbation rates 
within both the inpatient and outpatient settings. We also hypothesize there will be spatio-
temporal variation in the associations between respiratory disease, climatic and 
sociodemographic covariates, and certain regions within NYC will have elevated risk relative to 
other regions. 
 
3.2 Methods 
Data 
This study combines health and spatial data from a variety of sources. The outcome of interest – 
hospital discharges related to COPD and asthma exacerbation episodes – are provided by the 
New York State (NYS) Statewide Planning and Research Cooperative System (SPARCS), as 
summarized in chapter 2.  
 
COPD and/or Asthma Exacerbation 
The outcome of interest was obtained from NYS SPARCS, which was measured by an 
International Classification of Diseases 10th Revision Codes (ICD-10CM)50,51 pertaining to 
either a COPD exacerbation: 
J44.1 for “Chronic obstructive pulmonary disease with acute exacerbation, unspecified,” 
Or an asthma exacerbation: 
J45.21 for “Mild intermittent asthma with [acute] exacerbation,” 
J45.31 for “Mild persistent asthma with [acute] exacerbation,”  
J45.41 for “Moderate persistent asthma with [acute] exacerbation,” 
J45.51 for “Severe persistent asthma with [acute] exacerbation,”   
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J45.901 for “Unspecified asthma with [acute] exacerbation.” 
 
Type of Diagnosis Code 
Data on the type of diagnosis code was obtained from NYS SPARCS, which indicates whether 
diagnosis was “PR” Principal; “OT” Other; “EX” External Cause of Injury; “AD” Admitting; 
“RV” Reason for Visit.52 For this study, only ‘Admitting Diagnosis (AD)’ was used for the 
inpatient dataset and ‘Reason for Visit (RV)’ was used for the outpatient dataset.  
 
Discharge Date 
Discharge data for each patient record was provided by the NYS SPARCS hospital discharge 
dataset. Discharge data was provided for each patient record in month and year format, between 
January 2016 through December 2018. 
 
NYC Spatial Designation 
The NYC spatial designation was derived from the CUNY Baruch College NYC Geodatabase53, 
which contained an individual database layer for NYC ZCTAs. The spatial designation was used 
to assign each patient hospital record to a specific ZCTA within NYC, after cross-walking NYC 
ZIP codes to ZCTAs. ZCTAs were also linked to their corresponding latitude and longitudinal 
coordinates using data obtained from the US Census Gazetteer54 files.  
 
Sociodemographic Variables 
American Community Survey (ACS) is a cross-sectional sample which provides single-year 
poverty estimates for geographies with populations of 65,000 or greater and estimates for five-
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year periods at all geographies.55 For this study, the Census Bureau’s ‘American Community 
Survey’ (ACS) 5-year estimates for 2014 through 2018 was used to obtain ZCTA-level estimates 
on the following community-level co-variates:  
Sex, measured as percentage of the population being female 
Age, measured as percentage of the population ‘under 20 years old’ for the asthma  
diagnoses as asthma is more prevalent in the young56, or percentage of the  
population ‘over 64 years old’ for the COPD diagnoses as COPD is more 
prevalent among the elderly.57 
Race, measured as percentage of the population being black (non-Hispanic Latino or  
Hispanic Latino) 
Income, measured continuously as an average of the median income within annual  
inflation-adjusted dollars  
Poverty, measured as percentage of the population below poverty level (out of population  
for whom poverty status is determined)  
Educational attainment, measured as percentage of the population having completed a 4- 
year college degree or higher. 
Type of house heating fuel, measured as percentage of the population using fuel  
oil/kerosene/etc. as their main source of house heating fuel 
 
Climatic Variables 
Monthly data on air temperature, precipitation, wind and relative humidity was obtained from 
NOAA, which acquires recordings through their weather monitoring stations around NYC. 
These data include quality controlled daily and monthly measurements of58: 
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Temperature: maximum temperature in degrees Fahrenheit 
Precipitation: total precipitation in inches  
Wind: average wind speed in miles per hour 
Relative humidity: average percent (measurement of water vapor, but relative to the  
temperature of the air). 
The search tool allows for users to access past weather and climate data by zip code, city, county, 
state, or country. Given availability, climate data will be obtained from the three main weather 
monitoring stations across NYC: Central Park in Manhattan, LaGuardia Airport and John F. 
Kennedy Airport, both located in Queens.  
 
PM 2.5 
Data on PM 2.5 levels is provided by the New York City Community Air Survey (NYCCAS). 
NYCCAS air quality monitoring began in December 2008. Field teams sampled the air at 150 
NYC locations per year during the first two years and at 60 to 100 locations per year in 
subsequent years.(Figure 3.2) Samples are collected bi-weekly in all seasons for all pollutants, 
including PM 2.5, producing two-week averages.59 Furthermore, data on particulate matter is 
only collected periodically within the 14-day period. Nevertheless, the data is averaged within 
community districts, which is the smallest geographic unit available from NYCCAS. Data on 
PM 2.5 from 2016 and 2017 was only available at the geographic level of city boroughs, whereas 
2018 data was available at the level of community districts (CDs). The 2018 data was used for 
the purposes of this study given its availability in a finer geographic unit. The data collected was 
annual average PM 2.5 in the 90th percentile in mcg per cubic meter (mcg/m3) in order to capture 
exposure extremes. 
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Figure 3.2: PM 2.5 Air pollution monitoring stations across NYC, 2008-2020. Source: NYCCAS. 
 
Analyses 
Data Preparation 
NYS SPARCS Hospital discharge data information was prepared using SAS version 9.4, as per 
NYS SPARCS data usage guideline recommendations52. The data was then transferred to R 
version 3.6.2, where it was organized into 4 final outcomes, as described prior in chapter 2:  
COPD Inpatient (COPD IP) 
COPD Outpatient (COPD OP) 
Asthma Inpatient (Asthma IP) 
Asthma Outpatient (Asthma OP) 
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These final data frames were aggregated by discharge month-year and by ZCTA and included 
respiratory exacerbation cases. However, 29 of the 214 ZCTAs had population counts of ‘0’ as 
per the ACS. These ZCTAs were removed from the final datasets as they were unpopulated. 
Table 3.1 shows a list of the unpopulated ZCTAs across NYC and Figure 3.3 displays them 
spatially. They appear to align with the location of office buildings, college campuses, PO 
Boxes, parks, and airports across NYC.60  
 
Unpopulated NYC ZCTAs 
10020 
10103 
10110 
10111 
10112 
10115 
10119 
10152 
10153 
10154 
10165 
10167 
10168 
10169 
10170 
10171 
10172 
10173 
10174 
10177 
10271 
10278 
10311 
11351 
11359 
11371 
11424 
11425 
11451 
Table 3.1: Table listing unpopulated ZCTAs across NYC. Source: U.S. Census 2010. 
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Figure 3.3: Map portraying location of unpopulated ZCTAs across NYC. Source: The shapefile was obtained from the 
Geospatial Data Library at the City University of New York (CUNY) Baruch College.  Population data was obtained from the 
U.S. Census 2010. 
 
Linking co-variates by ZCTA 
The sociodemographic co-variates obtained from the ACS (sex, age, race, income, poverty, 
educational attainment, and type of house heating fuel) were available by ZCTA across the study 
period. They were then matched to the hospital discharge data by ZCTA for each ‘disease-
medical facility setting’ dataset. The climate co-variates (temperature, precipitation, wind levels 
and relative humidity) obtained from the NOAA were only available across 3 weather 
monitoring stations in NYC. These data were averaged across the 3 weather stations to create a 
uniform value applicable across all ZCTAs. Additionally, the climate data were made available 
by month-year enabling us to match it to the hospital discharge data by month-year of discharge 
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across all ZCTAs. PM 2.5 was only available at the level of the community district and was 
linked to corresponding ZCTAs. 
 
A Series of Poisson Regression Modelling 
Interest may focus on the use of exposure predictions from spatially misaligned exposure data 
with random effects in generalized linear models for discrete outcomes (e.g. a binary or a count 
variable).61 Therefore, our model was fitted with a Poisson distribution to model count events of 
respiratory exacerbation. The Poisson model has many strengths in modeling count data, 
analyzing rate data (where the rate is the count of events occurring per some unit of observation) 
and time series of disease counts, as well as comparing rates between circumstances (e.g. 
historical time) or between specific subgroup characteristics.62-64 A Poisson regression analysis 
also assumes that counts of independent rare events follow a Poisson distribution, and models the 
logarithm of outcome variables as a linear function of the predictor variables.65  
 
A table presenting all four outcomes and potential predictor variables by type (Socio-
demographic and Meteorological) is described in Table 3.2.  
 
Response variables  
  
Asthma exacerbation – inpatient cases*, 
year 2016-2018 monthly case counts 
 Asthma exacerbation – outpatient cases*, 
year 2016-2018 monthly case counts 
 COPD exacerbation – inpatient cases*, 
year 2016-2018 monthly case counts 
 COPD exacerbation – outpatient cases*, 
year 2016-2018 monthly case counts 
Socio-demographic predictor 
variables  
2014 5-year ACS** community estimates 
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offset Total population 
 % female Percent of the population who are female 
% under 20 years old Percent of the population age under 20 years (Asthma outcomes only) 
% over 64 years old Percent of the population age over 64 years (COPD outcomes only) 
 % black alone Percent of total population that is Black or African American alone, 
regardless of ethnicity  
% college Percent of the population who have a 4-year college degree or higher 
 % poverty Percent of total population who live in poverty 
 Median income Median income of total population in 2018-inflation adjusted dollars 
 % heat fuel Percent of the population using fuel oil/kerosene/etc. as their main 
source of house heating fuel 
Climate predictor variables 2016 – 2018 NOAA estimates*** 
Average maximum temperature Average monthly maximum temperature in degrees Fahrenheit 
 Total precipitation Total monthly precipitation in inches 
 Average relative humidity Average monthly relative humidity in percentage 
 Average wind speed Average monthly wind speed in miles per hour  
 Average PM 2.5 90th percentile Average annual PM 2.5 in the 90th percentile in micrograms per meters 
cubed (mcg/m3) 
Table 3.2: Table presenting all four response variables and potential predictor variables by type (Socio-demographic, 
Meteorological).  
*NYS DOH SPARCS, **American Community Survey, ***National Oceanic and Atmospheric Administration 
 
Assessing the presence of Multicollinearity among the Covariates 
Multicollinearity represents a high degree of linear intercorrelation between explanatory 
variables in a multiple regression model and leads to incorrect results of regression analyses.66 
We assessed for multicollinearity using the ‘ggscatter’ function within R to determine if any two 
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potential predictor variables were highly correlated with one another, and if one of the two 
should be removed from our final model.  
 
Poisson Regression General Linear Model (GLM) 
Initially, a Poisson generalized linear model (GLM) of the form: 
Ykt ~ Poisson(μkt𝑛𝑘𝑡)       (1)  
Log(μkt) = β + β1−7𝑠𝑜𝑐𝑖𝑜𝑑𝑒𝑚𝑜𝑔𝑟𝑎𝑝ℎ𝑖𝑐kt + β8−12𝑐𝑙𝑖𝑚𝑎𝑡𝑖𝑐kt + log(𝑛𝑘𝑡) 
was fitted to each outcome data with just the potential socio-demographic and climatic 
covariates. Here, μkt is the expectation risk of the observed respiratory case count in ZCTA k at 
month t multiplied by the offset population at-risk nkt. This was done in R using the ‘fitglm’ 
function.  
 
Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal 
Autocorrelation 
After removing potential predictor variables that were not statistically significant from our GLM 
model, we included the remaining potential predictors into our Poisson general linear mixed 
model (GLMM) using Penalized Quasi-Likelihood67 (PQL), which accounted for time-dependent 
influences that are not identified in the covariates through random effects that follow a 
multivariate normal distribution. The GLMM adjusts for temporal autocorrelation which occurs 
from the data largely relating to the same populations in consecutive time periods. This model68 
is specified as: 
Ykt ~ Poisson(μkt𝑛𝑘𝑡)       (2)  
Log(μkt) = β + βxkt
T 𝑠𝑜𝑐𝑖𝑜𝑑𝑒𝑚𝑜𝑔𝑟𝑎𝑝ℎ𝑖𝑐kt + βxkt
T 𝑐𝑙𝑖𝑚𝑎𝑡𝑖𝑐kt + μj + log(𝑛𝑘𝑡) 
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and was fitted to each outcome data with just the potential socio-demographic and climatic 
covariates. Here, μkt is the expected risk of the observed respiratory case count of an individual 
living in ZCTA k at month t multiplied by the offset population at-risk 𝑛𝑘𝑡. The terms 
βxkt
T 𝑠𝑜𝑐𝑖𝑜𝑑𝑒𝑚𝑜𝑔𝑟𝑎𝑝ℎ𝑖𝑐kt and βxkt
T 𝑐𝑙𝑖𝑚𝑎𝑡𝑖𝑐kt are the remaining sociodemographic and climatic 
variables, and μj is the random effect representing time (by discharge month). This was done in 
R using the ‘fitglmmPQL’ function.  
 
We went on to remove those variables that were not statistically significant from our GLMM 
analyses and used the remaining predictor variables into our final Bayesian spatio-temporal 
model of case counts for each of our outcome. This was done in R using the ‘CARBayesST 
package developed by Lee et al69.   
 
Poisson Generalized Linear Mixed Model (GLMM) with Bayesian Spatio-Temporal Modelling 
Traditional regression models are unable to model data that are spatio-temporal autocorrelated. 
Spatial autocorrelation can arise due to unmeasured confounding, neighborhood effects and 
grouping effects.70 Thereby, spatio-temporal autocorrelation can lead to case observations from 
geographically close areal units and temporally close time periods to have more similar values 
than units and time periods that are further apart.70  
 
A few of the covariates within our final datasets were spatially and temporally misaligned with 
the hospital discharge data: PM 2.5 levels were only made available at the geographic unit of 
community district, of which there are 55. In addition, the sociodemographic covariates obtained 
from the ACS and the PM 2.5 values obtained from the NYCCAS only vary across space 
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(ZCTA) but are fixed for all 36 months. Furthermore, the climatic variables obtained from the 
NOAA are fixed for all ZCTAs but vary across time (discharge months) and occur randomly in 
nature, affecting the underlying (offset) population of interest differently71.  
 
A Bayesian inferential approach is taken to model these data, where the spatio-temporal 
autocorrelation is modelled via sets of autocorrelated random effects using the conditional 
autoregressive (CAR) method proposed by Rushworth, Lee and Mitchell (2014).72 In this 
method70, each set of random effects is mean-centered and can be written as: 
Ykt ~ Poisson(μkt𝑛𝑘𝑡)    
ln(μkt𝑛𝑘𝑡) =  βxkt
T + ψkt + ln(𝑛𝑘𝑡)  (3) 
where μkt, the expected risk of an individual living in ZCTA k and discharge month t, is 
multiplied by 𝑛𝑘𝑡, the offset population at-risk, of the observed respiratory case count Ykt. The 
explanatory space–time covariates, Xkt, are associated with the mean process through the β 
coefficients and ψkt is a set of spatio-temporally autocorrelated random effects for ZCTA k and 
discharge month t.  
 
The Bayesian paradigm naturally incorporates our prior belief about the unknown parameter φ, 
and updates this belief based on observed data.73 This yields the posterior distribution of φ, 
which represents our knowledge about the parameter φ after having observed the data X.73 The 
proposed model represents the spatio-temporal structure with a multivariate first order 
autoregressive process (which predicts future behavior from near-term past behavior) with a 
spatially autocorrelated precision matrix.72 The model estimates the evolution of the spatial fitted 
value surface over time: 
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φ𝑡|φ𝑡−1  ~   N (ρ𝑇φ𝑡−1, τ
2Q(W, ρ𝑆)
−1)          𝑡 = 2, … , 𝑁, 
      φ1       ~   N (0, τ
2Q(W, ρ𝑆)
−1)                                       (4) 
In this model70 φ𝑡 =  (φ1t, … , φK𝑡) and is the vector of random effects for time period t, which 
evolves over time via a multivariate first order autoregressive process with temporal 
autoregressive parameter ρ𝑇. Therefore, φK𝑡 is the overall spatial main effect with k representing 
ZCTA and t representing discharge month. Temporal autocorrelation is thus induced via the 
mean ρ𝑇φ𝑡−1, while spatial autocorrelation is induced by the variance τ
2Q(W, ρ𝑆)
−1.70 N 
represents the non-overlapping areal units that make up the study region. In our study, the spatial 
relationships between ZCTAs were binary neighborhood matrixes W, which is based on the 
contiguity structure of the N areal units.72,74 In the second part of this model, the equation 
estimates that at the first time period, t = 1,  temporal autocorrelation induced via the mean is set 
to 0.  
 τ²  ∼ Inverse-Gamma(a, b)   (5) 
ρS, ρT ∼ Uniform(0, 1)   (6) 
In equation 5, τ² represents random effects for conjugate priors (when the computed posterior 
distribution ends up being in the same distribution as the prior or preconceived75-78) wherein 
equation 6, ρS and ρT are spatial and temporal dependence parameters, respectively, that govern 
the strength of spatial and temporal autocorrelations.70,72 
 
Bayesian spatio-temporal modeling of respiratory exacerbation cases was performed using the 
CARBayesST package developed by Lee et al.70 Models goodness of fit were compared using 
the deviance information criterion (DIC).77 All models were fitted in a hierarchical Bayesian 
spatio-temporal setting using Markov chain Monte Carlo (MCMC) simulation.74 For inpatient 
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outcomes (Asthma, COPD) that were more rare, the posterior distributions of model parameters 
were run for three parallel Markov chain, each of which were run for 220,000 MCMC samples 
with the first 20,000 samples removed as the burn-in period. The samples were then thinned by 
100 to reduce the autocorrelation in the Markov chains, resulting in 6,000 samples for inference. 
Whereas for each outpatient outcomes (Asthma, COPD), the posterior distributions of model 
parameters were obtained on 2,000 MCMC samples generated from a single Markov chain, 
which was executed for 220,000 iterations with a burn-in period of 20,000 and then thinned 
by 100 to reduce Markov chain autocorrelation. Convergence was monitored across all 
outcomes, both graphically through trace-plots of the parameters69 and by convergence 
diagnostics proposed by Geweke79 using the geweke.diag() function in R.79  
 
Assessing the presence of spatial autocorrelation in the case counts of Respiratory Exacerbation 
The spatial autocorrelation of respiratory exacerbation cases across all four outcomes was 
assessed by computing residuals from a preliminary non-spatial over-dispersed Poisson log-
linear model that incorporates covariate effects at the ZCTA level. The covariates we used were 
factors that may influence the likelihood of a respiratory exacerbation.19,21-25,36,46-48,80-83 
To quantify the presence of spatial autocorrelation in residuals from our non-spatial GLM and 
GLMM models, Moran’s I statistic was computed for each discharge month.84 Two spatial points 
data frames were created in R using the coordinates for each ZCTA and the corresponding 
residuals (averages per ZCTA) of our GLM and GLMM models, respectively. Using these 
spatial points data frames, we constructed a weights matrix W for each model using the weights 
assigned to the 10 nearest neighbors. To quantify the presence of spatial autocorrelation in 
residuals from our Bayesian spatio-temporal model, Moran’s I statistic was computed for each 
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discharge month.84 To compute Moran’s I statistic, a binary neighborhood matrix W based on the 
border sharing of ZCTAs was created.85 Two ZCTAs were neighbors if they shared a common 
boundary, so  𝑤𝑗𝑖 was assigned a value of 1 when 𝑆𝑗 and 𝑆𝑖 ZCTAs shared a common border, or 
0 otherwise.69,74,84 
 
After computing the Moran’s I statistic we conducted the permutation test using the moran.mc() 
function from the ‘spdep’ package in R.69  The null hypothesis states there is no spatial 
autocorrelation and the alternative hypothesis states positive spatial autocorrelation. Therefore, a 
low p-value, such as p < 0.05, indicates spatial autocorrelation is present within the model. 
 
3.3 Results 
Multicollinearity 
Multicollinearity represents a high degree of linear intercorrelation between explanatory 
variables in a multiple regression model and leads to incorrect results of regression analyses.66 In 
order to reduce the number of redundant variables in our model, we used the ‘ggscatter’ function 
within R to determine if any two potential predictors were highly correlated. We found 
‘college_pct’ and ‘income_median’ were highly correlated (R=0.84, p<2.2e-16) and so were 
‘tempmax_avg’ and ‘wind_avg’ (R=-0.86, p<2.2e-16) (Figure 3.4).  
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Figure 3.4: Potential predictor variables highly correlated. 
(1) ‘college_pct’ and ‘income_median’ were highly correlated (R = 0 .84, p < 2.2e-16), (2) ‘tempmax_avg’ and 
‘wind_avg’ (R = - 0.86, p < 2.2e-16) 
 
Asthma Exacerbation Inpatient 
Asthma exacerbation inpatient (AEi) cases across New York City, 2016 to 2018 
At the city-wide level, the overall annual observed number of asthma exacerbation inpatient 
discharges decreased between 2016 and 2018. The annual AEi crude case counts were estimated 
at 4755, 4070 and 3871 per year for 2016, 2017, and 2018, respectively. The time-series 
decompositions of the monthly AEi population-based rates over the study period peaked between 
February and March of 2016. (Figure 3.5) We also observe that there is great variability for AEi 
crude case counts as well as large outliers each month over the course of the study period, 
especially for January through March 2016, October 2016 through March 2017, and October 
2018. (Figure 3.6)   
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Figure 3.5: Monthly New York City Asthma Exacerbation Inpatient Population-Based Rates per 100,000 residents, 2016 to 2018. 
Source: NYS Department of Health SPARCS. 
 
 
Figure 3.6: Monthly New York City Asthma Exacerbation Inpatient Case Counts, 2016 to 2018. Source: NYS Department of 
Health SPARCS. 
 
Poisson Regression General Linear Model (GLM) 
Initially we used ‘fitglm’ function in R to fit our GLM model with Poisson regression for our 
AEi outcome against our potential predictor variables, which did not consider spatial or temporal 
autocorrelation. The covariate ‘female_pct’ (Pr[>|z|] 0.91) also determined to have marginal 
significance in our output, possibly due to a near constant 50% female population across the 
NYC ZCTAs. Our output also determined ‘income_median’ (Pr[>|z|] 0.28) and ‘wind_avg’ 
(Pr[>|z|] 0.09) had marginal significance in our model. Further results from our test of 
multicollinearity indicated ‘income_median’ and ‘wind_avg’ were highly correlated with 
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‘college_pct’ and ‘tempmax_avg’, respectively. Therefore, we removed the following potential 
predictor variables from our model moving forward: ‘female_pct’, ‘income_median’, and 
‘wind_avg’. 
 
A 10% increase in the population under 20 years old (RR = 0.85) and in the population with at 
least a 4-year college degree (RR = 0.87) was protective of asthma exacerbation in the inpatient 
setting. However, the community was at a greater risk of someone being hospitalized for asthma 
exacerbation in the inpatient setting for each 10% increase of the total population being black 
(RR = 1.86), 10% increase in the total population being in poverty (RR = 1.18), and 10% 
increase in homes heated with fuel oil, kerosene and etc. (RR = 1.1). When looking at the 
potential meteorological covariates, all were protective of AEi (RR < 1). (Table 3.3) 
 
Next, we ran a Moran I test under randomization to determine if residual spatial autocorrelation 
was present.69 Our output determined the p-value for the Moran I statistics is 0.0001, which is    
< 0.05 and significant indicating this model is not properly specified, either due to the presence 
of spatial autocorrelation or covariates (probably clustered in the landscape) that were not 
included in the model. 
 
Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal 
Autocorrelation 
We used ‘fitglmmPQL’ function in R to fit our GLMM model with multivariate normal random 
effects, using Penalized Quasi-Likelihood67 to account for the situation where our random effects 
are correlated. In this model, we set time as measured in discharge month as our random effect. 
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Our output determined the beta estimates for ‘precip_total’ (p = 0.13) and ‘rel_hum_avg’ (p = 
0.42) were statistically insignificant, therefore we removed these potential predictors from our 
model moving forward. 
 
A 10% increase in the population under 20 years old (RR = 0.84) and in the population with at 
least a 4-year college degree (RR = 0.85) was protective of asthma exacerbation in the inpatient 
setting. However, the community was at a greater risk of someone being hospitalized for asthma 
exacerbation in the inpatient setting for each 10% increase of the total population being black 
(RR = 1.06), 10% increase in the total population being in poverty (RR = 1.2), and 10% increase 
in homes heated with fuel oil, kerosene and etc. (RR = 1.09). When looking at the potential 
meteorological covariates, all were protective of AEi (RR < 1). (Table 3.3) 
 
Next, we ran a Moran I test under randomization to determine if spatial autocorrelation was still 
present.69 Our output determined the p-value for the Moran I statistics was 3.96e-05, which is 
significant, indicating this model is not properly specified due to the presence of spatial 
autocorrelation.  
 
Asthma Inpatient Covariates GLM RR GLMM RR 
10% increase in 'Under 20' 0.850 0.844 
10% increase in 'Black' 1.860 1.062 
10% increase in 'Poverty' 1.180 1.197 
10% increase in at least '4-year College 
graduate' 0.866 0.852 
10% increase in homes heated with 
'Fuel oil, kerosene, etc.' 1.099 1.094 
10-degree increase in average 'monthly 
maximum temperature' 0.916 0.923 
2-inch increase in total 'monthly 
precipitation' 0.996 --- 
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10% increase in average relative 
humidity 0.931 --- 
10 mile/hour increase in average wind 
speed 0.795 --- 
Increase of annual average 
PM2.5_90%-tile by 2 micrograms/m3 0.936 0.9268 
Table 3.3: Relative risks (RR) of potential predictor covariates for asthma exacerbation in the inpatient setting, across two 
models: general linear model (GLM) and general linear mixed model (GLMM). 
 
Bayesian results for Spatio-Temporal Changes in Asthma Exacerbation Inpatient Case Counts 
The Markov chains appeared to have converged indicating posterior distributions of parameters 
are essentially identical. This is the distribution representing our belief about 
the parameter values after we have performed our calculations and taking the observed data into 
account.86 The trace-plots of the parameters suggest convergence as they are stationary and show 
random fluctuations around a single mean level.69 In addition, CARBayesST presents the 
convergence diagnostic proposed by Geweke79 for sample parameters, which uses the 
geweke.diag() function. This statistic is in the form of a Z-score, and values between (-1.96, 
1.96) are suggestive of convergence.79 All covariates had values between (-1.96, 1.96) and can 
be seen in Table 3.4.  
 
 
Asthma 
Inpatient 
  
Socio-demographic Variables  
Percentage female --- 
Percentage under 20 years old 1.7 
Percentage over 64 years old --- 
Percentage identifying as 'Black 
(Hispanic and Non-Hispanic)' 0.6 
Percentage in Poverty -0.7 
Percentage having a 4-year 
college degree or higher -0.6 
Percentage using fuel 
oil/kerosene/etc. as their main 
source of house heating fuel 1.4 
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Median income --- 
  
Meteorological Variables  
Average maximum temperature 0.5 
Total precipitation --- 
Average relative humidity --- 
Average wind speed --- 
Average PM 2.5 in the 90th 
percentile (micrograms/m3) 1.1 
Table 3.4: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all 
covariates across Asthma Inpatient outcomes.  
Values between (-1.96, 1.96) are suggestive of convergence. 
 
The estimated Moran’s I statistics obtained from the residuals of this model was -0.027 and the 
p-value was 0.666, which is greater than (>) 0.05 and suggested no evidence of unexplained 
spatial autocorrelation after accounting for the covariate effects.  
 
The spatial and temporal dependence parameters were ρS = 0.964 and ρT = 0.967. The seasonal 
AEi posterior incidence case counts for the inpatient setting exhibited a spatial heterogenicity 
across the city (Figure 3.7). The highest AEi posterior case counts mainly occurred in the ZCTAs 
located throughout majority of the Bronx, Upper Manhattan, eastern Brooklyn and Central 
Queens. Northern and central Staten Island ZCTAs were also affected. However, the lowest AEi 
posterior case counts mainly occurred in the ZCTAs located in Mid- to Lower Manhattan, south-
western Brooklyn, southern Staten Island, and north-eastern Queens. 
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Figure 3.7: Spatio-temporal dynamic of asthma exacerbation inpatient case counts of fitted values (based on seasonal averages 
of posterior medians) per ZIP Code Tabulated Area (ZCTA) per for years 2016 – 2018 
 
Source: The shapefile was obtained from the Geospatial Data Library at the City University of New York (CUNY) 
Baruch College. The asthma exacerbation inpatient case counts were obtained from NYC Department of Health 
SPARCS. 
 
Effects of covariates on case counts of AEi 
Table 3.5 summarizes the three models, general linear model (GLM), general linear mixed model 
(GLMM) and Bayesian spatio-temporal model, evaluating the effects of covariates on case 
counts of AEi. The latter model further evaluates the spatio-temporal random effects on the case 
counts of AEi across NYC ZCTAs. In models 1 and 2, the Moran I statistic p-value was 
significant indicating the models were not properly fitted due to spatial autocorrelation. 
However, model 3 had an insignificant p-value for the Moran I statistic indicating this model was 
properly fitted and was able to adjust for spatial autocorrelation. Covariates with insignificant p-
values in models 1 and 2 were also dropped in model 3 as they had no statistical significance on 
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the outcome. Covariates that were also highly correlated with one another were dropped in 
models 2 and 3, based on both their statistical significance in model 1 and prior understanding of 
their relationship with the outcome. 
 
Asthma Inpatient Indicator 
General GLM 
Model            
(Coeff, [Pr(>|z|)]) 
GLMM Temporal-
Adjusted Model        
(Coeff, [p-value]) 
Bayesian Spatio-Temporal 
Adjusted Model                
(Coef, [95% CrI]) 
Fixed Effects    
Intercept -8.327 (<2e-16) -8.677 (0.000) -8.817 (-9.49, -8.207) 
Socio-demographic 
Variables    
Percentage female 5.605e-04 (0.909) --- --- 
Percentage under 20 years 
old 
-1.621e-02 (5.01e-
09) -0.017 (0.000) -0.02 (-0.031, -0.008) 
Percentage over 64 years 
old --- --- --- 
Percentage identifying as 
'Black (Hispanic and Non-
Hispanic)' 6.205e-02 (<2e-16) 0.006 (0.000) 0.007 (0.005, 0.009) 
Percentage in Poverty 
1.657e-02 (5.75e-
16) 0.018 (0.000) 0.023 (0.016, 0.03) 
Percentage having a 4-year 
college degree or higher -1.443e-02 (<2e-16) -0.016 (0.000) -0.012 (-0.017, -0.008) 
Percentage using fuel 
oil/kerosene/etc. as their 
main source of house 
heating fuel 9.401e-03 (<2e-16) 0.009 (0.000) 0.0004 (-0.006, 0.005) 
Median income -1.001e-06 (0.276) --- --- 
Meteorological Variables    
Average maximum 
temperature 
-8.797e-03 (8.59e-
15) -0.008 (0.001) -0.009 (-0.013, -0.006) 
Total precipitation -2.005e-03 (0.003) -0.029 (0.131) --- 
Average relative humidity -7.141e-03 (0.002) -0.005 (0.421) --- 
Average wind speed 
-2.292e-02 
(0.08530) --- --- 
Average PM 2.5 in the 90th 
percentile (micrograms/m3) -3.283e-02 (0.022) -0.038 (0.017) -0.072 (-0.134, -0.007) 
Spatio-temporal random 
effects variances --- --- 0.039 (0.027, 0.055) 
Spatial and Temporal 
Dependence --- ---  
Spatial dependence (ρS) --- --- 0.964 (0.924, 0.981) 
Temporal dependence (ρT) --- --- 0.967 (0.945, 0.988) 
Moran I test (p-value) 0.0001 3.96E-05 0.666 
DIC    
MCMC Chain 1 --- --- 19312 
MCMC Chain 2 --- --- 19310 
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MCMC Chain 3 --- --- 19310 
Table 3.5: Asthma exacerbation inpatient discharges reported by month and ZCTA, New York City, 2016 – 2018, as presented 
across three models 
General linear model (GLM) regression coefficients and p-values, General linear mixed model (GLMM) regression 
coefficients and p-values, and Median of posterior regression coefficients and 95% credible interval from 
hierarchical Bayesian spatio-temporal modelling. Note: CrI: credible interval, DIC: deviation information criteria. 
 
Regarding socio-demographic variables, the results (Table 3.6) showed that the posterior median 
and 95% credible interval for the relative risk of a 10% increase in the percentage of the 
population under 20 years old within a ZCTA was 0.819 (0.734, 0.923) and a 10% increase in 
the percentage of the population within a ZCTA having at least a 4-year college degree was 
0.886 (0.886, 0.926), indicating that an increase of this magnitude corresponds to a decrease in 
the episodes of AEi by 18.1% and 11.4%, respectively. In addition, the posterior median and 
95% credible interval for the relative risk of a 10% increase in the percentage of the population 
that is Black (Hispanic and non-Hispanic) within a ZCTA was 1.068 (1.047, 1.091), a 10% 
increase in the percentage of the population that is in poverty within a ZCTA was 1.257 (1.176, 
1.346), and a 10% increase in the percentage of the population that have their homes heated with 
fuel oil, kerosene and etc. was 1.004 (0.946, 1.054), indicating that an increase of this magnitude 
corresponds to an increase in the episodes of AEi by 6.8%, 25.7% and 0.4%, respectively. 
 
Regarding meteorological variables, the results (Table 3.6) showed that the posterior median and 
95% credible interval for the relative risk of a 10-degree Fahrenheit increase in the average 
monthly maximum temperature within a ZCTA was 0.913 (0.881, 0.944), indicating that an 
increase of this magnitude corresponds to a decrease in the episodes of AEi by 8.7%. The results 
also showed that the posterior median and 95% credible interval for the relative risk of a 2 
micrograms/meters cubed (mcg/m3) increase in the annual average PM 2.5 90th percentile within 
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a ZCTA was 0.872 (0.771, 1.012), indicating that an increase of this magnitude corresponds to a 
decrease in the episodes of AEi by 12.8%. 
 
Asthma Inpatient Covariates RR 95% CrI 
10% increase in 'Under 20' 0.819 (0.734, 0.923) 
10% increase in 'Black' 1.068 (1.047, 1.091) 
10% increase in 'Poverty' 1.257 (1.176, 1.346) 
10% increase in at least '4-year College 
graduate' 0.886 (0.886, 0.926) 
10% increase in homes heated with 'Fuel 
oil, kerosene, etc.' 1.004 (0.946, 1.054) 
10-degree increase in average 'monthly 
maximum temperature' 0.913 (0.881, 0.944) 
Increase of annual average PM2.5_90%-
tile by 2 micrograms/m3 0.872 (0.771, 1.012) 
Table 3.6: A summary of the Asthma Inpatient parameter estimates from the spatio-temporal model.   
The estimated asthma inpatient covariate effects are relative risks (RR) associated with a multiplier of 10 in all 
covariates except for PM 2.5 90th percentile which is associated with a multiplier of 2. 
 
Asthma Exacerbation Outpatient 
Asthma exacerbation outpatient (AEO) cases across New York City, 2016 to 2018 
At the city-wide level, the overall annual observed number of asthma exacerbation outpatient 
(AEo) discharges decreased between 2016 and 2018. The annual AEo crude case counts were 
estimated at 77 863, 74 137 and 69 016 per year for 2016, 2017, and 2018, respectively. The 
time-series decompositions of the monthly AEo population-based rates over the study period 
peaked between March and May of 2017. (Figure 3.8) We also observe great variability for AEo 
crude case counts as well as large outliers each month over the course of the study period, 
especially for January through May 2016, October 2016 through February 2017, May 2017, 
September 2017 through January 2018, and October through December 2018. (Figure 3.9)   
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Figure 3.8: Monthly New York City Asthma Exacerbation Outpatient Population-Based Rates per 100,000 residents, 2016 to 
2018. Source: NYS Department of Health SPARCS. 
 
 
Figure 3.9: Monthly New York City Asthma Exacerbation Outpatient Case Counts, 2016 to 2018. Source: NYS Department of 
Health SPARCS. 
 
Poisson Regression General Linear Model (GLM) 
We used ‘fitglm’ function in R to fit our GLM model with Poisson regression for our AEo 
outcome against our potential predictor variables, which did not consider spatial or temporal 
autocorrelation. Our output did not determine any potential predictor variables that were 
insignificant. However, in order to prevent multicollinearity we removed ‘income_median’ as a 
potential predictor variable because its beta estimate was negatively associated with our outcome 
(- 5.22e-06, Pr[>|z|] 2e-16) (as compared to the beta estimate of ‘college_pct’ which was positively 
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associated (5.22e-03 (Pr[>|z|] 2e-16)). We also removed ‘wind_avg’ as its beta estimate was -
3.42e-2 (Pr[>|z|] 2e-16 was more negatively associated with our outcome as compared to the beta 
estimate of ‘tempmax_avg’ being -1 .14e-02 (Pr[>|z|] 2e-16, and we are using average maximum 
temperature as a primary measure of climate variability.  
 
A 10% increase in the population under 20 years old (RR = 0.82) was protective of asthma 
exacerbation in the outpatient setting. However, the community was at a greater risk of someone 
being hospitalized for asthma exacerbation in the outpatient setting for each 10% increase of the 
total population being female (RR = 1.06), 10% increase of the total population being black (RR 
= 1.17), 10% increase in the total population being in poverty (RR = 1.61), 10% increase in the 
total population having at least a 4-year college degree (RR = 1.05), and 10% increase in homes 
heated with fuel oil, kerosene and etc. (RR = 1.11). When looking at the potential meteorological 
covariates, a 10-degree increase in average monthly maximum temperature (RR = 0.89), a 2-inch 
increase in total monthly precipitation (RR = 0.98) and a 10 mile/hour increase in average wind 
speed (RR = 0.71) were protective against AEo. However, a 10% increase in average relative 
humidity (RR = 1.02) and an increase of annual average PM 2.5 in the 90th percentile by 2 
micrograms per cubed meter (RR = 1.02) placed the community at higher risk of someone being 
hospitalized for AEo. (Table 3.7) 
 
Next, we ran a Moran I test under randomization to determine if spatial autocorrelation is 
present.69 Our output determined the p-value for the Moran I statistics is < 2.2e-16, which is         
< 0.05 and significant indicating this model is not properly specified due to the presence of 
spatial autocorrelation.  
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Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal 
Autocorrelation 
We used ‘fitglmmPQL’ function in R to fit our GLMM model with multivariate normal random 
effects, using Penalized Quasi-Likelihood67 to account for the situation where our random effects 
are correlated. In this model, we set time as measured in discharge month as our random effect. 
Our output determined the beta estimates for ‘college_pct’ (-0.001, p = 0.13), ‘precip_total’ (-
0.027, p = 0.13) and ‘rel_hum_avg’ (0.005, p = 0.42) were statistically insignificant, therefore 
we removed these potential predictors from our model moving forward. 
 
A 10% increase in the population under 20 years old (RR = 0.78) was protective of asthma 
exacerbation in the outpatient setting. However, the community was at a greater risk of 
hospitalizations for asthma exacerbation in the outpatient setting for each 10% increase of the 
total population being female (RR = 1.09), 10% increase of the total population being black (RR 
= 1.16), 10% increase in the total population being in poverty (RR = 1.73), and 10% increase in 
homes heated with fuel oil, kerosene and etc. (RR = 1.11). When looking at the potential 
meteorological covariates, a 10-degree increase in average monthly maximum temperature (RR 
= 0.91) and an increase of annual average PM 2.5 in the 90th percentile by 2 micrograms per 
cubed meter (RR = 0.97) were protective against hospitalizations for AEo within a community. 
(Table 3.7) 
 
Next, we ran a Moran I test under randomization to determine if spatial autocorrelation was 
present.69 Our output determined the p-value for the Moran I statistics was < 2.2e-16, which is 
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less than (<) 0.05 and significant indicating this model is not properly specified, either due to the 
presence of spatial autocorrelation or covariates (probably clustered in the landscape) that were 
not included in the model. 
 
Asthma Outpatient Covariates GLM (RR) GLMM (RR) 
10% increase in ‘female’ 1.064 1.094 
10% increase in 'Under 20' 0.815 0.779 
10% increase in 'Black' 1.167 1.162 
10% increase in 'Poverty' 1.612 1.733 
10% increase in at least '4-year College 
graduate' 1.054 --- 
10% increase in homes heated with 'Fuel oil, 
kerosene, etc.' 1.106 1.105 
10-degree increase in average 'monthly 
maximum temperature' 0.892 0.905 
Increase in total 'monthly precipitation' by 2-
inches 0.976 --- 
Increase in average relative humidity by 10% 1.016 --- 
Increase in average wind speed by 10 
miles/hour 0.710 --- 
Increase of annual average PM2.5_90%-tile by 
2 micrograms/m3 1.019 0.970 
Table 3.7: Relative risks (RR) of potential predictor covariates for asthma exacerbation in the outpatient setting, across two 
models: general linear model (GLM) and general linear mixed model (GLMM). 
 
Bayesian results for Spatio-Temporal Changes in Asthma Exacerbation Outpatient Case Counts 
The Markov chains appeared to have converged indicating posterior distributions of parameters 
are essentially identical. Despite the Geweke convergence diagnostic inadvertently suggesting 
there is a lack of convergence for majority of the covariates, it does suggest convergence for 
‘Percentage female’ with a value inside (-1.96, 1.96).(Table 3.8) We were further able to 
determine the presence of convergence among all of the covariates through trace-plot 
visualization of the parameters as they were stationary and showed random fluctuations around a 
single mean level.69  
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Asthma 
Outpatient 
  
Socio-demographic Variables  
Percentage female 0.8 
Percentage under 20 years old -11.9 
Percentage over 64 years old --- 
Percentage identifying as 'Black 
(Hispanic and Non-Hispanic)' 20 
Percentage in Poverty 17.6 
Percentage having a 4-year 
college degree or higher --- 
Percentage using fuel 
oil/kerosene/etc. as their main 
source of house heating fuel 14.9 
Median income --- 
  
Meteorological Variables  
Average maximum temperature -18.2 
Total precipitation --- 
Average relative humidity --- 
Average wind speed --- 
Average PM 2.5 in the 90th 
percentile (micrograms/m3) -6.9 
Table 3.8: Table showing statistics in the form of a Z-score for Geweke diagnostic function assessing convergence of all 
covariates across Asthma Outpatient outcomes.  
Values between (-1.96, 1.96) are suggestive of convergence. 
 
The estimated Moran’s I statistics obtained from the residuals of this model was -0.036 and the 
p-value was 0.195, which is greater than 0.05 and suggested no evidence of unexplained spatial 
autocorrelation after accounting for the covariate effects.  
 
The spatial and temporal dependence parameters were ρS = 0.999 and ρT = 0.884. The seasonal 
AEo posterior incidence case counts for the inpatient setting exhibited a spatial heterogenicity 
across the city (Figure 3.10). The highest AEo posterior case counts mainly occurred in the 
ZCTAs located throughout mid- and South Bronx, mid- and Upper Manhattan, eastern Brooklyn 
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and Central and Southern Queens. Parts of northern and eastern Staten Island ZCTAs were also 
affected.  
 
Figure 3.10: Spatio-temporal dynamic of asthma exacerbation outpatient case counts of fitted values (based on seasonal 
averages of posterior medians) per ZIP Code Tabulated Area (ZCTA) per for years 2016 – 2018. 
Source: The shapefile was obtained from the Geospatial Data Library at the City University of New York (CUNY) 
Baruch College. The asthma exacerbation inpatient case counts were obtained from NYC Department of Health 
SPARCS. 
 
Effects of covariates on case counts of AEo 
Table 3.9 summarizes the three models, general linear model (GLM), general linear mixed model 
(GLMM) and Bayesian spatio-temporal model, evaluating the effects of covariates on case 
counts of AEo. The latter model further evaluates the spatio-temporal random effects on the case 
counts of AEo across NYC ZCTAs. In models 1 and 2, the Moran I statistic p-value was 
significant indicating the models were not properly fitted due to spatial autocorrelation. 
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However, model 3 had an insignificant p-value for the Moran I statistic indicating this model was 
properly fitted and was able to adjust for spatial autocorrelation. Covariates with insignificant p-
values in models 1 and 2 were also dropped in model 3 as they had no statistical significance on 
the outcome. Covariates that were also highly correlated with one another were dropped in 
models 2 and 3, based on both their statistical significance in model 1 and prior understanding of 
their relationship with the outcome. 
 
Asthma Outpatient 
Indicator 
General GLM 
model                
(Coeff, [Pr(>|z|)]) 
GLMM Temporal-
Adjusted Model          
(Coeff, [p-value]) 
Bayesian Spatio-
Temporal Adjusted 
Model                    
(Coef, [95% CrI]) 
Fixed Effects    
Intercept -7.773 (<2e-16) -8.395 (0.000) -7.913 (-8.064, -7.756) 
Socio-demographic 
Variables    
Percentage female 6.237e-03 (2.07e-09) 0.009 (0.000) 
-0.0003 (-0.003, 
0.002) 
Percentage under 20 years 
old -2.043e-02 (<2e-16) -0.025 (0.000) 
-0.0003 (-0.002, 
0.001) 
Percentage over 64 years 
old --- --- --- 
Percentage identifying as 
'Black (Hispanic and Non-
Hispanic)' 1.547e-02 (<2e-16) 0.015 (0.000) 
0.0001 (-0.0002, 
0.0005) 
Percentage in Poverty 4.776e-02 (<2e-16) 0.055 (0.000) 
0.0007 (-0.0003, 
0.0023) 
Percentage having a 4-year 
college degree or higher 5.244e-03 (<2e-16) -0.001 (0.121) --- 
Percentage using fuel 
oil/kerosene/etc. as their 
main source of house 
heating fuel 1.005e-02 (<2e-16) 0.01 (0.000) 
0.000 (-0.0004, 
0.0003) 
Median income -5.224e-06 (<2e-16) --- --- 
Meteorological Variables    
Average maximum 
temperature -1.141e-02 (<2e-16) -0.010 (0.000) 
-0.0001 (-0.0004, 
0.0002) 
Total precipitation -1.2e-02 (3.2e-13) -0.027 (0.185) --- 
Average relative humidity 1.544e-03 (0.005) 0.005 (0.469) --- 
Average wind speed -3.422e-02 (<2e-16) --- --- 
Average PM 2.5 in the 90th 
percentile 
(micrograms/m3) 9.477e-03 (0.007) -0.015 (0.049) -0.001 (-0.008, 0.006) 
Spatio-temporal random 
effects variances --- --- 0.042 (0.028, 0.06) 
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Spatio and Temporal 
Dependence --- --- 
0.0003 (0.0003, 
0.0004) 
Spatial dependence (ρS) --- --- 0.9999 (0.9999, 1) 
Temporal dependence (ρT) --- --- 0.884 (0.846, 0.918) 
Moran I test (p-value) 2.20E-16 2.20E-16 0.195 
DIC --- --- 30068 
Table 3.9: Asthma exacerbation outpatient discharges reported by month and ZCTA, New York City, 2016 – 2018, as presented 
across three models  
General linear model (GLM) regression coefficients and p-values, General linear mixed model (GLMM) regression 
coefficients and p-values, and Median of posterior regression coefficients and 95% credible interval from 
hierarchical Bayesian spatio-temporal modelling. Note: CrI: credible interval, DIC: deviation information criteria 
 
Regarding socio-demographic variables, the results (Table 3.10) showed that the posterior 
median and 95% credible interval for the relative risk of a 10% increase in the percentage of the 
population within a ZCTA being female was 0.997 (0.972, 1.024) and a 10% increase in the 
percentage of the population under 20 years old within a ZCTA was 0.997 (0.984, 1.009), 
indicating that an increase of this magnitude corresponds to a decrease in the episodes of AEo by 
0.3% and 0.3%, respectively. In addition, the posterior median and 95% credible interval for the 
relative risk of a 10% increase in the percentage of the population that is Black (Hispanic and 
non-Hispanic) within a ZCTA was 1.001 (0.998, 1.005), a 10% increase in the percentage of the 
population that is in poverty within a ZCTA was 1.007 (0.997, 1.024), and a 10% increase in the 
percentage of the population that have their homes heated with fuel oil, kerosene and etc. was 
1.000 (0.996, 1.003) indicating that an increase of this magnitude corresponds to an increase in 
the episodes of AEo by 0.1%, 0.7% and 0%, respectively. 
 
Regarding meteorological variables, the results (Table 3.10) showed that the posterior median 
and 95% credible interval for the relative risk of a 10-degree Fahrenheit increase in the average 
monthly maximum temperature within a ZCTA was 0.999 (0.996, 1.002), indicating that an 
increase of this magnitude corresponds to a decrease in the episodes of AEo by 0.1%. The results 
 
75 
also showed that the posterior median and 95% credible interval for the relative risk of a 2 
micrograms/meters cubed (mcg/m3) increase in the annual average PM 2.5 90th percentile within 
a ZCTA was 0.998 (0.984, 1.012), indicating that an increase of this magnitude corresponds to a 
decrease in the episodes of AEo by 0.2%. 
 
Asthma Outpatient Covariate RR 95% CrI 
10% increase in 'Female' 0.997 (0.972, 1.024) 
10% increase in 'Under 20' 0.997 (0.984, 1.009) 
10% increase in 'Black' 1.001 (0.998, 1.005) 
10% increase in 'Poverty' 1.007 (0.997, 1.024) 
10% increase in homes heated 
with 'Fuel oil, kerosene, etc.' 1 (0.996, 1.003) 
10-degree increase in average 
'monthly maximum 
temperature' 0.999 (0.996, 1.002) 
Increase of annual average 
PM2.5_90%-tile by 2 
micrograms/m3 0.998 (0.984, 1.012) 
Table 3.10: A summary of the Asthma Outpatient parameter estimates from the spatio-temporal model.   
The estimated asthma outpatient covariate effects are relative risks (RR) associated with a multiplier of 10 in all 
covariates except for PM 2.5 90th percentile which is associated with a multiplier of 2. 
 
COPD Inpatient 
COPD exacerbation inpatient (CEi) cases across New York City, 2016 to 2018 
At the city-wide level, the overall annual observed number of COPD exacerbation inpatient 
(CEi) discharges decreased between 2016 and 2018. The annual CEi crude case counts were 
estimated at 11 752, 10 861 and 10 241 per year for 2016, 2017, and 2018, respectively. The 
time-series decompositions of the monthly CEi population-based rates over the study period 
peaked between November 2016 and January 2017. (Figure 3.11)  We also observe that there is 
great variability for CEi crude case counts as well as large outliers each month over the course of 
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the study period, especially for March 2016, February and May 2017, and January, October and 
December 2018. (Figure 3.12)   
 
 
Figure 3.11: Monthly New York City COPD Exacerbation Inpatient Population-Based Rates per 100,000 residents, 2016 to 
2018. Source: NYS Department of Health SPARCS. 
 
 
Figure 3.12: Monthly New York City COPD Exacerbation Inpatient Case Counts, 2016 to 2018. Source: NYS Department of 
Health SPARCS. 
 
Poisson Regression General Linear Model (GLM) 
We used ‘fitglm’ function in R to fit our GLM model with Poisson regression for our CEi 
outcome against our potential predictor variables, which did not consider spatial or temporal 
autocorrelation. Our output did not determine any potential predictor variables that were 
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insignificant. However, in order to prevent multicollinearity we removed ‘income_median’ as a 
potential predictor variable because the p-value for its beta estimate was Pr[>|z|] = 2.2e-08 (as 
compared to the p-value for the beta estimate of ‘college_pct’ being Pr[>|z|] 1.01e-11). We also 
removed ‘wind_avg’ as its p-value for its beta estimate was Pr[>|z|] = 8.42e-14 (as compared to 
the p-value for the beta estimate of ‘tempmax_avg’ being Pr[>|z|] < 2e-16) and we are using 
average maximum temperature as a primary measure of climate variability.  
 
A 10% increase in the population with at least a 4-year college degree (RR = 0.88) was 
protective of COPD exacerbation in the inpatient setting. However, the community was at a 
greater risk of someone being hospitalized for CEi  for each 10% increase of the total population 
being over 64 years old (RR = 1.39), 10% increase of the total population being black (RR = 
1.02), 10% increase in the total population being in poverty (RR = 1.33), and 10% increase in 
homes heated with fuel oil, kerosene and etc. (RR = 1.01). When looking at the potential 
meteorological covariates, all were protective of CEi (RR < 1). (Table 3.11) 
 
Next, we ran a Moran I test under randomization to determine if spatial autocorrelation is 
present.69 Our output determined the p-value for the Moran I statistics is 3.21e-05, which is < 0.05 
and significant indicating this model is not properly specified, either due to the presence of 
spatial autocorrelation or covariates (probably clustered in the landscape) that were not included 
in the model. 
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Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal 
Autocorrelation 
We used ‘fitglmmPQL’ function in R to fit our GLMM model with multivariate normal random 
effects, using Penalized Quasi-Likelihood67 to account for the situation where our random effects 
are correlated. In this model, we set time as measured in discharge month as our random effect. 
Our output determined the beta estimates for ‘rel_hum_avg’ (-0.01, p = 0.17) was statistically 
insignificant, therefore we removed this potential predictor variable from our model moving 
forward. 
 
A 10% increase in the population with at least a 4-year college degree (RR = 0.91) was 
protective of COPD exacerbation in the inpatient setting. However, the community was at a 
greater risk for CEi hospitalizations for each 10% increase of the total population being over 64 
years old (RR = 1.19), 10% increase of the total population being black (RR = 1.02), 10% 
increase in the total population being in poverty (RR = 1.26), and 10% increase in homes heated 
with fuel oil, kerosene and etc. (RR = 1.01). When looking at the potential meteorological 
covariates, all were protective of CEi (RR < 1). (Table 3.11) 
 
Next, we ran a Moran I test under randomization to determine if spatial autocorrelation was 
present.69 Our output determined the p-value for the Moran I statistics was 8.57e-05, which is 
less than 0.05 and significant indicating this model is not properly specified, either due to the 
presence of spatial autocorrelation or covariates (probably clustered in the landscape) that were 
not included in the model.  
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COPD Inpatient Covariates GLM (RR) GLMM (RR) 
10% increase in ‘female’ 1.014 1.185 
10% increase in 'Over 64' 1.389 1.336 
10% increase in 'Black' 1.022 1.020 
10% increase in 'Poverty' 1.328 1.259 
10% increase in at least '4-year 
College graduate' 0.879 0.914 
10% increase in homes heated with 
'Fuel oil, kerosene, etc.' 1.011 1.010 
10-degree increase in average 
'monthly maximum temperature' 0.926 0.970 
Increase in total 'monthly 
precipitation' by 2-inches 0.980 0.949 
Increase in average relative 
humidity by 10% 0.901 --- 
Increase in average wind speed by 
10 miles/hour 0.534 --- 
Increase of annual average 
PM2.5_90%-tile by 2 
micrograms/m3 0.858 0.876 
Table 3.11: Relative risks (RR) of potential predictor covariates COPD exacerbation in the inpatient setting, across two models: 
general linear model (GLM) and general linear mixed model (GLMM). 
 
Bayesian results for Spatio-Temporal Changes in COPD Exacerbation Inpatient Case Counts 
The Markov chains appeared to have converged indicating posterior distributions of CEi 
parameters are essentially identical. We were able to determine convergence from the trace-plots 
of the parameters, as they were stationary and showed random fluctuations around a single mean 
level.69 In addition, the convergence diagnostic proposed by Geweke79 for sample parameters 
showed all covariates for CEi had values between (-1.96, 1.96), which is suggestive of 
convergence.79 (Table 3.12) 
 
 COPD Inpatient 
  
Socio-demographic Variables  
Percentage female 1.5 
Percentage under 20 years old --- 
Percentage over 64 years old -1.5 
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Percentage identifying as 'Black (Hispanic 
and Non-Hispanic)' -1.9 
Percentage in Poverty -1.5 
Percentage having a 4-year college degree 
or higher -1.1 
Percentage using fuel oil/kerosene/etc. as 
their main source of house heating fuel 0.1 
Median income --- 
  
Meteorological Variables  
Average maximum temperature 1.1 
Total precipitation 0 
Average relative humidity --- 
Average wind speed --- 
Average PM 2.5 in the 90th percentile 
(micrograms/m3) 1.7 
Table 3.12: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all 
covariates across COPD Inpatient outcomes.  
Values between (-1.96, 1.96) are suggestive of convergence. 
 
The estimated Moran’s I statistics obtained from the residuals of this model was -0.03 and the p-
value was 0.225, which is greater than 0.05 and suggested no evidence of unexplained spatial 
autocorrelation after accounting for the covariate effects.  
 
The spatial and temporal dependence parameters were ρS = 0.924 and ρT = 0.963. The seasonal 
CEi posterior incidence case counts for the inpatient setting exhibited a spatial heterogenicity 
across the city (Figure 3.13). The highest CEi posterior case counts mainly occurred in the 
ZCTAs located throughout mid- and south-Western Bronx, Upper Manhattan, eastern Brooklyn 
and central Staten Island. Northern Queens near LGA airport as well as parts of south/central 
Queens near JFK airport were also affected. However, the lowest CEi posterior case counts 
mainly occurred in the ZCTAs located in Mid- to Lower Manhattan, southern Staten Island, and 
eastern Queens. 
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Figure 3.13: Spatio-temporal dynamic of COPD exacerbation inpatient case counts of fitted values (based on seasonal averages 
of posterior medians) per ZIP Code Tabulated Area (ZCTA) per for years 2016 – 2018. 
Source: The shapefile was obtained from the Geospatial Data Library at the City University of New York (CUNY) 
Baruch College. The asthma exacerbation inpatient case counts were obtained from NYC Department of Health 
SPARCS. 
 
Effects of covariates on case counts of CEi 
Table 3.13 summarizes the three models, general linear model (GLM), general linear mixed 
model (GLMM) and Bayesian spatio-temporal model, evaluating the effects of covariates on 
case counts of CEi. The latter model further evaluates the spatio-temporal random effects on the 
case counts of CEi across NYC ZCTAs. In models 1 and 2, the Moran I statistic p-value was 
significant indicating the models were not properly fitted due to spatial autocorrelation. 
However, model 3 had an insignificant p-value for the Moran I statistic indicating this model was 
properly fitted and was able to adjust for spatial autocorrelation. Covariates with insignificant p-
values in models 1 and 2 were also dropped in model 3 as they had no statistical significance on 
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the outcome. Covariates that were also highly correlated with one another were dropped in 
models 2 and 3, based on both their statistical significance in model 1 and prior understanding of 
their relationship with the outcome. 
 
COPD Inpatient Indicator 
General GLM 
Model (Coeff, 
[Pr(>|z|)]) 
GLMM 
Temporal-
Adjusted Model    
(Coeff, [p-value]) 
Bayesian Spatio-
Temporal Adjusted 
Model                         
(Coef, [95% CrI]) 
Fixed Effects    
Intercept -8.384 (<2e-16) -9.48 (0.000) -9.871 (-10.749, -9.121) 
Socio-demographic Variables    
Percentage female 1.372e-03 (0.000) 0.017 (0.001) 0.01 (-0.004, 0.025) 
Percentage under 20 years old --- --- --- 
Percentage over 64 years old 3.284e-02 (<2e-16) 0.029 (0.000) 0.033 (0.024, 0.043) 
Percentage identifying as 
'Black (Hispanic and Non-
Hispanic)' 2.174e-03 (7.63e-11) 0.002 (0.000) 0.003 (0.0004, 0.005) 
Percentage in Poverty 2.839e-02 (<2e-16) 0.023 (0.000) 0.025 (0.02, 0.031) 
Percentage having a 4-year 
college degree or higher -1.285e-02 (<2e-16) -0.009 (0.000) -0.008 (-0.012, -0.004) 
Percentage using fuel 
oil/kerosene/etc. as their main 
source of house heating fuel 1.070e-03 (0.007) 0.001 (0.013) 
-0.005 (-0.0086, -
0.0012) 
Median income 3.588e-06 (<2e-16) --- --- 
Meteorological Variables    
Average maximum 
temperature -7.64e-03 (<2e-16) -0.003 (0.019) -0.005 (-0.006, -0.003) 
Total precipitation -1.022e-02 (0.016) -0.026 (0.027) -0.025 (-0.037, -0.014) 
Average relative humidity -1.038e-02 (3.41e-13) -0.005 (0.166) --- 
Average wind speed -6.265e-02 (8.42e-14) --- --- 
Average PM 2.5 in the 90th 
percentile (micrograms/m3) -7.657e-02 (<2e-16) -0.066 (0.000) -0.008 (-0.049, 0.031) 
Spatio-temporal random 
effects variances --- --- 0.042 (0.028, 0.06) 
Spatio and Temporal 
Dependence --- --- 0.03 (0.024, 0.038) 
Spatial dependence (ρS) --- --- 0.924 (0.873, 0.955) 
Temporal dependence (ρT) --- --- 0.963 (0.946, 0.978) 
Moran I test (p-value) 1.59E-05 0.0002 0.233 
DIC    
MCMC Chain 1 --- --- 26951 
MCMC Chain 2 --- --- 26954 
MCMC Chain 3 --- --- 26949 
Table 3.13: COPD exacerbation inpatient discharges reported by month and ZCTA, New York City, 2016 – 2018, as presented 
across three models  
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General linear model (GLM) regression coefficients and p-values, General linear mixed model (GLMM) regression 
coefficients and p-values, and Median of posterior regression coefficients and 95% credible interval from 
hierarchical Bayesian spatio-temporal modelling. Note: CrI: credible interval, DIC: deviation information criteria. 
 
Regarding socio-demographic variables, the results (Table 3.14) showed that the posterior 
median and 95% credible interval for the relative risk of a 10% increase in the percentage of the 
population that had at least a 4-year college degree within a ZCTA was 0.892 (0.892, 0.959), a 
10% increase in the percentage of the population within a ZCTA being female was 0.957 (0.957, 
1.279) and a 10% increase in the percentage of the population that have their homes heated with 
fuel oil, kerosene and etc. was 0.917 (0.917, 0.988), indicating that an increase of this magnitude 
corresponds to a decrease in the episodes of CEi by 10.8%, 4.3% and 8.3%, respectively. 
Furthermore, the posterior median and 95% credible interval for the relative risk of a 10% 
increase in the percentage of the population over 64 years old within a ZCTA was 1.396 (1.266, 
1.536), and a 10% increase in the percentage of the population that is Black (Hispanic and non-
Hispanic) within a ZCTA was 1.004 (1.004, 1.049), and a 10% increase in the percentage of the 
population that is in poverty within a ZCTA was 1.219 (1.219, 1.363), indicating that an increase 
of this magnitude corresponds to an increase in the episodes of CEi by 39.6%, 0.4% and 21.9%, 
respectively. 
 
Regarding meteorological variables, the results (Table 3.14) showed that the posterior median 
and 95% credible interval for the relative risk of a 10-degree Fahrenheit increase in the average 
monthly maximum temperature within a ZCTA was 0.938 (0.938, 0.974), indicating that an 
increase of this magnitude corresponds to a decrease in the episodes of CEi by 6.2%. The results 
also showed that the posterior median and 95% credible interval for the relative risk of a 2-inch 
increase in the total monthly precipitation within a ZCTA was 0.951 (0.928, 0.975), indicating 
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that an increase of this magnitude corresponds to a decrease in the episodes of CEi by 4.9%. In 
addition, the results showed that the posterior median and 95% credible interval for the relative 
risk of a 2 micrograms/meters cubed (mcg/m3) increase in the annual average PM 2.5 90th 
percentile within a ZCTA was 0.989 (0.916, 1.0184), indicating that an increase of this 
magnitude corresponds to a decrease in the episodes of CEi by 1.1%. 
 
COPD Inpatient Covariate RR 95% CrI 
10% increase in 'Over 64' 1.396 (1.266, 1.536) 
10% increase in 'Black' 1.004 (1.004, 1.049) 
10% increase in 'Poverty' 1.219 (1.219, 1.363) 
10% increase in at least '4-year College 
graduate' 0.892 (0.892, 0.959) 
10% increase in 'Female' 0.957 (0.957, 1.279) 
10% increase in homes heated with 'Fuel 
oil, kerosene, etc.' 0.917 (0.917, 0.988) 
10-degree increase in average 'monthly 
maximum temperature' 0.938 (0.938, 0.974) 
2-inch increase in total 'monthly 
precipitation' 0.951 (0.928, 0.975) 
Increase of annual average PM2.5_90%-
tile by 2 micrograms/m3 0.989 (0.916, 1.084) 
Table 3.14: A summary of the COPD Inpatient parameter estimates from the spatio-temporal model.  
The estimated COPD inpatient covariate effects are relative risks (RR) associated with a multiplier of 10 in all 
covariates except for PM 2.5 90th percentile and total precipitation which are associated with a multiplier of 2. 
 
COPD Outpatient 
COPD exacerbation outpatient (CEo) cases across New York City, 2016 to 2018 
At the city-wide level, the overall annual observed number of COPD exacerbation outpatient 
(CEo) discharges decreased between 2016 and 2018. The annual CEo crude case counts were 
estimated at 8 118, 8 354 and 8 075 per year for 2016, 2017, and 2018, respectively. The time-
series decompositions of the monthly CEo population-based rates over the study period peaked 
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between November 2016 and January 2017, as well as between September and November 2018. 
(Figure 3.14) We also observe that there is great variability for CEo crude case counts as well as 
large outliers each month over the course of the study period, especially for January, March and 
June 2016, January and February 2017, and then again for October 2018. (Figure 3.15)   
 
 
Figure 3.14: Monthly New York City COPD Exacerbation Outpatient Population-Based Rates per 100,000 residents, 2016 to 
2018. Source: NYS Department of Health SPARCS. 
 
 
 
Figure 3.15: Monthly New York City COPD Exacerbation Outpatient Case Counts, 2016 to 2018. Source: NYS Department of 
Health SPARCS. 
 
Poisson Regression General Linear Model (GLM) 
We used ‘fitglm’ function in R to fit our GLM model with Poisson regression for our CEo 
outcome against our potential predictor variables, which did not consider spatial or temporal 
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autocorrelation. Our output determined ‘wind_avg’ was not statistically significant (Pr[>|z|] 
0.44) with our outcome. Therefore, we removed this potential predictor variable as it was also 
highly correlated with our primary measure of climate variability, average maximum 
temperature. We also removed ‘income_median’ (Pr[>|z|] 1.56e-15) in order to prevent 
multicollinearity as it was highly correlated with ‘college_pct’ (Pr[>|z|] < 2e-16) and had less 
statistical significance within our output.  
 
A 10% increase in the population that are female (RR = 0.89) as well as a 10% increase in homes 
heated with fuel oil, kerosene and etc. (RR = 0.99) was protective of COPD exacerbation in the 
outpatient setting. However, the community was at a greater risk of a CEo hospitalization for 
each 10% increase of the total population being over 64 years old (RR = 1.16), 10% increase of 
the total population being black (RR = 1.14), 10% increase in the total population being in 
poverty (RR = 1.61), and 10% increase in the population with at least a 4-year college degree 
(RR = 1.24). When looking at the potential meteorological covariates, all were protective of CEo 
(RR < 1) except for an increase in the relative humidity by 10% (RR = 1.04) which was a risk 
factor for CEo. (Table 3.15) 
 
Next, we ran a Moran I test under randomization to determine if spatial autocorrelation is 
present.69 Our output determined the p-value for the Moran I statistics was 0.59, which is greater 
than (>) 0.05 and insignificant indicating this model may be properly specified. Regardless, we 
will continue with adjusting for spatio-temporal autocorrelation as we understand our data are 
spatially and temporally misaligned and climate may still have a random effect. 
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Poisson Regression General Linear Mixed Model (GLMM) with Adjustment for Temporal 
Autocorrelation 
We used ‘fitglmmPQL’ function in R to fit our GLMM model with multivariate normal random 
effects, using Penalized Quasi-Likelihood67 to account for the situation where our random effects 
are correlated. In this model, we set time as measured in discharge month as our random effect. 
Our output determined the beta estimates for ‘precip_total’ (-0.01, p = 0.24) and ‘rel_hum_avg’ 
(0.05, p = 0.28) were statistically insignificant so we removed these potential predictor variables 
from our model moving forward. 
 
Sociodemographic covariates protective of COPD exacerbation in the outpatient setting included 
a 10% increase in the population that are female (RR = 0.89) as well as a 10% increase in homes 
heated with fuel oil, kerosene and etc. (RR = 0.98). However, the community was at a greater 
risk of CEo hospitalizations for each 10% increase of the total population being over 64 years old 
(RR = 1.21), 10% increase of the total population being black (RR = 1.14), 10% increase in the 
total population being in poverty (RR = 1.72), and 10% increase in the population with at least a 
4-year college degree (RR = 1.17). In regards to the potential meteorological covariates, all were 
protective of CEo (RR < 1). (Table 3.15) 
 
Next, we ran a Moran I test under randomization to determine if spatial autocorrelation was 
present.69 Our output determined the p-value for the Moran I statistics was 0.51 which is greater 
than (>) 0.05 and insignificant indicating this model may be properly specified. Regardless, we 
will continue with adjusting for spatio-temporal autocorrelation as we understand our data are 
spatially and temporally misaligned and climate may still have a random effect. 
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COPD Outpatient Covariates GLM (RR) GLMM (RR) 
10% increase in ‘female’ 0.890 0.887 
10% increase in 'Over 64' 1.160 1.209 
10% increase in 'Black' 1.140 1.139 
10% increase in 'Poverty' 1.613 1.716 
10% increase in at least '4-year College 
graduate' 1.241 1.174 
10% increase in homes heated with 'Fuel oil, 
kerosene, etc.' 0.989 0.980 
10-degree increase in average 'monthly 
maximum temperature' 0.959 0.961 
Increase in total 'monthly precipitation' by 2-
inches 0.977 --- 
Increase in average relative humidity by 10% 1.039 --- 
Increase in average wind speed by 10 miles/hour 0.929 --- 
Increase of annual average PM2.5_90%-tile by 2 
micrograms/m3 0.961 0.931 
Table 3.15: Relative risks (RR) of potential predictor covariates COPD exacerbation in the outpatient setting, across two 
models: general linear model (GLM) and general linear mixed model (GLMM). 
 
 
Bayesian results for Spatio-Temporal Changes in COPD Exacerbation Outpatient Case Counts 
The Markov chains appeared to have converged indicating posterior distributions of CEo 
parameters are essentially identical. We are able to determine convergence from the trace-plots 
of the parameters, as they were stationary and showed random fluctuations around a single mean 
level.69 In addition, the convergence diagnostic proposed by Geweke79 for sample parameters 
shows all covariates for CEo had values between (-1.96, 1.96), which is suggestive of 
convergence.79 (Table 3.16) 
 
 
COPD 
Outpatient 
  
Socio-demographic Variables  
Percentage female -0.7 
Percentage under 20 years old --- 
Percentage over 64 years old 0.2 
Percentage identifying as 'Black 
(Hispanic and Non-Hispanic)' 1.9 
Percentage in Poverty -0.5 
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Percentage having a 4-year 
college degree or higher 0.9 
Percentage using fuel 
oil/kerosene/etc. as their main 
source of house heating fuel 0.4 
Median income --- 
  
Meteorological Variables  
Average maximum temperature -0.8 
Total precipitation --- 
Average relative humidity --- 
Average wind speed --- 
Average PM 2.5 in the 90th 
percentile (micrograms/m3) -0.6 
Table 3.16: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all 
covariates across COPD Outpatient outcomes..  
Values between (-1.96, 1.96) are suggestive of convergence. 
 
 
The estimated Moran’s I statistics obtained from the residuals of this model was -0.057 and the 
p-value was 0.864, which is greater than 0.05 and suggested no evidence of unexplained spatial 
autocorrelation after accounting for the covariate effects.  
 
The spatial and temporal dependence parameters were ρS = 0.81 and ρT = 0.948. The seasonal 
CEo posterior incidence case counts for the outpatient setting exhibited a spatial heterogenicity 
across the city (Figure 3.16). The highest CEo posterior case counts mainly occurred in the 
ZCTAs located throughout mid- and southern Bronx, Upper Manhattan, eastern and southern 
Brooklyn and north-Western Staten Island. The island off Queens housing Far Rockaway, 
Breezy Point and Broad Channel was also affected. However, the lowest CEo posterior case 
counts mainly occurred in the ZCTAs located in north Bronx, Mid- to Lower Manhattan, 
northern and eastern Queens, and southern Staten Island. 
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Figure 3.16: Spatio-temporal dynamic of COPD exacerbation outpatient case counts of fitted values (based on seasonal 
averages of posterior medians) per ZIP Code Tabulated Area (ZCTA) per for years 2016 – 2018. 
Source: The shapefile was obtained from the Geospatial Data Library at the City University of New York (CUNY) 
Baruch College. The asthma exacerbation inpatient case counts were obtained from NYC Department of Health 
SPARCS. 
 
Effects of covariates on case counts of CEo 
Table 3.17 summarizes the three models, general linear model (GLM), general linear mixed 
model (GLMM) and Bayesian spatio-temporal model, evaluating the effects of covariates on 
case counts of CEo. The latter model further evaluates the spatio-temporal random effects on the 
case counts of CEo across NYC ZCTAs. In all three models, the Moran I statistic p-value was 
insignificant indicating the models were properly fitted and lacked spatial autocorrelation. 
Covariates with insignificant p-values in models 1 and 2 were also dropped in model 3 as they 
had no statistical significance on the outcome. Covariates that were also highly correlated with 
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one another were dropped in models 2 and 3, based on both their statistical significance in model 
1 and prior understanding of their individual relationship with the outcome. 
 
COPD Outpatient Indicator 
General GLM Model 
(Coeff, [Pr(>|z|)]) 
GLMM Temporal-
Adjusted Model     
(Coeff, [p-value]) 
Bayesian Spatio-
Temporal Adjusted 
Model                     
(Coef, [95% CrI]) 
Fixed Effects    
Intercept -1.058e+01 (<2e-16) -10.843 (0.000) 
-10.967 (-11.865, -
10.087) 
Socio-demographic 
Variables    
Percentage female -1.169e-02 (0.000) -0.012 (0.007) -0.004 (-0.017, 0.011) 
Percentage under 20 years 
old --- --- --- 
Percentage over 64 years 
old 1.485e-02 (2.37e-13) 0.019 (0.000) 0.018 (0.006, 0.03) 
Percentage identifying as 
'Black (Hispanic and Non-
Hispanic)' 1.309e-02 (<2e-16) 0.013 (0.000) 0.009 (0.006, 0.11) 
Percentage in Poverty 4.779e-02 (<2e-16) 0.054 (0.000) 0.041 (0.035, 0.048) 
Percentage having a 4-year 
college degree or higher 2.159e-02 (<2e-16) 0.016 (0.000) -0.0001 (-0.005, 0.004) 
Percentage using fuel 
oil/kerosene/etc. as their 
main source of house 
heating fuel -1.135e-03 (0.014) -0.002 (0.024) -0.004 (-0.009, 0.001) 
Median income -4.628e-06 (1.56e-15) --- --- 
Meteorological Variables    
Average maximum 
temperature -4.154e-03 (3.9e-07) -0.004 (0.012) -0.004 (-0.006, -0.001) 
Total precipitation -1.168e-02 (0.018) -0.013 (0.244) --- 
Average relative humidity 3.839e-03 (0.02) 0.004 (0.278) --- 
Average wind speed -7.405e-03 (0.44) --- --- 
Average PM 2.5 in the 90th 
percentile (micrograms/m3) -1.992e-02 (0.029) -0.036 (0.006) 0.069 (0.003, 0.134) 
Spatio-temporal random 
effects variances --- --- 0.042 (0.028, 0.06) 
Spatio and Temporal 
Dependence --- --- 0.08 (0.066, 0.096) 
Spatial dependence (ρS) --- --- 0.81 (0.711, 0.882) 
Temporal dependence (ρT) --- --- 0.948 (0.932, 0.964) 
Moran, I test (p-value) 0.59 0.513 0.864 
DIC --- --- 24112 
Table 3.17: COPD exacerbation outpatient discharges reported by month and ZCTA, New York City, 2016 – 2018, as presented 
across three models  
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General linear model (GLM) regression coefficients and p-values, General linear mixed model (GLMM) regression 
coefficients and p-values, and Median of posterior regression coefficients and 95% credible interval from 
hierarchical Bayesian spatio-temporal modelling. Note: CrI: credible interval, DIC: deviation information criteria. 
 
Regarding socio-demographic variables, the results (Table 3.18) showed that the posterior 
median and 95% credible interval for the relative risk of a 10% increase in the percentage of the 
population that had at least a 4-year college degree within a ZCTA was 0.999 (0.955, 1.041), a 
10% increase in the percentage of the population within a ZCTA being female was 0.964 (0.84, 
1.113) and a 10% increase in the percentage of the population that have their homes heated with 
fuel oil, kerosene and etc. was 0.961 (0.912, 1.011), indicating that an increase of this magnitude 
corresponds to a decrease in the episodes of CEo by 0.1%, 3.6% and 3.9%, respectively. 
Furthermore, the posterior median and 95% credible interval for the relative risk of a 10% 
increase in the percentage of the population over 64 years old within a ZCTA was 1.199 (1.063, 
1.354), and a 10% increase in the percentage of the population that is Black (Hispanic and non-
Hispanic) within a ZCTA was 1.088 (1.062, 1.116), and a 10% increase in the percentage of the 
population that is in poverty within a ZCTA was 1.505 (1.414, 1.621), indicating that an increase 
of this magnitude corresponds to an increase in the episodes of CEo by 19.9%, 8.8% and 50.5%, 
respectively. 
 
Regarding meteorological variables, the results (Table 3.18) showed that the posterior median 
and 95% credible interval for the relative risk of a 10-degree Fahrenheit increase in the average 
monthly maximum temperature within a ZCTA was 0.966 (0.943, 0.986), indicating that an 
increase of this magnitude corresponds to a decrease in the episodes of CEo by 3.4%. The results 
also showed that the posterior median and 95% credible interval for the relative risk of a 2 
micrograms/meters cubed (mcg/m3) increase in the annual average PM 2.5 90th percentile within 
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a ZCTA was 1.146 (1.016, 1.291), indicating that an increase of this magnitude corresponds to 
an increase in the episodes of CEo by 14.6%. 
 
COPD Outpatient Covariate RR 95% CrI 
10% increase in 'Over 64' 1.199 (1.063, 1.354) 
10% increase in 'Black' 1.088 (1.062, 1.116) 
10% increase in 'Poverty' 1.505 (1.414, 1.621) 
10% increase in at least '4-year 
College graduate' 0.999 (0.955, 1.041) 
10% increase in 'Female' 0.964 (0.84, 1.113) 
10% increase in homes heated 
with 'Fuel oil, kerosene, etc.' 0.961 (0.912, 1.011) 
10-degree increase in average 
'monthly maximum 
temperature' 0.966 (0.943, 0.986) 
Increase of annual average 
PM2.5_90%-tile by 2 
micrograms/m3 1.146 (1.016, 1.291) 
Table 3.18: A summary of the COPD outpatient parameter estimates from the spatio-temporal model.  
 The estimated COPD outpatient covariate effects are relative risks (RR) associated with a multiplier of 10 in all 
covariates except for PM 2.5 90th percentile and total precipitation which are associated with a multiplier of 2. 
 
Outliers and model quality 
Each outcome was assessed for the presence of outliers to confirm model quality. The ZCTA 
‘11430’ appeared as an extreme outlier across all four outcomes. This ZCTA mostly lies in John 
F. Kennedy Airport in Jamaica, Queens, NY and only has a total population 198. All three 
models were run with this ZCTA removed for each outcome and results were not much different. 
This implies the presence of outliers within our study did not greatly inflate the variance estimate 
of our predictor covariates.   
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3.4 Discussion 
This study aimed to estimate morbidity of respiratory exacerbation in NYC residents between 
2016 and 2018. While causality cannot be inferred from this cross-sectional study, our results 
suggest spatial and temporal heterogeneity in the relationship between asthma and COPD 
exacerbation and key socio-demographic and climatic characteristics in NYC. Each of the 
models within our three series adjusted for potential predictive covariates. However, time was 
also adjusted for within the second GLMM series. Within the third series using the Bayesian 
spatio-temporal approach, the modelling adjusted for time as well as the random effect of space. 
 
The crude inpatient case counts across Asthma and COPD exacerbation decreased gradually over 
the course of the study period. However, the crude outpatient case counts across Asthma and 
COPD exacerbation first increased from 2016 to 2017 and then decreased from 2017 to 2018. 
This may indicate possible fluctuation in the cases of outpatient respiratory exacerbation cases 
per year, despite an overall decline in the trend. However, a study assessing a longer time period 
may be better suited to address these concerns. Furthermore, crude case counts were higher for 
asthma exacerbation episodes occurring within the outpatient setting than the inpatient, as 
compared to crude case counts being higher for COPD exacerbation episodes occurring within 
the inpatient setting than the outpatient. This suggests patients experiencing a COPD 
exacerbation episode may primarily seek care within the inpatient setting, as opposed to those 
experiencing an asthma exacerbation episode.  
 
This disparity may be a result of asthma management policies that were implemented across 
New York State and New York City promoting proper self-care and guidance for asthmatic 
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disease, namely the ‘Asthma Action Plan’.87 Part of the ‘Asthma Action Plan’ provides guidance 
for those pre-diagnosed with asthma in learning how to assess signs and symptoms of an 
impending exacerbation episode and knowing where to seek care within the outpatient setting 
(e.g., primary care physician[PCP]). This information is distributed in the form of educational 
posters, handouts and a formal action plan to be completed in conjunction with the patient and 
their PCP. In addition, part of the ‘Asthma Action Plan’ provides clinical guidelines for the 
diagnosis, evaluation and management of adults and children with asthma.88 COPD, however, 
lacks similar resources across both NYS and NYC. Although there are a number of resources for 
patients with pre-diagnosed COPD such as online and local support groups organized by 
organizations such as Freedom From Smoking® and a New York State Smokers’ Quitline 
organized by the NYS Tobacco Control Program and the Roswell Park Cancer Institute, there is 
no available formal ‘action plan’ for COPD disease management and education within NYC at 
this time.89 
 
We found high respiratory exacerbation rates peaked between February through March 2016, 
October 2016 through May 2017, Jan 2018 and October through December 2018. These findings 
indicate seasonal allergies may have played a role. Meteorological conditions may have also 
influenced the temporal distribution of respiratory exacerbation rates, especially for October 
through December of 2018, as mentioned prior in chapter 2.13  
 
Bayesian spatio-temporal modelling showed neighborhoods located mainly in south Bronx, 
upper Manhattan, eastern Brooklyn (as well as parts of north-western Brooklyn), north-central 
Queens (near LGA airport) and southern Queens (near JFK airport) exhibited the highest risk 
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levels, whereas neighborhoods located in Mid- to Lower Manhattan, southern Staten Island, and 
eastern Queens (for COPD outcomes only) exhibited the lowest risk levels overall. The 
neighborhoods with the highest risk appeared closest to major highways and airports (JFK in 
southern Queens and LGA in north-central Queens).90 The literature substantiates these findings 
showing about half of children residing in Manhattan and the Bronx live within close proximity 
of a state or county highway and zones of elevated concentrations of traffic-related pollutants.91 
These children presented with wheeze, asthma and high levels of immunoglobulin (Ig) E.91A 
study further assessing asthma hospitalizations within New York City found the Bronx, East 
Harlem and some neighborhoods in North/Central Brooklyn close to some of the biggest 
highways of the city (e.g., Brooklyn-Queens Expressway, Long Island Expressway) to have the 
highest hospitalization rates of the whole city, together with the highest pollution level of all the 
neighborhoods excluding the wealthiest areas of Manhattan.92 They further found those areas 
with the highest hospitalization rates also had the highest poverty rates as well as the lowest 
percentage of insured people in the city.92 Research has also found that these areas (Bronx, East 
Harlem, Southeast Queens and East Brooklyn, especially Crown Heights, Flatbush and 
Brownsville) with the highest asthma-related hospitalization rates within NYC also had the 
highest percentage of NYC residents identifying as non-Hispanic black.92 These findings align 
with the results from our study portraying neighborhoods with the highest respiratory 
exacerbation risk also having the highest population of lower income and minority groups. 
 
Bayesian Spatio-temporal modelling further showed the effects of predictive sociodemographic 
and climatic covariates on the outcome of respiratory exacerbation. Beginning with 
sociodemographic covariates, an increasing proportion of people under age 20 was protective of 
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asthma inpatient exacerbation, which may be explained by occupational exposures, smoking, and 
obesity, variables that are all likely to be lower in this age group.93,94  However, an increasing 
proportion of people over age 64 was a risk factor for COPD exacerbation across both the 
inpatient and outpatient settings within a community. This finding may be explained by the 
nature of the disease where an individual will not exhibit prominent signs and symptoms of 
COPD until years after first exposure (e.g., smoking), despite loss of lung function more 
accelerated in the early stages of COPD than in the later stages.95  
 
It seems likely there are gender disparities with regards to asthma and COPD, but our findings 
were inconsistent across our outcomes. Regardless, the literature shows as children, boys have 
increased prevalence of asthma compared to girls. However, as adults, women have increased 
prevalence of asthma compared to men.96 In regards to COPD, it seems likely there are gender 
disparities but it is unclear which gender is associated with a higher risk of COPD.97 Further 
research in this area should attempt to better elucidate these interactions and their mechanisms. 
 
An increasing proportion of blacks, regardless of ethnicity, was a consistent risk factor across 
COPD and asthma within a community. African American youth have greater odds of an asthma 
diagnosis even compared with other minority groups, and the odds increase with each decrease 
in socioeconomic status.98 Differences in illness management may account for some of these 
disparities.99 Similarly, an increasing proportion of people living below the federal poverty level 
was also a consistent risk factor. Further findings from our study determined higher increases in 
the episodes of AEi as compared to AEo, given an increase in the percentage of the population 
that is in poverty within a ZCTA. This indicates that those who are of a lower socioeconomic 
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status continue to seek emergency care for asthma exacerbation as compared to those of higher 
SES. Lower SES has long been associated with greater emergency health service use, worse 
asthma control and worse asthma self-efficacy.100 This may be due to the influence of SES on 
accessibility, affordability, acceptability and actual utilization of various available health 
facilities.101 
 
An increasing proportion of the adult population with at least a 4-year college degree was 
protective against exacerbation in the inpatient setting for both asthma and COPD within a 
community. This observation agrees with the literature suggesting educational attainment 
reduces the risk for health morbidity and mortality due to increased accessibility to resources 
such as health insurance through the employer, lack of occupational exposure, and lower 
smoking prevalence.93,94 Other downstream benefits of educational attainment include the 
resources and knowledge to adopt healthier behaviors and the resources to live in healthier 
neighborhoods, which can inadvertently decrease air pollution exposure both indoors and 
outdoors.102 
 
Our findings across homes heated with fuel oil, kerosene, etc. were inconsistent across the 
outcomes. However, these heating methods are all sources of combustion products and 
particulate matter, which can be directly emitted from the remaining residual oil boilers in 
buildings or released when fuels are incompletely burned.37 As a result, PM 2.5 can contribute to 
poor air quality and lead to adverse health effects by lodging in the lungs and irritating or 
damaging lung tissue.37 However, we were unable to assess the ventilation systems of homes 
being heated with utility gas, or account for the adequacy of central air handling systems, 
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including furnaces, flues and chimneys (e.g., whether or not they inspected annually or if any 
cracks or damaged parts were properly repaired). Additionally, due to monthly data 
unavailability we were unable to adjust for seasonal exposure to heating fuel demonstrating 
higher uses of heating fuel during the winter as compared to the summer.  
 
The meteorological covariates were similar across all four outcomes. Average monthly 
maximum temperature was consistently protective of respiratory exacerbation across all four 
outcomes. However, the increase in respiratory exacerbation episodes was only marginal for 
asthma patients within the outpatient setting. These findings suggest less cases of both asthma 
and COPD exacerbation during the summer and more in the winter, aligning with our spatial risk 
analyses in chapter 2 where the Fall and Winter seasons presented with higher case counts of 
respiratory exacerbation. Because it is well-known that the spring and summer seasons present 
with more allergens, those pre-diagnosed with respiratory disease may take more precautionary 
measures by utilizing inhalers during these periods. A major trigger of respiratory exacerbation 
during the fall and winter season is cold air, which may present with a greater difficulty with 
prevention. Although reduction in lung function may be caused by increased airway 
inflammation in winter, which can be treated with inhalers or bronchodilators, recent work has 
shown that exacerbations of asthma are largely precipitated by viral infections, especially with 
rhinovirus, and it is likely that viruses are also important in increasing airway inflammation in 
COPD in the winter.103 Furthermore, inflammatory changes in COPD could contribute to a 
persistent decline in lung function without the presence of a symptomatic exacerbation.104 This 
may be due to the role of mucous hypersecretion as a potential mediator of the COPD response 
to cold temperature.105 
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Total monthly precipitation was only assessed for the COPD exacerbation inpatient outcome as it 
was insignificant against the other three outcomes. In this scenario, precipitation also appeared 
protective of COPD exacerbation episodes within the inpatient setting. This may have occurred 
because the rainfall may not have been as heavy to induce hydration and fragmentation of pollen 
grains, which could release allergenic biological aerosols into the atmosphere making it more 
difficult for those patients pre-diagnosed with respiratory conditions to breathe.106 It may also be 
due to atmospheric washout which is recognized as one of the main mechanisms of reduction in 
atmospheric particulate pollution.42 
 
Finally, annual average PM 2.5 in the 90th percentile was very marginally protective for asthma 
exacerbation (regardless of setting) and COPD exacerbation in the inpatient setting; while it was 
a risk factor for COPD exacerbation in the outpatient setting. Atmospheric “washout” from 
heavy rainfall is recognized as one of the main mechanisms of reducing atmospheric particulate 
pollution, which may explain the findings in the AEi, AEo and CEi outcomes.15 Nevertheless, 
PM 2.5 was still a risk factor for COPD exacerbation in the outpatient setting and had 
disproportionate levels that aligned with results from our spatial risk analysis in chapter 2.59 PM 
2.5 in the 90th percentile was highest in Midtown, Manhattan (12.4 mcg/m3), where 11.1% of the 
population was in poverty, showing exposure may not have necessarily influenced SES within 
our findings. However, our findings may be explained by industrialization of the neighborhood. 
Midtown Manhattan is one of the world's largest central business district, with 400 million 
square feet (37.2 million m2) of office space in 2018.107 Furthermore, it has one of the smallest 
densities or persons per square mile within NYC, including a low density of children.108 It is 
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important to note however, that data for PM 2.5 was only made available in 2018 and does not 
accurately reflect levels in 2016 or 2017, which may have presented with higher or lower values. 
 
We were able to declare approximate convergence in the results from our Bayesian spatio-
temporal modelling concluding that each individual sequence of a Markov chain appeared 
stationary and that the observed sequences have mixed well with each other.78 This suggests that 
for our current study, the stationarity of the Markov chain and the sample size obtained was 
adequate for the estimation of mean values of the three iterations.109  
 
When using the convergence diagnostic proposed by Geweke79, the covariates for the Asthma 
Outpatient outcome had values outside of (-1.96, 1.96), except for ‘Percentage female’, which 
may be suggestive of non-convergence. The lack of convergence for our Asthma Outpatient 
outcome using the Geweke diagnostic may indicate that the number of samples to generate, 
whether or not to thin the Markov chains, and as a result how many samples to discard as the 
burn-in period and then how many more to generate on which to base inference may have needed 
to be altered.69,78 However, there has been a long and continuing debate about whether the issue 
of selecting a model as a basis for inferences is amenable to a strict mathematical analysis. The 
literature shows that although it is useful to have measures of fit and complexity, and to combine 
them into overall criteria that have some theoretical justification, an overformal approach to 
model ‘selection’ may be inappropriate since so many other features of a model should be taken 
into account before using it as a basis for reporting inferences, e.g. the robustness of its 
conclusions and its inherent plausibility.77 Nevertheless, the trace-plots of the parameters for the 
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Asthma Outpatient outcome suggest convergence as they are stationary and show random 
fluctuations around a single mean level. 
 
The Moran’s I statistic for each outcome using Bayesian spatio-temporal modelling had p-values 
ranging from 0.195 to 0.864, which were all greater than 0.05. This suggests little to no evidence 
of unexplained spatial autocorrelation after accounting for the covariate effects in the Bayesian 
spatio-temporal models.(Table 3.19) Given the Moran’s I test results were insignificant after 
Bayesian spatio-temporal modelling, we can confirm this model was most appropriate for 
addressing spatial autocorrelation within our study as compared to GLM and GLMM modelling. 
The Moran’s I statistic was also negative across all four outcomes suggesting the spatial 
distribution of high case counts and low cases counts in the study were probably more spatially 
dispersed than would be expected if underlying spatial processes were random.110 A dispersed 
spatial pattern often reflects some type of competitive process—a feature with a high value 
repels other features with high values; similarly, a feature with a low value repels other features 
with low values.110,111 This process can be explained by the heterogeneity of NYC where social 
and environmental conditions vary significantly within relatively small distances.92  
 
 
Moran's I 
Statistic P-value 
Asthma Inpatient -0.027 0.666 
Asthma Outpatient -0.036 0.195 
COPD Inpatient -0.03 0.225 
COPD Outpatient -0.057 0.864 
Table 3.19: Moran’s I statistic and associated p-values for Bayesian spatio-temporal modelling.  
This table suggests models across all four outcomes were insignificant and lacked spatial autocorrelation. 
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In our GLMM model with temporal adjustment, there is still residual spatial autocorrelation. The 
spatial and temporal dependence parameters from the Bayesian models across all four outcomes 
(ρS and ρT), presented in Tables 3.5, 3.9, 3.13 and 3.17, further showed spatial dependency and 
temporal autocorrelation. Although we did not test for temporal autocorrelation, the values for ρT 
are all quite high (maximum value is 1) indicating significant temporal autocorrelation. These 
findings corroborate our rationale for using more complex models (Bayesian) that further adjust 
for spatial residual autocorrelation.   
 
Despite spatial dispersion noticed in the findings from the Moran I’s statistic, the spatial and 
temporal dependence parameters still suggest that the intensity of the respiratory exacerbation 
from neighborhood communities tends to be more similar than that in communities that are 
further apart.112 This situation could have some implications for the management and 
surveillance at a ZCTA-level and can be replicated in the population between 19 and 65 years 
old or in the general population. Notably, spatial and temporal dependency must be considered as 
information sources rather than something to be corrected.113 Local authorities of neighboring 
communities, in tandem with local health managers, could make concerted efforts to improve 
routine health information systems (systematic collection of data, analysis, and interpretation) to 
improve and strengthen existing measures to support achievement of on-going respiratory 
management goals. More specifically in New York City, improvements can be made to the 
Department of Health and Mental Hygiene’s asthma management policies which aims to 
minimize symptoms and exacerbations so people with asthma can lead full, active 
lives.74,114 Efforts should be in place to further include COPD as part of the city’s respiratory 
management goals as this disease has a similar pathophysiology to asthma with comparable risk 
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factors. Finally, it may be beneficial for the city and/or state departments to integrate the 
geographic information system into routine surveillance programs to regularly produce and 
update maps of asthma and COPD risk in general, but particularly of respiratory disease burden 
during cases of extreme climate variability. Although COPD and asthma exacerbation 
population-based rates appear to have decreased over the course of the study period, this 
decrease is relatively small, and rates still appear high within disadvantaged neighborhoods. The 
crude outpatient case counts across Asthma and COPD exacerbation both increased from 2016 to 
2017, and then decreased from 2017 to 2018, indicating annual fluctuations that were not 
properly accounted for in this study due to the short study time period. 
 
One of the strengths of our study is the type of analysis used to explore the spatio-temporal 
variations in the burden of respiratory exacerbation through routinely collected observational 
health data. As recommended by the first principle of the National Asthma Control Program 
(NACP) developed by the CDC, tracking is essential for collecting and analyzing data to 
understand when, where, and in whom asthma occurs so that interventions can be better targeted, 
and stakeholder partnerships can be created to develop, implement and evaluate local health 
programs.115 An additional strength of this study is that it analyzes respiratory exacerbation 
across NYC at the level of the ZCTA. USPS ZIP Codes lack a pre-defined geographic area so the 
USPS assigns ZIPs to ranges of addresses associated with street segments. However, the ZCTA 
is composed of aggregated census blocks where majority of addresses have the same ZIP Code. 
Lastly, the application of the hierarchical Bayesian CAR approach with data from several 
sources can address unknown sources of bias.74 Likewise, the CAR model smooths the 
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respiratory exacerbation case counts, considering the potential impact of model instability caused 
by the small number of reported cases and the diversity of data sources.116,117 
 
3.5 Conclusion 
In summary, this study addresses important problems in the fields of public health, 
environmental health, climate science, health care, and sociology. In particular, it addresses the 
need for focused studies in major cities such as New York City, where there are diverse 
sociodemographic and socioeconomic groups who experience adverse health effects from 
seasonal climate patterns in varying ways.  
 
Long latency times, the effects of cumulative exposures, and multiple exposures to different 
pollutants which might act synergistically all create difficulties in unraveling associations 
between environmental pollution and health.82 Current knowledge about weather effects on air 
pollution is still unsatisfactory; there is still a need for better emission inventories and 
observational datasets.21   
 
The results from this study mostly agree with the original hypothesis. Our results were best fitted 
after utilizing the Bayesian spatio-temporal approach to adjust for spatio-temporal 
autocorrelation. Our outcomes and potential predictive covariates varied significantly, both over 
the course of the study period and across the NYC ZCTAs. Results from our Bayesian spatio-
temporal model suggest certain sociodemographic predictive factors increased the risk of 
respiratory exacerbation within a community. However, the effect of climatic predictors was 
slightly different than what was expected, except for PM 2.5 being a risk factor for COPD 
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exacerbation in the outpatient setting. We expected temperature to have a different effect than 
what was observed, however, our findings indicate that lower temperatures may potentially serve 
as a risk factor for respiratory exacerbation instead.  
 
The findings from this research support on-going respiratory management goals, specifically 
New York City Department of Health and Mental Hygiene’s asthma management, which aim to 
minimize symptoms and exacerbations so people with asthma can lead full, active lives.114  
The results also support adaptation measures for disadvantaged individuals residing in specific 
geographical locations that may likely be unable to cope during adverse climatic events. 
Improvements can begin at the level of the Primary Care Physician (PCP) providing acute 
(outpatient) medical care.  
 
Future research can study patients within specific socioeconomic classes or disadvantaged 
neighborhoods frequenting primary care and/or pulmonology-focused medical practices for their 
prevention of respiratory exacerbations. Studies can further evaluate the effect of proximity to 
one’s PCP and/or a formal pulmonary rehabilitation program on reducing respiratory 
exacerbation. Potential research assessing public health interventions on risk of respiratory 
exacerbation can include proper medication education using a formalized education tracking 
system within a medical dashboard, improved electronic medical record documentation to 
include sociodemographic variables predictive of respiratory exacerbation, and environmental 
monitoring tracking applications that can be easily downloaded unto patients’ cellphones.  
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This study has several limitations, including the 3-year time period.118  However, the results of 
this study can be used to inform future research with the capability of accessing respiratory 
exacerbation for a longer period of time. Misclassification of case location could have occurred, 
as was described in chapter 2.119 However, these limitations are hypothetical in nature and there 
is no available evidence that these potential location errors are systematic. Therefore, they should 
be minimized by the use of ZCTAs as the unit of analysis, as done in this study, rather than the 
specific geocoded address points.120  
 
Additional limitations with this study’s methods involve point estimates of the slope parameters 
(beta coefficients) in a linear model. The beta coefficient themselves will not be biased, but their 
associated standard errors will be if the residuals are not randomly distributed and independent of 
each other.  Regression with connected spatial units like this will typically yield residual spatial 
autocorrelation, which we were able to adjust for using our Bayesian spatio-temporal 
model. Omitting covariables that may act as confounders or effect modifiers for some potential 
predictive covariable could also bias the coefficient associated with the predictive variable of 
interest121; however, this will typically manifest itself in residual spatial autocorrelation, which 
again we were able to adjust for.  
 
In addition, the range of margin of error can be high with ACS data resulting in loss of precision. 
However, it is beneficial to work with small geographic boundaries that the ACS data provides 
such as ZCTAs, as opposed to larger geographic boundaries (e.g., Public Use Microdata Areas or 
PUMAs, Community Districts or CDs) provided by other data sources such as the NYC 
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Community Health Survey. The tradeoff between geographic resolution allows the study to 
account for variation across finer geographic units. 
 
Another limitation is the lack of primary care or pediatrician visits captured by SPARCS,52  as 
was described in chapter 2. Further limitations involve the PM 2.5 dataset obtained from the 
New York City Community Air Survey. Although this is a robust dataset with over one-hundred 
monitors across NYC with data spanning a decade, it does have drawbacks. Notably, it is a two-
week average and particulate matter data is collected only periodically within the 14-day 
period.59 Therefore, this research is unable to obtain peak PM 2.5 exposures, which may be the 
driver for hospital admissions, depending on the respiratory illness. 
 
An additional limitation of this study was the inability to analyze indoor air quality (IAQ) co-
variates, especially the main drivers of poor IAQ: Crowding, second-hand smoke, pests 
(cockroaches, mice/rats) and pets.122,123 Crowding or the number of people in the household and 
number of people per room can be an indicator as concentration could indicate greater generation 
sources over a smaller volume. The relative importance of these different triggers varies based 
on different environmental factors depending on geographic, climatic, socioeconomic, and 
housing conditions.123 Although ‘crowding’ was calculated by the American Community Survey 
(ACS) using the estimated number of housing units with more than 1 occupant per room,124 this 
data was collected at the geographic level of CDs, of which there are only 59. Additionally, 
‘crowding’ was only made available as an average from 2013 to 2017, which doesn’t cover any 
part of the time period used within this study. Nevertheless, multiple social and behavioral 
factors can influence environmental exposures and health conditions.125 We posited poverty, 
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educational attainment and ethnicity may all be potential indicators of higher likelihood of 
worsened IAQ. For example, studies have found individuals with a higher educational attainment 
and those who lived out of poverty had lower odds of second-hand smoke exposure at 
home.126 Research has also shown bedroom allergen levels were associated with ethnicity and 
housing instability.127 Future research may investigate additional proxy variables for IAQ, 
potentially tenure by occupants per room. We were further unable to assess for ‘second-hand 
smoke within the home’, ‘cockroaches’, and ‘mice/rats, as these data were last collected by the 
New York City Community Health Survey (CHS) in 2012, four years prior to the beginning of 
this study period.128 They were also collected at the geographic level of United Hospital Fund 
(UHF) neighborhoods, of which there are only 34. Further, the data for ‘pets (dog or cat in the 
home)’ and solely ‘cats in the home’ was also collected by NYC CHS at the UHF level and prior 
to the beginning of the study period, in 2008 and 2013, respectively.  
 
Prediction about the effects of climate variability on health-related air pollution is further 
hampered by limits including population growth, economic development, energy use and 
production. Current knowledge about weather effects on air pollution is still unsatisfactory; there 
is still a need for better emission inventories and observational datasets.21   
 
Nevertheless, the findings from this study can be generalizable to other individuals living within 
NYC that are pre-diagnosed with asthma and COPD but were not included in this research, as 
well as to individuals in other urban areas diagnosed with a chronic health condition (e.g., 
cardiac), that may be also experience health inequities. The New York State SPARCS hospital 
discharge data includes outcomes from a representative sample of an urban area (New York 
 
110 
City) within the NYS population and includes individuals who were discharged from a NYS 
hospital or article 28 medical facility, regardless of age, sex, race/ethnicity and socioeconomic 
status. Therefore, this study could also be transportable to other diverse urban populations within 
the U.S. with a similar population structure, where there is a disproportionate burden of chronic 
health disease (e.g., respiratory, cardiac) among disadvantaged populations. Given our findings 
in NYC, research can focus on similar racial and socioeconomic disparities that are expected in 
other large cities with a similar population makeup across the United States.  
 
As COPD and asthmatic events are often triggered by environmental irritants, and can be 
augmented by certain socioeconomic conditions, climate variability can impact air quality and 
pose a quantifiable threat by permanently affecting the overall function of an individual’s 
respiratory system. Data generated from this study is essential in identifying the interplay 
between certain sociodemographic and environmental triggers of COPD and asthma 
exacerbation on a spatio-temporal scale. In so doing, public health research can be better targeted 
to populations within specific socioeconomic classes or disadvantaged neighborhoods that are at 
higher risk for respiratory exacerbation. Support can also be garnered on a policy level towards 
reducing air emissions from sources such as traffic and neighboring highways, along with 
factories, warehouses, and other toxic release inventories. 
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Chapter 4. Bayesian Spatio-temporal Modelling to Assess the 
Future Burden of Socio-economic and Climate Predictive Factors in 
New York City, New York 
 
4.1 Introduction 
Climate variability leaves the most vulnerable individuals of a population, including COPD and 
asthmatic patients, susceptible to augmented chronic health outcomes. Asthma is already 
understood to be the leading chronic disease in children1 and is the third-ranking cause of 
hospitalization among children younger than 15 years old.2 Moreover, it is known that COPD 
stands as the third leading cause of death and second leading cause of disability in the United 
States.3,4 The literature has shown climate variability is associated with an increase in same-day 
respiratory hospitalizations5 and an increased risk of premature death up to six times higher 
among respiratory patients than in the rest of the population.6  
 
During the winter season, COPD patients have been reported to experience more frequent 
exacerbation of their disease and were found to have higher hospitalization and morbidity 
rates.7,8 This may be due to the increased prevalence in respiratory viral infections during the 
winter season.9,10 Evidence also cites increased mortality and acute morbidity from respiratory 
illness during the summer season, mainly from increased exposure to pollutants such as grass 
pollen in the air, and high levels of the gaseous pollutant ozone which is associated with elevated 
temperatures.11-13 Ozone, a respiratory irritant created by chemical reactions between oxides of 
nitrogen (NOx), VOC, carbon monoxide (CO) and methane (CH4), can cause a reduction in lung 
function and increase in respiratory symptoms.14 Over the last century, global temperatures have 
risen and are projected to continue to rise and cause changes in weather and climate.11 With the 
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overall increase of global temperatures, many climate models have predicted a general increase 
in atmospheric water vapor accompanied by an increase in relative humidity and the intensity of 
heavy rainfall events.15-17 Changes in temperature, air pressure, and most importantly 
precipitation patterns affect the probability of storms and floods. Heavy rain and flooding may 
cause water damage on buildings, leading to an increase in mold exposure. Although mold 
allergy is rare, there is a clear relationship between damp houses and respiratory diseases such as 
asthma.18 Other studies carried out in the Brazilian Amazon have even found peaks in the 
number of hospital visits due to respiratory disease during the wet seasons (between the months 
of March and April), which may of had an association with relative humidity in the air.19 
Nevertheless, periods of heavy rainfall can also reduce the amount of ambient air pollution by 
“washing” particulate matter pollutants out of the atmosphere.20 
 
Recent epidemic thunderstorm asthma has been reported about a dozen times in the past 35 
years; the threshold for reporting seems to be an increase of at least five to ten times in asthma 
presentations to emergency departments over a short time.21 Nonetheless, many individuals are 
affected by these events but do not seek acute medical care.22 This emerging phenomenon is 
accompanied with periods of heavy rainfall and intense wind, which are believed to increase 
extreme exposure to allergens, predominantly grass pollen, in susceptible allergic individuals.23 
Heavy rainfall, wind speed, air turbulence, and mixing depth can affect how pollutants disperse 
within a region, or even cause a reverse effect and spread pollutants away from a region.24 
 
During periods of climate variability accompanied by temperature and/or precipitation extremes, 
individuals who are socio-economically disadvantaged are most vulnerable. Research has 
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consistently shown the impact of an individual’s social or economic standing on morbidity, 
mortality, and access to health care with regards to respiratory health.25-27 Studies addressing low 
SES among individuals diagnosed with COPD and asthma have found associations with 
disproportionate access to respiratory health care. For instance, there is an inverse relationship 
between SES and COPD prevalence associated with mortality, health utilization costs and 
health-related quality of life (HRQoL).27 There is also a relationship between lower SES and 
increased severity of asthma leading to subsequent hospitalization.27 
 
Public health authorities are interested in reducing hospitalizations rate for several reasons. They 
include improving the population's well-being and reducing healthcare costs and consumption of 
resources; this is particularly true in New York City (NYC).28 For instance, the New York State 
(NYS) healthcare system spends US$1.3 Billion dollars per year for asthma alone (second 
highest state in the United States [US]) and the current asthma prevalence in adults living in 
NYC is 10.2%, higher than 9.3% of adults who live in the rest of the State.29  
 
COPD also presents with its own burdens on morbidity and mortality and subsequent challenge 
on healthcare systems. Although there is limited research done on COPD in NYC, national 
studies have modelled the financial burden associated with COPD prevalence showing direct 
healthcare costs ranged from US$1,681 for patients in stage I COPD (early stage), US$5,037 for 
patients in stage II (moderate stage) and US$10,812 for those in stage III (severe stage).30 A 
majority of these costs are associated with exacerbations requiring hospitalizations. COPD 
constitutes a larger proportion of respiratory inpatient exacerbations, as compared with asthma.31 
Some studies have shown that the cost of hospital stay represents 40–57% of the total direct costs 
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generated by patients with COPD, reaching up to 63% in severe patients.30-32 In the USA, the 
mean cost of hospital admission by COPD in a cohort of patients with severe COPD was 
estimated to be US$7,100.33 
 
IPCC (Intergovernmental Panel on Climate Change) future climate projections 
Temperature and precipitation extremes and their potential future changes are evaluated in an 
ensemble of global coupled climate models participating in the Intergovernmental Panel on 
Climate Change (IPCC) diagnostic exercise for the Fourth Assessment Report (AR4).34 Climate 
extremes are expressed in terms of 20-year return values of annual extremes of near-surface 
temperature and 24-hour precipitation amounts.35 The simulated changes in extremes are 
documented in three 30-year time periods for years 2010-2039, 2040-2069 and 2070-2099 across 
different emissions scenarios provided within the Special Report on Emissions Scenarios 
(SRES).36 The tools most commonly adopted for projecting future climate are coupled 
atmosphere-ocean general circulation models (AOGCMs). AOGCMs are numerical models that 
provide a comprehensive three-dimensional representation of the climate system, and can 
generate regional estimates of climate in response to given changes in greenhouse gas (which 
tends to warm the earth) and aerosol concentrations (which tends to have a cooling effect).37  
 
Our objective is to estimate the influence of temperature and precipitation scenarios modelled by 
the IPCC on the future burden of COPD and Asthma hospitalizations accompanied by a burden 
on healthcare systems as a whole. This study contributes to the literature on respiratory-related 
hospitalizations by examining the association between predictive climatic variables provided by 
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the IPCC and hospitalizations from COPD and asthma exacerbation, as influenced by 
socioeconomic and sociodemographic factors.   
 
Specific Aims 
The aim of this study is to estimate the future burden of COPD and asthma-related hospital 
discharges across the entire city of New York with IPCC predicted temperature and precipitation 
measures, as well as predictive factors that are socio-demographic (age) and socio-economic 
(race and poverty) in nature. The sub-aims entail looking at similar associations using the 
following sub-outcomes: 1) Total charges and 2) Length of stay (LOS) (for inpatient settings 
only). The aims will be carried out using Bayesian spatio-temporal modelling to adjust for 
spatio-temporal autocorrelation.38 
 
Hypotheses 
We hypothesize the number of cases of respiratory-related hospitalizations (primary outcome), 
number of total charges (secondary outcome), and length of stay [for inpatient settings only] 
(secondary outcome) will increase into the year 2039 across New York City as a whole, given 
the IPCC predicted temperature and precipitation values, as well as the socio-economic and 
socio-demographic predictive covariates. 
 
4.2 Methods 
Data 
This study combines health and spatial data from a variety of sources. The outcomes of interest – 
hospital discharges related to COPD and asthma exacerbation episodes (primary), length of stay 
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(inpatient medical setting) and total charges per visit – are provided by the New York State 
(NYS) Statewide Planning and Research Cooperative System (SPARCS) as described in chapter 
2.  
 
COPD and/or Asthma Exacerbation 
The primary outcome of interest was obtained from NYS SPARCS, which was measured by an 
International Classification of Diseases 10th Revision Codes (ICD-10CM)39,40 pertaining to 
either a COPD exacerbation: 
J44.1 for “Chronic obstructive pulmonary disease with acute exacerbation, unspecified,” 
Or an asthma exacerbation: 
J45.21 for “Mild intermittent asthma with [acute] exacerbation,” 
J45.31 for “Mild persistent asthma with [acute] exacerbation,”  
J45.41 for “Moderate persistent asthma with [acute] exacerbation,” 
J45.51 for “Severe persistent asthma with [acute] exacerbation,”   
J45.901 for “Unspecified asthma with [acute] exacerbation.” 
The secondary outcomes of interest were total charges in United States Dollars (USD) and length 
of stay (LOS) (inpatient medical setting only) in days, for each respiratory exacerbation episode. 
Data on the secondary outcomes were also made available by NYS SPARCS. 
 
Type of Diagnosis Code 
For this study, ‘Admitting Diagnosis (AD)’ was used for the inpatient dataset and ‘Reason for 
Visit (RV)’ was used for the outpatient dataset.  
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Socioeconomic and sociodemographic Variables 
The American Community Survey (ACS) is a cross-sectional sample which provides single-year 
poverty estimates for geographies with populations of 65,000 or greater and estimates for five-
year periods at all geographies.41 For this study, the Census Bureau’s ‘American Community 
Survey’ (ACS) 5-year estimates for 2014 through 2018 was used to obtain NYC-wide estimates 
on the following community-level co-variates:  
Age, measured as percentage of the population ‘under 20 years old’ for the asthma  
diagnoses as asthma is more prevalent in the young42 or percentage of the  
population ‘over 64 years old’ for the COPD diagnoses as COPD is more 
prevalent among the elderly.43 
Race, measured as percentage of the population being black (non-Hispanic Latino or  
Hispanic Latino) 
Poverty, measured as percentage of the population below poverty level (out of population  
for whom poverty status is determined)  
 
Climatic Variables 
The IPCC provides projections for temperature and precipitation in three 30-year time periods 
(2010-2039, 2040-2069, 2070-2099) relative to baseline levels from 1961 through 1990.37 
Climate projections are based on special emissions scenarios that seek specifically to exclude the 
effects of climate change and climate policies on society and the economy (“non-
intervention”).36 The scenario with which our predictions are based upon include the second 
scenario (B2), which defines emissions through economic, social and environmental 
sustainability. In this emissions scenario, an emphasis is placed on community initiative and 
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social innovation to find local as opposed to global solutions. Furthermore, the IPCC employed 
seven different coupled atmosphere-ocean general circulation models (AOGCMs) models to 
provide future climate projections. For this study we chose the temperature and precipitation 
predictions provided using the GFDL-R30 which employs flux adjustment and eliminates 
background noise from unrealistic sea surface temperatures.37 
 
Our research focused on climate projections modelled until the end of the first 30-year time 
period 2039, as we expect the total population of NYC to increase substantially from now into 
the future. IPCC projections were made available on a seasonal basis (December through 
February, March through May, June through August, and September through November) with 
climate predictions through the year 2039. IPCC projected temperature and precipitation 
increases were measured in:  
Temperature: maximum temperature in degrees Celsius 
Precipitation: total precipitation in centimeters 
IPCC temperature increase projections to 2039 ranged from 1.1 to 3.7 degrees Celsius; IPCC 
precipitation increase projections to 2039 ranged from -17.4 to 5.9 cm.37 
 
A table presenting all four primary outcomes, six secondary outcomes, and potential predictor 
variables by type (Socio-demographic, socio-economic and Meteorological) is described in 
Table 4.1.  
 
Primary Response variables  
  
Asthma exacerbation – inpatient cases* 
 Asthma exacerbation – outpatient cases* 
 COPD exacerbation – inpatient cases* 
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 COPD exacerbation – outpatient cases* 
Secondary Response variables  
 
Asthma exacerbation – inpatient length of stay (LOS) (in days)* 
 Asthma exacerbation – inpatient total charges (in United States Dollars 
[USD])* 
 Asthma exacerbation – outpatient total charges (in USD)* 
 COPD exacerbation – inpatient length of stay (LOS) (in days)* 
 COPD exacerbation – inpatient total charges (in USD)* 
 COPD exacerbation – outpatient total charges (in USD)* 
Socio-demographic and socio-
economic predictor variables  
2014 5-year ACS** community estimates 
Offset – primary outcomes Total population** 
% under 20 years old Percent of the population age under 20 years (Asthma outcomes only) 
% over 64 years old Percent of the population age over 64 years (COPD outcomes only) 
 % black alone Percent of total population that is Black or African American alone, 
regardless of ethnicity  
 % poverty Percent of total population who live in poverty 
Climate predictor variables 2010 - 2039 IPCC projections*** 
Maximum temperature increase Seasonal maximum temperature increase in degrees Celsius (°C) 
Maximum precipitation increase Seasonal maximum precipitation increase in centimeters (cm) 
Table 4.1: Table presenting all four primary outcomes, six secondary outcomes, and potential predictor variables by type (Socio-
demographic, socio-economic and Meteorological).   
*NYS DOH SPARCS, **American Community Survey, ***Intergovernmental Panel on Climate Change 
 
Assessing the presence of Multicollinearity among the Covariates 
Multicollinearity represents a high degree of linear intercorrelation between explanatory 
variables in a multiple regression model and leads to incorrect results of regression analyses.44 
We assessed for multicollinearity using the ‘ggscatter’ function within R to determine if any two 
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potential predictor variables were highly correlated with one another, and if one of the two 
should be removed from our final model.  
 
Bayesian Spatio-Temporal Modelling using Poisson and Gaussian distributions 
Poisson distributions were used to model our primary outcomes, whereas Gaussian distributions 
were used to model our secondary outcomes. However, traditional regression models are unable 
to model data that are spatio-temporally autocorrelated. Spatio-temporal autocorrelation can lead 
to case observations from geographically close areal units and temporally close time periods to 
have more similar values than units and time periods that are further apart.38 A few of the 
covariates within our final datasets were spatially and temporally misaligned with the hospital 
discharge data as hospital discharge information and ACS data were made available at the level 
of the ZCTA from different time periods, 2016 – 2018 and 2014 – 2018, respectively. In 
addition, IPCC climate projections were modelled for the years 2010 – 2039 and cover the 
eastern North American region of the world. The IPCC projected estimates are further modelled 
to occur randomly in nature.45  
 
A Bayesian inferential approach is taken to model these data, where the spatio-temporal 
autocorrelation is modelled via sets of autocorrelated random effects using the conditional 
autoregressive (CAR) method proposed by Leroux et al.46 In this method38, each set of random 
effects is mean-centered and can be written as either: 
Ykt ~ Poisson(μkt𝑛𝑘𝑡) 
ln(μkt𝑛𝑘𝑡) =  βxkt
T + ψkt + ln(𝑛𝑘𝑡)   (1) 
or 
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Ykt ~ N(μkt, 𝑣
2) 
g(μkt) =  βxkt
T + ψkt     (2) 
where in equation (1), μkt is the expected risk of an individual living in ZCTA k and discharge 
month t, is multiplied by nkt, the offset population at-risk, of the observed respiratory case count 
Ykt. Xkt are explanatory space–time covariates associated with the mean process with β 
coefficients and ψkt is a set of spatio-temporally autocorrelated random effects for ZCTA k and 
discharge month t. Equation (2) presents the gaussian likelihood model with an identity link 
function. The additional scale parameter v2 is the observation variance. The scale parameter v2 
for the Gaussian likelihood is assigned a conjugate inverse gamma prior distribution, where the 
default specification is v2 ∼ Inverse-Gamma(0.001, 0.001).47 The expected values of the 
responses are related to the linear predictor via an invertible link function, which in this software 
is either the identity (g(.)) (Gaussian family) or the natural log (ln(.)) (Poisson family) function.47  
 
The Bayesian paradigm naturally incorporates our prior belief about the unknown parameter φ, 
and updates this belief based on observed data.48 This yields the posterior distribution of φ, 
which represents our knowledge about the parameter φ after having observed the data X.48 The 
proposed model represents the spatio-temporal structure with a multivariate first order 
autoregressive process (which predicts future behavior from near-term past behavior) with a 
spatially autocorrelated precision matrix.49 The models are summarized in chapter 3.  
 
Assessing the presence of spatial autocorrelation across our primary and secondary outcomes 
A Moran’s I statistic was computed for each discharge month to quantify the presence of spatial 
autocorrelation in residuals from our Bayesian spatio-temporal model.50 The process explaining 
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how this statistic was computed is described in chapter 3. The null hypothesis for the Moran’s I 
test states there is no spatial autocorrelation and the alternative hypothesis states positive spatial 
autocorrelation. Therefore, a significant result (p-value < 0.05) indicates spatial autocorrelation is 
present within the model. 
 
4.3 Results 
Multicollinearity 
We found none of the potential predictors were highly correlated, so we were able to include all 
into our model. 
 
Asthma Exacerbation Inpatient 
Predicted Asthma exacerbation inpatient (AEi) outcomes across New York City, through 2039 
The Markov chains appeared to have converged indicating posterior distributions of parameters 
are essentially identical. This is the distribution representing our belief about 
the parameter values after we have performed our calculations and have taken the observed data 
into account.51 The trace-plots of the parameters, suggest convergence as they were stationary 
and showed random fluctuations around a single mean level.47 In addition, CARBayesST 
presents the convergence diagnostic proposed by Geweke52 for sample parameters, which uses 
the geweke.diag() function. This statistic is in the form of a Z-score, and values between (-1.96, 
1.96) are suggestive of convergence.52 All covariates had values between (-1.96, 1.96) and can 
be seen in Table 4.2.  
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Asthma 
Inpatient 
Cases 
Asthma Inpatient 
Length of Stay 
(in days) 
Asthma Inpatient 
Total Charges (in 
hundred thousands) 
  
  
Socio-demographic/Socio-
economic Variables 
   
Percentage under 20 years old - 1.4 -0.4 0.7 
Percentage identifying as 'Black 
(Hispanic and Non-Hispanic)' 
0.1 0.3 -0.3 
Percentage in Poverty 0.9 1.2 -0.9 
IPCC Climate Variables 
   
Maximum temperature increase -1.6 1.8 -1.3 
Maximum precipitation increase -0.6 1.4 -1.4 
Table 4.2: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all 
covariates across Asthma Inpatient outcomes.   
Values between (-1.96, 1.96) are suggestive of convergence. 
 
Effects of covariates on AEi primary and secondary outcomes across NYC 
Tables 4.3 and 4.4 summarize the Bayesian models which evaluates the spatio-temporal random 
effects on the case counts, length of stay (LOS) and total charges across NYC into the year 2039. 
Case counts were modelled using Poisson regression, whereas Gaussian regression was used to 
model LOS and total charges. The covariates exhibited substantial effects on LOS and total 
charges except for age (across LOS and total charges), race (across LOS and total charges), 
temperature (across total charges only) and precipitation (across total charges only) as their 95% 
credible intervals did not include zero.(Table 4.4) 
 
The estimated Moran’s I statistics and p-value obtained from the residuals of this model for AEi 
cases, length of stay and total charges was 0.006 (0.38), 0.18 (7.999e-4) and 0.14 (4.3e-3), 
respectively. The p-value for all Moran’s I statistics was only greater than 0.05 for AEi cases and 
suggested no evidence of unexplained spatial autocorrelation after accounting for the covariate 
effects.(Table 4.3) However, because the p-value for the Moran’s I statistic in the LOS and total 
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charges models were both less than 0.05, this suggests these models were not properly 
fitted.(Table 4.4) The spatial random effect was not enough to adjust for unidentified covariates; 
therefore, the significance of any potential predictor covariates cannot be verified. 
 
Asthma Inpatient Indicator 
Asthma Inpatient 
Cases  
(RR, 95% CI) 
Fixed Effects 
 
Intercept † -12.4 (-12.78, -12) 
Socio-demographic/socio-
economic Variables 
 
10% increase in population 
under 20 years old 
1.55 (1.28, 1.84) 
10% increase in population 
identifying as 'Black 
(Hispanic and Non-
Hispanic)' 
1.14 (1.1, 1.2) 
2% increase in population 
under Poverty 
1.17 (1.14, 1.2) 
IPCC Climate Variables 
 
1-degree Celsius increase in 
total temperature 
0.98 (0.97, 0.99) 
2 cm total increase in 
precipitation 
1.01 (0.99, 1.04) 
Spatio-temporal random 
effects variances † 
2.14 (1.95, 2.35) 
Spatial and Temporal 
Dependence † 
 
Spatial dependence (ρS) 0.1 (0.07, 0.13) 
Temporal dependence (ρT) 0.58 (0.55, 0.61) 
Moran I test (statistic, p-
value) 
0.006 (0.38) 
DIC 
 
MCMC Chain 1 24773 
MCMC Chain 2 24736 
MCMC Chain 3 24733 
Table 4.3: Predicted asthma exacerbation inpatient discharges across New York City, modelled through 2039. A summary of the 
parameter estimates from the Bayesian spatio-temporal model with Poisson regression.   
The estimated covariate effects are relative risks (RR) and their 95% confidence interval associated with a 
multiplier of 10, except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was 
used and for ‘maximum temperature increase’ where a multiplier was not added. Note: †Coefficient on log scale, 
DIC: deviation information criteria. 
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Asthma Inpatient Indicator 
Asthma Inpatient 
Length of Stay  
(in days)  
(Coef, 95% CrI) 
Asthma Inpatient  
Total Charges (in 
hundred thousands) 
(Coef, 95% CrI) 
Fixed Effects 
  
Intercept -7.28 (-7.87, -6.65) -0.52 (-1.67, 0.76) 
Socio-demographic/socio-
economic Variables† 
  
10% increase in population 
under 20 years old 
3.57 (-1.12, 8.05) 0.3 (-0.3, 0.9) 
10% increase in population 
identifying as 'Black 
(Hispanic and Non-
Hispanic)' 
0.54 (-0.44, 1.47) 0.01 (-0.1, 0.1) 
2% increase in population 
under Poverty 
1.85 (1.32, 2.4) 0.16 (0.09, 0.23) 
IPCC Climate Variables† 
  
1-degree Celsius increase in 
total temperature 
-0.22 (-0.4, -0.04) -0.01 (-0.04, 0.01) 
2 cm total increase in 
precipitation 
0.27 (-0.47, 0.96) 0.02 (-0.1, 0.14) 
Spatio-temporal random 
effects variances 
1.36 (-2.36 4.82) 0.17 (0.11, 0.27) 
Spatial and Temporal 
Dependence 
  
Spatial dependence (ρS) 0.11(0.008, 0.37) 0.03 (0.001, 0.19) 
Temporal dependence (ρT) 0.998 (0.99, 1) 0.998 (0.99, 1) 
Moran I test (statistic, p-
value) 
0.18 (7.999e-4) 0.14 (4.3e-3) 
DIC 
  
MCMC Chain 1 73191 47113 
MCMC Chain 2 73070 47057 
MCMC Chain 3 73085 47057 
Table 4.4: Predicted asthma exacerbation outpatient length of hospital stay and total charges per hospital stay across New York 
City, modelled through 2039. A summary of the parameter estimates from the Bayesian spatio-temporal model with Gaussian 
regression.   
The estimated covariate effects are posterior medians and 95% credible intervals associated with a multiplier of 10, 
except for ‘population in poverty’ and ‘total precipitation increase’ where a multiplier of 2 was used, and for 
‘maximum temperature increase’ where a multiplier was not added. Note: CrI: credible interval, DIC: deviation 
information criteria, italicized values indicate covariates whose 95% CrI include zero and therefore do not exhibit 
substantial effects on the response. 
 
Effects of covariates on Predicted AEi cases 
Regarding socio-demographic and socio-economic variables, the results (Table 4.3) showed that 
the posterior median and 95% credible interval for the relative risk of a 10% increase in the 
percentage of the NYC population under 20 years old into the year 2039 was 1.55 (1.28, 1.84) 
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and a 10% increase in the percentage of the population that is Black (Hispanic and non-Hispanic) 
was 1.14 (1.1, 1.2), indicating that an increase of this magnitude corresponds to an increase in 
the episodes of AEi into the year 2039 by 55% and 14%, respectively. In addition, the posterior 
median and 95% credible interval for the relative risk of only a 2% increase in the percentage of 
the NYC population that is in poverty into the year 2039 was 1.17 (1.14, 1.2) indicating that an 
increase of this magnitude corresponds to an increase in the episodes of AEi into 2039 by 17%. 
Regarding IPCC predicted meteorological variables, the results showed that the posterior median 
and 95% credible interval for the relative risk of a 1-degree Celsius increase in the maximum 
temperature across NYC into the year 2039 was 0.98 (0.97, 0.99), indicating that an increase of 
this magnitude corresponds to a decrease in the episodes of AEi into 2039 by 2%. However, the 
posterior median and 95% credible interval for the relative risk of a 2 cm increase in total 
precipitation across NYC into the year 2039 was 1.01 (0.99, 1.04), indicating that an increase of 
this magnitude corresponds to an increase in the episodes of AEi into 2039 by 1%. 
 
Asthma Exacerbation Outpatient 
Predicted Asthma exacerbation inpatient (AEo) outcomes across New York City, through 2039 
The Markov chains appeared to have converged indicating posterior distributions of parameters 
are essentially identical. Despite the Geweke convergence diagnostic inadvertently suggesting 
there was a lack of convergence for percentage in poverty, it did determine convergence for the 
rest of the covariates with values inside (-1.96, 1.96).(Table 4.5) We were further able to 
visualize the presence of convergence among the covariates through trace-plot visualization of 
the parameters as they were stationary and showed random fluctuations around a single mean 
level.47  
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Asthma 
Outpatient 
Cases 
Asthma Outpatient 
Total Charges (in 
hundred thousands) 
  
 
Socio-demographic/Socio-
economic Variables 
  
Percentage under 20 years old - 1.4 1.7 
Percentage identifying as 'Black 
(Hispanic and Non-Hispanic)' 
-1.2 0.4 
Percentage in Poverty -1.7 -2.5 
IPCC Climate Variables 
  
Maximum temperature increase 0.2 0.0 
Maximum precipitation increase -0.5 -0.7 
Table 4.5: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all 
covariates across Asthma Outpatient outcomes.   
Values between (-1.96, 1.96) are suggestive of convergence. 
 
Effects of covariates on AEo primary and secondary outcomes across NYC 
Tables 4.6 and 4.7 summarize the Bayesian models which evaluates the spatio-temporal random 
effects on the case counts, length of stay (LOS) and total charges across NYC into the year 2039. 
Case counts were modelled using Poisson regression, whereas Gaussian regression was used to 
model total charges. The covariates for total charges exhibited substantial effects on each 
outcome variable except for age and total precipitation increase, as their 95% credible intervals 
did not include zero.(Table 4.7) 
 
The estimated Moran’s I statistics and p-value obtained from the residuals of this model for AEo 
cases and total charges was -0.13 (0.996) and 0.16 (0.004), respectively. The p-value for Moran’s 
I statistics within the AEo case counts outcome was greater than 0.05 and suggested no evidence 
of unexplained spatial autocorrelation after accounting for the covariate effects. This indicates 
this model was properly fitted and was able to adjust for spatial autocorrelation.(Table 4.6) 
 
135 
However, the model for the AEo total charges outcome may not have been properly fitted.(Table 
4.7) The spatial random effect was not enough to adjust for unidentified covariates. 
 
Asthma Outpatient 
Indicator 
Asthma 
Outpatient Cases 
(RR, 95% CI) 
Fixed Effects 
 
Intercept† -9.32 (-9.65, -8.89) 
Socio-demographic/socio-
economic Variables 
 
10% increase in population 
under 20 years old 
0.94 (0.79, 1.09) 
10% increase in population 
identifying as 'Black 
(Hispanic and Non-
Hispanic)' 
1.28 (1.24, 1.32) 
2% increase in population 
under Poverty 
1.17 (1.14, 1.19) 
IPCC Climate Variables 
 
1-degree Celsius increase in 
total temperature 
0.99 (0.98, 1) 
2 cm total increase in 
precipitation 
1.01 (0.98, 1.03) 
Spatio-temporal random 
effects variances† 
1.51 (1.39, 1.63) 
Spatial and Temporal 
Dependence† 
 
Spatial dependence (ρS) 0.39 (0.33, 0.45) 
Temporal dependence (ρT) 0.53 (0.5, 0.56) 
Moran I test (statistic, p-
value) 
-0.13 (0.996) 
DIC 41348 
Table 4.6: Predicted asthma exacerbation outpatient discharges across New York City, modelled through 2039. A summary of 
the parameter estimates from the Bayesian spatio-temporal model with Poisson regression.   
The estimated covariate effects are relative risks (RR) and their 95% confidence interval associated with a 
multiplier of 10, except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was 
used and for ‘maximum temperature increase’ where a multiplier was not added. Note: †Coefficient on log scale, 
DIC: deviation information criteria. 
 
 
Asthma Outpatient 
Indicator 
Asthma Outpatient  
Total Charges (in 
hundred thousands) 
(Coef, 95% CrI) 
Fixed Effects 
 
Intercept -1.7 (-2.53, -0.88) 
Socio-demographic/socio-
economic Variables† 
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10% increase in population 
under 20 years old 
0.29 (-0.11, 0.68) 
10% increase in population 
identifying as 'Black 
(Hispanic and Non-
Hispanic)' 
0.39 (0.29, 0.48) 
2% increase in population 
under Poverty 
0.26 (0.21, 0.32) 
IPCC Climate Variables†  
1-degree Celsius increase in 
total temperature 
-0.02 (-0.03, -0.001) 
2 cm total increase in 
precipitation 
-0.003 (-0.6, 0.05) 
Spatio-temporal random 
effects variances 
1.39 (1.21, 1.59) 
Spatial and Temporal 
Dependence 
 
Spatial dependence (ρS) 3.52 (3.36, 3.68) 
Temporal dependence (ρT) 0.84 (0.77, 0.89) 
Moran I test (statistic, p-
value) 
0.16 (0.004) 
DIC 28333 
Table 4.7: Predicted asthma exacerbation outpatient total charges per hospital stay across New York City, modelled through 
2039. A summary of the parameter estimates from the Bayesian spatio-temporal model with Gaussian regression.  
The estimated covariate effects are posterior medians and 95% credible intervals associated with a multiplier of 10, 
except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was used, and for 
‘maximum temperature increase’ where a multiplier was not added. Note: CrI: credible interval, DIC: deviation 
information criteria, †Coefficient on antilog scale, italicized values indicate covariates whose 95% CrI include zero 
and therefore do not exhibit substantial effects on the response. 
 
Effects of covariates on Predicted AEo cases 
Regarding socio-demographic and socio-economic variables, the results (Table 4.6) showed that 
the posterior median and 95% credible interval for the relative risk of a 10% increase in the 
percentage of the NYC population under 20 years old into the year 2039 was 0.94 (0.79, 1.09), 
indicating that an increase of this magnitude corresponds to a decrease in the episodes of AEo 
into 2039 by 6%. In addition, the posterior median and 95% credible interval for the relative risk 
of a 10% increase in the percentage of the NYC population that is Black (Hispanic and non-
Hispanic) into the year 2039 was 1.28 (1.24, 1.32), indicating that an increase of this magnitude 
corresponds to an increase in the episodes of AEo into 2039 by 28%. Furthermore, the posterior 
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median and 95% credible interval for the relative risk of only a 2% increase in the percentage of 
the NYC population that is in poverty into the year 2039 was 1.17 (1.14, 1.19) indicating that an 
increase of this magnitude corresponds to an increase in the episodes of AEo into 2039 by 17%. 
Regarding IPCC predicted meteorological variables, the results showed that the posterior median 
and 95% credible interval for the relative risk of a 1-degree Celsius increase in the maximum 
temperature across NYC into the year 2039 was 0.99 (0.98, 1.0), indicating that an increase of 
this magnitude corresponds to a decrease in the episodes of AEo into 2039 by 1%. However, the 
posterior median and 95% credible interval for the relative risk of a 2 cm increase in total 
precipitation across NYC into the year 2039 was 1.01 (0.98, 1.03), indicating that an increase of 
this magnitude corresponds to an increase the episodes of AEo into 2039 by 1%. 
 
COPD Exacerbation Inpatient 
Predicted COPD exacerbation inpatient (CEi) outcomes across New York City, through 2039 
The Markov chains appeared to have converged indicating posterior distributions of parameters 
are essentially identical. Despite the Geweke convergence diagnostic inadvertently suggesting 
there was a lack of convergence for age in the LOS outcome, it did confirm convergence for the 
rest of the covariates with a value inside (-1.96, 1.96).(Table 4.8) We were further able to 
visualize the presence of convergence among the covariates through trace-plot visualization of 
the parameters as they were stationary and showed random fluctuations around a single mean 
level.47  
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COPD 
Inpatient 
Cases 
COPD Inpatient 
Length of Stay 
(in days) 
COPD Inpatient 
Total Charges (in 
hundred thousands) 
  
  
Socio-demographic/Socio-
economic Variables 
   
Percentage over 64 years old -1.7 -0.6 1.3 
Percentage identifying as 'Black 
(Hispanic and Non-Hispanic)' 
-1.3 -1.5 -1.2 
Percentage in Poverty -0.6 0.9 -0.1 
IPCC Climate Variables 
   
Maximum temperature increase 0.0 0.2 -0.4 
Maximum precipitation increase -0.3 -0.2 0.2 
Table 4.8: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all 
covariates across COPD Inpatient outcomes.   
Values between (-1.96, 1.96) are suggestive of convergence. 
 
Effects of covariates on CEi primary and secondary outcomes across NYC 
Tables 4.9 and 4.10 summarize the Bayesian models which evaluates the spatio-temporal random 
effects on the case counts, length of stay (LOS) and total charges across NYC into the year 2039. 
Case counts were modelled using Poisson regression, whereas Gaussian regression was used to 
model LOS and total charges. The covariates for LOS and total charges exhibited substantial 
effects on each outcome variable except for race (across LOS and total charges) and total 
temperature increase (across total charges only), as their 95% credible intervals did not include 
zero.(Table 4.10) 
 
The estimated Moran’s I statistics and p-value obtained from the residuals of this model for AEi 
cases, length of stay and total charges was 0.006 (0.38), -0.08 (0.99), and -0.04 (0.83), 
respectively. The p-value for all Moran’s I statistics were greater than 0.05 and suggested no 
evidence of unexplained spatial autocorrelation after accounting for the covariate effects. This 
indicates the models were properly fitted and were able to adjust for spatial autocorrelation.  
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COPD Inpatient Indicator 
COPD Inpatient 
Cases 
(RR, 95% CI) 
Fixed Effects 
 
Intercept†  
-10.56 (-10.81,         
-10.3) 
Socio-demographic/socio-
economic Variables 
 
10% increase in population 
over 64 years old 
1.41 (1.27, 1.55) 
10% increase in population 
identifying as 'Black 
(Hispanic and Non-
Hispanic)' 
1.03 (1.0, 1.05) 
2% increase in population 
under Poverty 
1.06 (1.05, 1.08) 
IPCC Climate Variables 
 
1-degree Celsius increase in 
total temperature 
0.99 (0.98, 1.0) 
2 cm total increase in 
precipitation 
1.01 (0.99, 1.03) 
Spatio-temporal random 
effects variances† 
1.21 (1.11, 1.32) 
Spatial and Temporal 
Dependence† 
 
Spatial dependence (ρS) 0.37 (0.32, 0.43) 
Temporal dependence (ρT) 0.45 (0.41, 0.5) 
Moran I test (statistic, p-
value) 
-0.07 (0.9) 
DIC 
 
MCMC Chain 1 27458 
MCMC Chain 2 27459 
MCMC Chain 3 27466 
Table 4.9: Predicted COPD exacerbation inpatient discharges across New York City, modelled through 2039. A summary of the 
parameter estimates from the Bayesian spatio-temporal model with Poisson regression.   
The estimated covariate effects are relative risks (RR) and their 95% confidence interval associated with a 
multiplier of 10, except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was 
used and for ‘maximum temperature increase’ where a multiplier was not added. Note: †Coefficient on log scale, 
DIC: deviation information criteria. 
 
 
COPD Inpatient Indicator 
COPD Inpatient 
Length of Stay  
(in days) 
(Coef, 95% CrI) 
COPD Inpatient  
Total Charges (in hundred 
thousands)  
(Coef, 95% CrI) 
Fixed Effects 
  
Intercept -6.48 (-6.95, -5.97) -1.81 (-3.99, 0.23) 
Socio-demographic/socio-
economic Variables 
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10% increase in population 
over 64 years old 
19.64 (9.88, 28.19) 2.07 (1.13, 3.07) 
10% increase in population 
identifying as 'Black 
(Hispanic and Non-
Hispanic)' 
0.55 (-1.58, 2.41) -0.01 (-0.21, 0.2) 
2% increase in population 
under Poverty 
3.25 (2.1, 4.35) 0.23 (0.12, 0.34) 
IPCC Climate Variables   
1-degree Celsius increase in 
total temperature 
-0.38 (-0.67, -0.11) -0.01 (-0.05, 0.03) 
2 cm total increase in 
precipitation 
1.14 (0.02, 2.29) 0.2 (0.03, 0.35) 
Spatio-temporal random 
effects variances 
275.55 (177.05, 
432.88) 
0.57 (0.36, 0.97) 
Spatial and Temporal 
Dependence 
  
Spatial dependence (ρS) 0.51 (0.29, 0.73) 0.08 (0.003, 0.37) 
Temporal dependence (ρT) 0.96 (0.93, 0.98) 0.996 (0.98, 1.0) 
Moran I test (statistic, p-
value) 
-0.08 (0.99) -0.04 (0.83) 
DIC 
  
MCMC Chain 1 77794 53170 
MCMC Chain 2 77796 53168 
MCMC Chain 3 77793 53165 
Table 4.10: Predicted COPD exacerbation inpatient length of hospital stay and total charges per hospital stay across New York 
City, modelled through 2039. A summary of the parameter estimates from the Bayesian spatio-temporal model with Gaussian 
regression.   
The estimated covariate effects are posterior medians and 95% credible intervals associated with a multiplier of 10, 
except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was used, and for 
‘maximum temperature increase’ where a multiplier was not added. Note: CrI: credible interval, DIC: deviation 
information criteria, italicized values indicate covariates whose 95% CrI include zero and therefore do not exhibit 
substantial effects on the response. 
 
Effects of covariates on Predicted CEi cases 
Regarding socio-demographic and socio-economic variables, the results (Table 4.9) showed that 
the posterior median and 95% credible interval for the relative risk of a 10% increase in the 
percentage of the NYC population over 64 years old into the year 2039 was 1.41 (1.27, 1.55) and 
a 10% increase in the percentage of the NYC population that is Black (Hispanic and non-
Hispanic) was 1.03 (1.0, 1.05), indicating that an increase of this magnitude corresponds to an 
increase in the episodes of CEi into 2039 by 41% and 3%, respectively. In addition, the posterior 
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median and 95% credible interval for the relative risk of only a 2% increase in the percentage of 
the population that is in poverty within NYC into the year 2039 was 1.06 (1.05, 1.08) indicating 
that an increase of this magnitude corresponds to an increase in the episodes of CEi into 2039 by 
6%. Regarding IPCC predicted meteorological variables, the results showed that the posterior 
median and 95% credible interval for the relative risk of a 1-degree Celsius increase in the 
maximum temperature across NYC into the year 2039 was 0.99 (0.98, 1.0), indicating that an 
increase of this magnitude corresponds to a decrease in the episodes of CEi into 2039 by 1%. 
However, the posterior median and 95% credible interval for the relative risk of a 2 cm increase 
in total precipitation across NYC into the year 2039 was 1.01 (0.99, 1.03), indicating that an 
increase of this magnitude corresponds to an increase in the episodes of CEi into 2039 by 1%. 
 
Effects of covariates on Predicted CEi hospital length of stay (LOS) 
The results in Table 4.10 showed that the beta coefficient estimate and 95% credible interval for 
a 10% increase in the percentage of the NYC population that is over 64 years old into the year 
2039 was 19.64 (9.88, 28.19), indicating an increase of this magnitude corresponds to an 
increase in the hospital LOS associated with CEi by 19.64 days. In addition, the beta coefficient 
estimate and 95% credible interval for only a 2% increase in the NYC population that is in 
poverty was 3.25 (2.1, 4.35), indicating that an increase of this magnitude corresponds to an 
increase in the hospital LOS associated with CEi into 2039 by 3.25 days. Regarding IPCC 
predicted meteorological variables, the results showed that the beta coefficient estimate and 95% 
credible interval of a 1-degree Celsius increase in the maximum temperature across NYC into 
2039 was -0.38 (-0.67, -0.11), indicating that an increase of this magnitude corresponds to a 
decrease in the hospital LOS associated with CEi by 0.38 days. However, the beta coefficient 
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estimate and 95% credible interval of a 2 cm increase in total precipitation across NYC into 2039 
was 1.1 (0.02, 2.29), indicating that an increase of this magnitude corresponds to an increase in 
the hospital LOS associated with CEi by 1.1 days. 
 
Effects of covariates on Predicted CEi total hospital charges 
The results in Table 4.10 also showed that the beta coefficient estimate and 95% credible interval 
for a 10% increase in the percentage of the NYC population that is over 64 years old into 2039 
was 2.07 (1.13, 3.07) per hundred thousand, indicating that an increase of this magnitude 
corresponds to an increase in the total hospital charges associated with CEi by $207,000. In 
addition, the beta coefficient estimate and 95% credible interval for only a 2% increase in the 
percentage of the NYC population that is in poverty was 0.23 (0.12, 0.34) per hundred thousand, 
indicating that an increase of this magnitude corresponded to an increase in total hospital charges 
associated with CEi into 2039 by $23,000. Regarding IPCC predicted meteorological variables, 
the results showed that the beta coefficient estimate and 95% credible interval for a 2 cm 
increase in maximum precipitation across NYC into 2039 was 0.2 (0.03, 0.35) per hundred 
thousand, indicating that an increase of this magnitude corresponded to an increase in total 
hospital charges associated with CEi into 2039 by $20,000. 
 
COPD Exacerbation Outpatient 
Predicted COPD exacerbation outpatient (CEo) outcomes across New York City, through 2039 
The Markov chains appeared to have converged indicating posterior distributions of parameters 
are essentially identical. Despite the Geweke convergence diagnostic inadvertently suggesting 
there was a lack of convergence for age, poverty and precipitation in CEo cases outcome, it did 
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determine convergence for the rest of the covariates with a value inside (-1.96, 1.96).(Table 4.11) 
We were further able to visualize the presence of convergence among all of the covariates 
through trace-plot visualization of the parameters as they were stationary and showed random 
fluctuations around a single mean level.47  
 
 
COPD 
Outpatient 
Cases 
COPD Outpatient 
Total Charges (in 
hundred thousands) 
  
 
Socio-demographic/Socio-
economic Variables 
  
Percentage over 64 years old -2.0 -1.2 
Percentage identifying as 'Black 
(Hispanic and Non-Hispanic)' 
-1.5 0.3 
Percentage in Poverty -4.0 1.1 
IPCC Climate Variables 
  
Maximum temperature increase -1.9 0.6 
Maximum precipitation increase -3.1 -0.5 
Table 4.11: Table showing statistics in the form of a Z-score for Geweke diagnostic function determining convergence of all 
covariates across COPD outpatient outcomes.   
Values between (-1.96, 1.96) are suggestive of convergence. 
 
Effects of covariates on CEo primary and secondary outcomes across NYC 
Tables 4.12 and 4.13 summarize the Bayesian models which evaluates the spatio-temporal 
random effects on the case counts and total charges across NYC into the year 2039. Case counts 
were modelled using Poisson regression, whereas Gaussian regression was used to model total 
charges. The covariates exhibited substantial effects on the outcome of total charges except for 
age, total temperature increase and total precipitation increase, as their 95% credible intervals did 
not include zero.(Table 4.13) 
 
The estimated Moran’s I statistics and p-value obtained from the residuals of this model for CEo 
cases and total charges was 0.03 (0.2) and -0.02 (0.7), respectively. The p-value for all Moran’s I 
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statistics were greater than 0.05 and suggested no evidence of unexplained spatial autocorrelation 
after accounting for the covariate effects. This indicates these models were properly fitted and 
were able to adjust for spatial autocorrelation.  
 
COPD Outpatient Indicator 
COPD Outpatient Cases  
(Coef, 95% CrI) 
Fixed Effects 
 
Intercept† -11.34 (-11.91, -9.99) 
Socio-demographic/socio-
economic Variables 
 
10% increase in population 
over 64 years old 
1.77 (1.29, 2.47) 
10% increase in population 
identifying as 'Black 
(Hispanic and Non-
Hispanic)' 
1.38 (1.21, 1.48) 
2% increase in population 
under Poverty 
1.01 (0.96, 1.04) 
IPCC Climate Variables  
1-degree Celsius increase in 
total temperature 
0.98 (0.975, 0.99) 
2 cm total increase in 
precipitation 
1.01 (0.96, 1.04) 
Spatio-temporal random 
effects variances† 
3.47 (3.2, 3.82) 
Spatial and Temporal 
Dependence† 
 
Spatial dependence (ρS) 0.16 (0.13, 0.21) 
Temporal dependence (ρT) 0.65 (0.62, 0.67) 
Moran I test (statistic, p-
value) 
0.03 (0.2) 
DIC 40510 
Table 4.12: Predicted COPD exacerbation outpatient discharges across New York City, modelled through 2039. A summary of 
the parameter estimates from the Bayesian spatio-temporal model with Poisson regression.   
The estimated covariate effects are relative risks (RR) and their 95% confidence interval associated with a 
multiplier of 10, except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was 
used and for ‘maximum temperature increase’ where a multiplier was not added. Note: †Coefficient on log scale, 
DIC: deviation information criteria. 
 
 
COPD Outpatient Indicator 
COPD Outpatient  
Total Charges (in hundred 
thousands) (Coef, 95% CrI) 
Fixed Effects 
 
Intercept -0.34 (-1.23, 0.48) 
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Socio-demographic/socio-
economic Variables† 
 
10% increase in population 
over 64 years old 
0.05 (-0.26, 0.36) 
10% increase in population 
identifying as 'Black 
(Hispanic and Non-
Hispanic)' 
0.13 (0.05, 0.2) 
2% increase in population 
under Poverty 
0.09 (0.05, 0.12) 
IPCC Climate Variables†  
1-degree Celsius increase in 
total temperature 
-0.002 (-0.03, 0.03) 
2 cm total increase in 
precipitation 
0.01 (-0.07, 0.1) 
Spatio-temporal random 
effects variances 
0.33 (0.27, 0.4) 
Spatial and Temporal 
Dependence 
 
Spatial dependence (ρS) 0.99 (0.985, 0.994) 
Temporal dependence (ρT) 0.997 (0.989, 1) 
Moran I test (statistic, p-
value) 
-0.02 (0.7) 
DIC 30208 
Table 4.13: Predicted COPD exacerbation outpatient total charges per hospital stay across New York City, modelled through 
2039. A summary of the parameter estimates from the Bayesian spatio-temporal model with Gaussian regression.   
The estimated covariate effects are posterior medians and 95% credible intervals associated with a multiplier of 10, 
except for ‘population in poverty’ and ‘total increase in precipitation’ where a multiplier of 2 was used, and for 
‘maximum temperature increase’ where a multiplier was not added. Note: CrI: credible interval, DIC: deviation 
information criteria, italicized values indicate covariates whose 95% CrI include zero and therefore do not exhibit 
substantial effects on the response. 
 
Effects of covariates on Predicted CEo cases 
Regarding socio-demographic and socio-economic variables, the results (Table 4.9) showed that 
the posterior median and 95% credible interval for the relative risk of a 10% increase in the 
percentage of the population over 64 years old within NYC was 1.77 (1.29, 2.47) and a 10% 
increase in the percentage of the population that is Black (Hispanic and non-Hispanic) was 1.38 
(1.21, 1.48), indicating that an increase of this magnitude corresponds to an increase in the 
episodes of CEo by 77% and 38%, respectively. In addition, the posterior median and 95% 
credible interval for the relative risk of only a 2% increase in the percentage of the population 
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that is in poverty within NYC was 1.01(0.96, 1.04) indicating that an increase of this magnitude 
corresponds to an increase in the episodes of CEo by 1%. Regarding IPCC predicted 
meteorological variables, the results showed that the posterior median and 95% credible interval 
for the relative risk of a 1-degree Celsius increase in the maximum temperature across NYC was 
0.98 (0.975, 0.99), indicating that an increase of this magnitude corresponds to a decrease in the 
episodes of CEo by 2%. However, the posterior median and 95% credible interval for the relative 
risk of a 2 cm increase in the total precipitation across NYC was 1.01 (0.96, 1.04), indicating that 
an increase of this magnitude corresponds to an increase in the episodes of CEo by 1%. 
 
Effects of covariates on Predicted CEo total hospital charges 
The results in Table 4.13 showed that the beta coefficient estimate and 95% credible interval for 
a 10% increase in the percentage of the NYC population that is over 64 years old into 2039 was 
0.13 (0.05, 0.2) per hundred thousand, indicating that an increase of this magnitude corresponds 
to an increase in the total hospital charges associated with CEo into 2039 by $13,000. In 
addition, the beta coefficient estimate and 95% credible interval for only a 2% increase in the 
percentage of the NYC population that is in poverty was 0.09 (0.05, 0.12) per hundred thousand, 
indicating that an increase of this magnitude corresponded to an increase in total hospital charges 
associated with CEo into 2039 by $9,000. The 95% credible intervals for the beta coefficient 
estimates of the IPCC predicted meteorological variables did not include zero and therefore do 
not exhibit substantial effects on the response. 
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4.4 Discussion 
This study aimed to estimate the future burden of respiratory exacerbation on NYC residents and 
the overall healthcare system into the year 2039. When assessing the risk of socioeconomic and 
climatic predictive covariates, the estimates indicate an overall increased risk of respiratory 
exacerbation from increased precipitation, race (regardless of ethnicity) and poverty status. 
When assessing the relationship between hospital LOS within the inpatient setting and predictive 
covariates, it was estimated the hospital LOS associated with CEi would increase if there was an 
increase in precipitation as well as an increase in populations that were over the age of 64 years 
old, black (regardless of ethnicity) and in poverty. When further assessing the relationship 
between total hospital charges and predictive covariates, it was estimated the total hospital 
charges associated with COPD exacerbation (regardless of medical setting) would increase if 
there was an increase in populations that were over the age of 64 years old and in poverty. It was 
also estimated there would be an increase in total charges associated with CEI specifically, if 
there was an increase in precipitation.  
 
Bayesian Spatio-temporal modelling presented the effects of the predictive socioeconomic and 
climatic covariates on the outcome of predicted respiratory exacerbation episodes into the future. 
Age (either under 20 years old for asthma exacerbation or over 64 years old for COPD 
exacerbation), race (black, regardless of ethnicity) and poverty status were risk factors for 
increased asthma and COPD exacerbation episodes within both medical settings into the year 
2039.  
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These results support the current understanding that asthma is more prevalent among individuals 
who are younger and COPD is more prevalent among the elderly: the pathophysiology of these 
diseases compromises the respiratory system among the young as their lungs are still 
developing42, and among the elderly as they have decreased lung function from long-term 
exposures to known irritants such as smoking 43. However, an increase in the population aged 20 
years and under appeared to decrease the number of asthma exacerbation cases in the outpatient 
setting into 2039. This finding may be explained by occupational exposures, smoking, and 
obesity, variables that are all likely to be lower in this age group.53,54  
 
Our findings also showed race and poverty status were increased risk factors for the future 
burden of respiratory exacerbation on morbidity. The literature supports these results as studies 
assessing respiratory-related hospitalizations within New York City found the highest rates were 
predominantly located in neighborhoods with the highest percentage of NYC residents 
identifying as non-Hispanic black.28 Racial disparities are an essential component in 
understanding the relationship between the future burden of climate variability on respiratory 
health outcomes. Not only does Medicare report black beneficiaries present with higher levels of 
overall morbidity than their white counterparts, they also report lower levels of office visits and 
more inpatient, emergency room, and nursing home visits.55 This may be due to black 
beneficiaries having markedly fewer visits to their primary care physicians and specialists, such 
as pulmonologists who typically diagnose and manage respiratory disease, as compared to their 
white counterparts.55,56 
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The IPCC predicted covariates presented risk factors for precipitation increase into the year 
2039. Although periods of heavy rainfall have been occasionally found associated with 
particulate matter “washout” in the atmosphere, our findings align with the notion suggesting 
heavy rain is still an important trigger factor for COPD exacerbation and may be under-
recognized.57 This indicates the projected rainfall into 2039 may increase exponentially at an 
unsustainable rate tolerated by COPD patients. Several studies have also highlighted elevated 
risk of asthma exacerbation following major thunderstorms.21,58-60 Thunderstorm events, or 
periods of heavy rainfall and intense wind, are a novel phenomenon believed to trigger the 
release of fungal spores and pollen (particularly grass pollen) that are carried by wind, thereby 
resulting in increased exposure to these triggers.21,58,59,61 Heavy rainfall events could further alter 
the humidity in the environment and contribute to changes in airflow in the respiratory system 
that could further exacerbate asthma.60,62,63 
 
IPCC projected temperature increase into 2039 consistently led to a decline in cases of 
respiratory exacerbation across all four outcomes, however. Although it does not align with our 
original hypotheses that temperature increase may be a risk factor for respiratory exacerbation, it 
does support the literature citing colder air may be predictive of respiratory exacerbation instead. 
Research has shown asthma exacerbation is largely precipitated by viral infections, especially 
with rhinovirus, and it is likely that viruses are also important in increasing airway inflammation 
in COPD during the winter.64 Furthermore, inflammatory changes in COPD could contribute to a 
persistent decline in lung function without the presence of a symptomatic exacerbation.65 This 
may be due to the role of mucous hypersecretion as a potential mediator of the COPD response 
to cold temperature.66 
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Our results estimate also estimated an increase in the populations over 64 years old, increase in 
the population that is black regardless of ethnicity, and an increase in the population that is in 
poverty, would all increase the hospital LOS associated with inpatient COPD exacerbation 
hospitalizations into 2039. The finding with age may be explained by the nature of the disease 
where an individual will not exhibit prominent signs and symptoms of COPD until years after 
first exposure (e.g., smoking), despite loss of lung function more accelerated in the early stages 
of COPD than in the later stages.67 The socioeconomic findings with race and poverty status 
align with the results from our estimates on respiratory exacerbation morbidity. This further 
indicates socioeconomic status may present with a heavy burden on the healthcare system within 
the future. Climate variability may also present with additional implications as precipitation 
increase led to an increase in hospital stay. These findings align with our results examining 
respiratory exacerbation on risk of future morbidity, further indicating climate variability may 
present with challenges on the healthcare system leading to longer duration of hospitalization. 
However, because of residual spatial autocorrelation found within our asthma inpatient (AEi) 
dataset, this research cannot conclude that climate variability coupled with socioeconomic status 
will adversely affect hospital LOS associated with AEi 
 
Total charges were not properly estimated in our models mostly due to residual spatial 
autocorrelation, which is a systematic spatial similarity between nearby observations.68 This is 
because the spatial random effect was not enough to adjust for unidentified covariates; therefore, 
the significance of any covariates cannot be verified (although their point estimates are still 
unbiased).  In addition, our models may have been missing covariates that may either act as 
confounders or effect modifiers that could also manifest in residual spatial autocorrelation. Our 
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findings across COPD-associated total hospital charges showed, however, an increase in the 
populations that were over the age of 64 years old and an increase in the populations that were in 
poverty would lead to an increase in the total hospital charges. The prevalence of COPD climbs 
appreciably higher with age, yet is under-recognized.69 Therefore, elderly patients with COPD 
have high morbidity rates associated with hospitalizations leading to a subsequent increase in 
cost of care.31 Hospital-associated costs may also be higher for socioeconomically disadvantaged 
populations as they lack continuity of care with a primary care physician for prevention of an 
exacerbation. Therefore, this population is more likely to receive care in nonoptimal 
organizational settings (such as emergency rooms),70  where they may incur higher costs of care. 
An increase in precipitation into the year 2039 was also found to increase estimates of total 
hospital charges associated with CEi. These results align with our findings indicating 
precipitation was a risk factor for morbidity associated with CEi. Increased hospitalizations from 
CEi into 2039 are likely to increase total hospital charges as a result. 
 
One of the primary strengths of our study is the application of the hierarchical Bayesian CAR 
approach with data from several sources can address unknown sources of bias.71 This model 
smooths the respiratory exacerbation case counts, considering the potential impact of model 
instability caused by the small number of reported cases and the diversity of data source.72,73 
Another strength is the ability to consider the driving impact of predictive sociodemographic and 
socioeconomic covariates on the association between IPCC predictive climate variability and 
future risk of respiratory exacerbation and subsequent burden unto the healthcare system. 
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Findings from this study can be used in future applications estimating these relationships given 
the context-specific conditions that are likely required to improve preparedness. Further research 
can evaluate other predictive factors that can make an individual more susceptible to climate 
extremes such as indoor air quality (IAQ) measures. Predictors of IAQ include house dust mites, 
pets such as dogs and cats, pests such as cockroach and rodents, and molds.74 Crowding or the 
number of people in the household and number of people per room can also be an indicator as 
concentration could indicate greater generation sources over a smaller volume. The relative 
importance of these different triggers varies based on different environmental factors depending 
on geographic, climatic, socioeconomic, and housing conditions.74  We also suggest future 
research investigate patterns involving day-to-day variation in local meteorological parameters 
and hospital admissions in order to support relevant hospital planning at local scales.75 
Nevertheless, understanding these context-specific relationships could be useful to improve 
preparedness and could support shifting from reactive to anticipatory climate change adaptation 
for the health sector.56 Opportunities for public health would benefit from providing inter-
sectoral support for climate solutions with health co-benefits, and using a healthcare framework 
to engage and mobilize communities, especially those presenting with highest risk.76 
 
4.5 Conclusions 
In summary this study used Bayesian spatio-temporal models to emphasize the importance of 
long-term implications from climatic trends; but also, the implications of socio-economic 
disparities on the associations between respiratory morbidity and subsequent impact on the 
healthcare systems within the future. The overall findings from our study largely support the 
original hypotheses regarding our primary and secondary outcomes of respiratory-related 
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hospitalizations across New York City, given socioeconomic predictive covariates and the IPCC 
predicted precipitation measures: it is estimated there will be increased respiratory exacerbation 
hospitalizations, longer length of stay (LOS) (COPD exacerbations within the inpatient setting 
only) and increased hospital charges (COPD exacerbations within the inpatient setting only).  
 
Although temperature increase was estimated to increase respiratory exacerbation episodes and 
hospital LOS, we can posit cooler temperatures may be indicative of future risk for respiratory 
exacerbation hospitalizations and may increase hospital stays instead. Our contrasting results 
suggest a very complex relationship between increasing temperature, precipitation and varying 
sources of air pollution within the atmosphere. Future research should be done to further 
investigate the relationship between temperature lows and varying sources of ambient air 
pollution such as ozone and particulate matter, and the overall combined effect on respiratory 
health outcomes.  
 
Results also showed sociodemographic and socioeconomic factors such as age, race and/or 
poverty status may increase risk of future asthma and COPD exacerbations as well as longer 
length of hospital stay associated with these conditions. Causal linkages between our outcomes, 
increased risk of respiratory exacerbation and an increase in associated hospital stays, and 
predictive climatic and socioeconomic factors should be viewed with caution due to likely 
unidentified confounding, but further research is merited to help safeguard the health of 
individuals pre-diagnosed with respiratory conditions in extreme climate conditions.  
 
 
154 
A major study limitation was the availability of the hospital discharge data, which also included 
information on length of stay and total charges. This data was only made available for a 3-year 
time period. Traditionally, scientists have defined a ‘Climate Normal’ as an average over a recent 
30-year period simply because it is the accepted convention.77  However, the results of this study 
can be used to inform future research with the capability of accessing respiratory exacerbation 
for a longer period of time. In addition, future studies may benefit from assessing day-to-day 
variation in climate to determine if there are any associations with respiratory exacerbation and 
associated burden on the healthcare system. 
 
Another limitation involves high uncertainty regarding projected changes in rainfall and 
temperature variability into the future. At this time, the IPCC78 provides little to no assessment of 
projected changes in extremes at spatial scales smaller than for large regions. Attempts to 
estimate changes in precipitation extremes from observations are complicated by large natural 
variability and spatial differences.79 Although these changes in precipitation extremes could lead 
to changes in flood frequency, the linkage between precipitation changes and flooding can be 
modulated by interactions between precipitation characteristics and river basin hydrology, the 
nature of which are not yet well understood.80,81 The literature on temperature and precipitation 
portray how an accurate scaling of extremes would not only have to involve average temperature 
change under future scenarios, but also the skewness of its distribution. Additionally, attempts to 
estimate changes in temperature extremes lack inclusion of key air pollution variables that may 
be increased by rising temperatures such as ozone and other greenhouse gases, as well as the 
effect of wind on dispersing air pollutants either throughout or away from a specified region. 
Therefore, this study is limited in providing correlation between potentially dangerous levels of 
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global temperature in the future contributing to the climate variability affecting respiratory 
disease. 
 
Further limitations include the ecological nature of the study making any findings from this study 
only interpretable at the ecological level. Lastly, this study is based on secondary data and 
observational information, which are both subject to selection and information bias, and may 
present with residual confounding unable to be assessed within this study.82-84 For example, the 
IPCC has stated that the ability of the models to simulate climate is best at large horizontal scales 
and is severely restricted as the scale is decreased. The scale of analysis adopted by the IPCC 
was at the sub-continental scale (106–108 km2) regions.37 Nevertheless, the IPCC mention 
AOGCMs may still provide useful information on climate change at smaller spatial scales, 
although they may be incapable of capturing many features of changes in local climate, such as 
storms, orographic rainfall and heavy precipitation events.37 Uncertainties with the IPCC models 
also lie in future emissions, which may impact the general climate system, and the natural 
variability of climate. Part of this variability is unforced, due to internal perturbations in the 
climate system, whereas another part is due to external forcing from natural phenomena such as 
variations in solar activity or volcanic eruptions.37 
 
The findings from this study can be generalizable to other individuals living within NYC that are 
pre-diagnosed with asthma and COPD but were not included in this research, as well as to 
individuals in other urban areas diagnosed with a chronic health condition (e.g., cardiac), that 
may be also experience health inequities. The New York State SPARCS hospital discharge data 
includes outcomes from a representative sample of an urban area (New York City) within the 
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NYS population and includes individuals who were discharged from a NYS hospital or article 28 
medical facility, regardless of age, sex, race/ethnicity and socioeconomic status. Therefore, this 
study could also be transportable to other diverse urban populations within the U.S. with a 
similar population structure, where there is a disproportionate burden of chronic health disease 
(e.g., respiratory, cardiac) among disadvantaged populations. Given our findings in NYC, 
research can focus on similar racial and socioeconomic disparities that are expected in other 
large cities with a similar population makeup across the United States.  
 
The results of this study underscore the importance of potential climate variability on the future 
burden of respiratory disease morbidity and subsequent impact on the healthcare system. The 
findings from this study further support the need for further research into assessing the varying 
ways individuals of different socioeconomic classes experience adverse health effects from 
climate variability. There are populations most vulnerable to environmental changes, and the 
consequences of these changes are either attenuated or amplified by different human and 
environmental conditions. Mediating influences and negative moderators to how a system can 
withstand changes in climate include neighborhood-level (e.g., proximity to highways, toxic 
waste sites) and individual-level (socioeconomic, pediatric, elderly, pre-existing medical 
condition) variables. Collectively, these influences determine which societies or communities are 
resilient and adaptive to climate variability. Potential outcomes include adverse health effects in 
communities that are less resilient, whereas adaptive capacities can support a system’s 
resiliency.85  
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Adaptive methods can be implemented to reduce vulnerability to change and can include 
increased annual primary care physician visits, increased access to specialty care within the 
outpatient setting or population health informatics tools to easily connect patients to medical 
resources. These capacities, either carried out individually or collectively, can support a system’s 
resiliency and therefore need to be evaluated in future research. A clearer understanding of the 
systems surrounding an individual’s risk for future respiratory morbidity can alleviate the impact 
on the healthcare system, but interventions should and can be appropriately targeted to certain 
sociodemographic and socioeconomic groups to include adaptive responses to variation in 
climate such as coping, adjustments, and adaptations. 
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Chapter 5. Summary of results, conclusions and future research 
directions 
The goal of this dissertation is to address the gaps in current understanding of respiratory 
morbidity and associated hospitalizations and to contribute to our understanding of how climate 
variability and sociodemographic factors impact respiratory disease among residents of NYC. 
The research in Chapters 2 and 3 examined the associations between respiratory disease as a 
function of space and time and the contextual factors surrounding an individual’s socioeconomic 
circumstances and climate extremes. The research in Chapter 4 examined the future burden of 
respiratory disease on morbidity and on the impact on the healthcare system, given predictive 
climatic, socio-demographic and socio-economic factors. 
 
5.1 Major findings from Chapter 2 
Respiratory exacerbation risk increased temporally and across NYC ZIP code tabulated areas 
(ZCTAs), with disproportionate increases in certain ZCTAs demonstrating geographic disparity. 
• Space-time permutation results showed a consistent amount of non-winter 2018 seasons 
(Spring 2018 and Autumn 2018) appearing in statistically significant clusters across total 
respiratory exacerbations (asthma and COPD). Seasonal allergies and meteorological 
conditions may have played a role, but further research is required to confirm this 
association.  
o When looking at statistically significant clusters of asthma exacerbation episodes 
across both medical facility settings, ‘Summer 2018’ appeared the most for a total 
of 8 clusters. When looking at COPD exacerbation episodes across both medical 
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facility settings, ‘Summer 2016’ appeared in the most statistically significant 
clusters for a total of 5 clusters. 
• Space-time permutation showed the Melrose neighborhood part of the South Bronx 
borough was persistent for the longest duration of the study period in both COPD 
inpatient and outpatient exacerbation space-time permutation analyses. Melrose is near 
facilities with air pollutant emissions, as well as within 400-480 m of a state or county 
highway.1 This neighborhood is also located within the South Bronx, an area known to 
have high poverty rates as well as the lowest percentage of insured people in the city.2 
Furthermore, the highest percentage of the NYC population identifying as black reside in 
the Bronx and Upper Manhattan (i.e. Harlem and East Harlem).2  
• Space-time permutation analyses revealed the Silver Lake neighborhood within the 
borough of Staten Island was included among statistically significant clusters across total 
respiratory (asthma and COPD) exacerbations for both inpatient and outpatient medical 
facility settings. No other ZCTA was persistent and significant across all four ‘diagnosis-
settings’ (asthma inpatient, asthma outpatient, COPD inpatient and COPD outpatient) for 
all three years of the study period. This finding may be attributed to high rates of obesity 
in northern Staten Island, which is formally understood to be a risk factor for respiratory 
disease.2; however, further research would be required to confirm this. 
 
5.2 Major findings from Chapter 3 
• The crude inpatient case counts across Asthma and COPD exacerbation decreased 
gradually over the course of the study period. However, the crude outpatient case counts 
across Asthma and COPD exacerbation first increased from 2016 to 2017 and then 
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decreased from 2017 to 2018. This may indicate possible fluctuation in the cases of 
outpatient respiratory exacerbation cases per year, despite an overall decline in the trend. 
o The annual asthma exacerbation inpatient crude case counts were estimated at 
4755, 4070 and 3871 per year for 2016, 2017, and 2018, respectively. The annual 
AEo crude case counts were estimated at 77 863, 74 137 and 69 016 per year for 
2016, 2017, and 2018, respectively. The annual CEi crude case counts were 
estimated at 11 752, 10 861 and 10 241 per year for 2016, 2017, and 2018, 
respectively. The annual CEo crude case counts were estimated at 8 118, 8 354 
and 8 075 per year for 2016, 2017, and 2018, respectively. 
• Crude case counts were higher for asthma exacerbation episodes occurring within the 
outpatient (221 016) setting than the inpatient (12 696), as compared to crude case counts 
being higher for COPD exacerbation episodes occurring within the inpatient (32 854) 
setting than the outpatient (24 547). This suggests patients experiencing a COPD 
exacerbation episode may primarily seek care within the inpatient setting, as opposed to 
those experiencing an asthma exacerbation episode.  
Results from our Bayesian model suggest spatial and temporal heterogeneity in the relationship 
between asthma and COPD exacerbation and key socio-demographic and climatic characteristics 
in NYC: 
• Through GIS mapping of posterior medians quantiles, we found high respiratory 
exacerbation rates peaked between February through March 2016, October 2016 through 
May 2017, Jan 2018 and October through December 2018. Meteorological conditions 
may have influenced the temporal distribution of respiratory exacerbation rates, 
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especially for October through December of 2018 as similarly found in Chapter 2, but 
further research is required to support this relationship. 
• Bayesian spatio-temporal modelling showed neighborhoods with the highest risk of 
respiratory exacerbation appeared closest to major highways and airports (JFK in 
southern Queens and LGA in north-central Queens).3  
Bayesian Spatio-temporal modelling further showed effects of the community-level 
sociodemographic and city-wide climatic covariates on the outcome of respiratory exacerbation: 
Socio-demographic predictive covariates 
• Increasing proportion of people under age 20 was protective of asthma inpatient 
exacerbation   (RR 0.819 [0.73, 0.92]) , which may be explained by occupational 
exposures, smoking, and obesity, variables that are all likely to be lower in this age 
group.4,5 However, increasing proportion of people over age 64 was a risk factor for 
COPD exacerbation across both the inpatient (RR 1.4 [1.27, 1.54]) and outpatient (RR 
1.2 [1.06, 1.35]) settings within a community. This finding may be explained by the 
nature of the disease where an individual will not exhibit prominent signs and symptoms 
of COPD until years after first exposure (e.g., smoking), despite loss of lung function 
more accelerated in the early stages of COPD than in the later stages.6  
• An increasing proportion of blacks, regardless of ethnicity, (Asthma Inpatient RR 1.07 
[1.05, 1.09], COPD Inpatient RR 1.004 [1.004, 1.049], and COPD Outpatient RR 1.09 
[1.06, 1.12]) was a consistent risk factor across COPD and asthma within a community. 
African American youth have greater odds of an asthma diagnosis even compared with 
other minority groups, and the odds increase as socioeconomic status decreases.7 
Differences in illness management may account for some of these disparities.8 Similarly, 
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an increasing proportion of people living below the federal poverty level was also a 
consistent risk factor (Asthma Inpatient RR 1.26 [1.18, 1.35], COPD Inpatient RR 1.22 
[1.219, 1.36], and COPD Outpatient RR 1.51 [1.41, 1.61]). This indicates that those who 
are of a lower socioeconomic status continue to seek emergency care for asthma 
exacerbation as compared to those of higher SES. Lower SES has long been associated 
with greater emergency health service use, worse asthma control and worse asthma self-
efficacy.9 This may be due to the influence of SES on accessibility, affordability, 
acceptability and actual utilization of various available health facilities.10 
• An increasing proportion of the adult population with at least a 4-year college degree was 
protective against exacerbation in the inpatient setting for both asthma (RR 0.89 [0.886, 
0.93]) and COPD (RR 0.892 [0.89, 0.96]) within a community.  This observation agrees 
with the literature suggesting educational attainment reduces the risk for health morbidity 
and mortality due to increased accessibility to resources such as health insurance through 
the employer, lack of occupational exposure, and lower smoking prevalence.4,5 Other 
downstream benefits of educational attainment include the resources and knowledge to 
adopt healthier behaviors and the resources to live in healthier neighborhoods, which can 
inadvertently decrease air pollution exposure both indoors and outdoors.11 
• Our findings across homes heated with fuel oil, kerosene, etc. were inconsistent across 
the outcomes. However, these heating methods are all sources of combustion products 
and particulate matter, which can be directly emitted from the remaining residual oil 
boilers in buildings or released when fuels are incompletely burned;12 nevertheless, 
further research would be required to confirm this.  
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Meteorological predictive covariates 
• Average monthly maximum temperature was consistently protective of respiratory 
exacerbation across all four outcomes (Asthma Inpatient RR 0.91 [0.88, 0.94], Asthma 
Outpatient RR 0.999 [0.996, 1.002], COPD Inpatient RR 0.94 [0.938, 0.97], and COPD 
Outpatient RR 0.97 [0.94, 0.99]). However, the increase in respiratory exacerbation 
episodes was only marginal for asthma patients within the outpatient setting. These 
findings suggest less cases of both asthma and COPD exacerbation during the summer 
and more in the winter, aligning with our spatial risk analyses where the Fall and Winter 
seasons presented with higher case counts of respiratory exacerbation. A major trigger of 
respiratory exacerbation during the fall and winter season is cold air and viral infections, 
(e.g. rhinovirus), and it is likely that viruses are also important in increasing airway 
inflammation in COPD in the winter.13  
• Total monthly precipitation was protective of COPD exacerbation episodes within the 
inpatient setting (RR 0.95 [0.93, 0.98]). This may have occurred because the rainfall may 
not have been as heavy to induce hydration and fragmentation of pollen grains, which 
could release allergenic biological aerosols into the atmosphere making it more difficult 
for those patients pre-diagnosed with respiratory conditions to breathe.14 It may also be 
due to heavy rainfall that can “wash out” atmospheric particulate pollution leading to 
respiratory exacerbation.15 Total monthly precipitation was not statistically associated 
with COPD outpatient risk or either of the Asthma hospital settings. 
Finally, annual average PM 2.5 in the 90th percentile was very marginally protective for Asthma 
Inpatient (RR 0.87 [0.77, 1.01]), Asthma Outpatient (RR 0.998 [0.98, 1.01]), and COPD 
Inpatient (RR 0.99 [0.92, 1.08]); while it was a risk factor  for COPD exacerbation in the 
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outpatient setting (RR 1.15 [1.02, 1.29]). The highest levels of annual average PM 2.5 in the 90th 
percentile was 10.1 mcg per cubic meter, observed in Williamsburg/Greenpoint in Brooklyn 
(nearby major highways and a site of heavy industrialization), and 8.6 mcg per cubic meter 
observed in the south Bronx (nearby major highways and housing higher populations of lower 
income and minority groups).16 However, atmospheric “washout” from heavy rainfall is 
recognized as one of the main mechanisms of reducing atmospheric particulate pollution, which 
may explain the findings in the AEi, AEo and CEi outcomes.15 
 
5.3 Major findings from Chapter 4 
• The overall findings from our study largely support the original hypotheses regarding our 
primary outcome of respiratory-related hospitalizations across New York City, given 
socioeconomic predictive covariates (a 10% increase in the percentage of the NYC 
population under 20 years old into the year 2039 had a RR of 1.55 (1.28, 1.84) for AEi 
and 0.94 (0.79, 1.09) for AEo; a 10% increase in the percentage of the NYC population 
over 64 years old into the year 2039 had a RR of 1.41 (1.27, 1.55) for CEi and 1.77 (1.29, 
2.47) for CEo; a 10% increase in the percentage of the population that is Black (Hispanic 
and non-Hispanic) had a RR of 1.14 (1.1, 1.2) for AEi, 1.28 (1.24, 1.32) for AEo, 1.03 
(1.0, 1.05) for CEi, and 1.38 (1.21, 1.48) for CEo; a 2% increase in the percentage of the 
NYC population that is in poverty into the year 2039 had a RR of 1.17 (1.14, 1.2) for 
AEi, 1.17 (1.14, 1.19) for AEo, 1.06 (1.05, 1.08) for CEi, and 1.01(0.96, 1.04) for CEo) 
and the IPCC predicted precipitation measures (a 2 cm increase in total precipitation 
across NYC into the year 2039 had a RR of 1.01 (0.99, 1.04) for AEi, 1.01 (0.98, 1.03) 
for AEo, 1.01 (0.99, 1.03) for CEi, and 1.01 (0.96, 1.04) for CEo). Although increased 
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temperature was found to decrease respiratory exacerbation into 2039 (RR of 1-degree 
Celsius increase in the maximum temperature across NYC into the year 2039 is: 0.98 
(0.97, 0.99) for AEi, 0.99 (0.98, 1.0) for AEo, 0.99 (0.98, 1.0) for CEi, and 0.98 (0.975, 
0.99) for CEo), this finding indicates colder temperatures may increase the risk of an 
exacerbation instead.  
• In addition, our findings for the secondary outcomes largely support the original 
hypotheses within the inpatient setting for COPD exacerbations where length of hospital 
stay was longer and total hospital charges were higher given socioeconomic predictive 
covariates (a 10% increase in the percentage of the NYC population that is over 64 years 
old into the year 2039 had a beta coefficient estimate of 19.64 (9.88, 28.19) days and 2.07 
(1.13, 3.07) per hundred thousand dollars for CEi, and 0.13 (0.05, 0.2) per hundred 
thousand dollars for CEo; a 2% increase in the NYC population that is in poverty had a 
beta coefficient estimate of 3.25 (2.1, 4.35) days and 0.23 (0.12, 0.34) per hundred 
thousand dollars for CEi, and 0.09 (0.05, 0.12) per hundred thousand dollars for CEo), 
and the IPCC predicted precipitation measures (a 2 cm increase in total precipitation 
across NYC into 2039 had a beta coefficient estimate of 1.1 (0.02, 2.29) days and 0.2 
(0.03, 0.35) per hundred thousand dollars for CEi). Although increased temperature was 
found to decrease hospital length of stay (a 1-degree Celsius increase in the maximum 
temperature across NYC into 2039 had a beta coefficient estimate of -0.38 (-0.67, -0.11) 
days for CEi), this finding indicates colder temperatures may potentially increase LOS 
instead.  
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5.4 Significance of findings and Key strengths 
The findings of the studies in this dissertation contribute to our understanding of how climate 
and sociodemographic covariates affect respiratory health. Although previous studies have 
provided information on sociodemographic predictive variables and respiratory health, the 
results are varied on specific climatic factors and the role of time and space. Within this 
dissertation, space-time permutation analyses revealed clusters of increased risk of respiratory 
exacerbation during varying time periods and spatial locations. Bayesian spatio-temporal Poisson 
regression methods indicate the complexity of factors such as overall climate and socioeconomic 
status. Overall, COPD and asthmatic events may be triggered by environmental factors such as 
cooler air and can be augmented by certain socioeconomic conditions such as race and poverty 
status. Respiratory health as a result of sociodemographic and climatic factors are conceptually 
inherent and have been quantified with different methods and outcomes.  
 
Moreover, this dissertation further quantifies the burden on our healthcare system of respiratory 
exacerbation hospitalizations in an urban population. Bayesian spatio-temporal modelling was 
applied to predict the expected cases, total hospital charges and length of stay (inpatient setting 
only) based on Intergovernmental Panel on Climate Change (IPCC) predictive climatic factors 
and other relevant predictive socio-demographic and socio-economic factors. By determining 
populations most vulnerable to environmental changes and the consequent burden unto our 
healthcare systems, we can have a clearer understanding of how the consequences of these 
changes are either attenuated or amplified by different socio-economic and socio-demographic 
conditions.  
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The findings from this dissertation research support on-going respiratory management goals, 
specifically New York City Department of Health and Mental Hygiene’s asthma management, 
which aim to minimize symptoms and exacerbations so people with asthma can lead full, active 
lives.17 Proper self-care and preventative guidance for asthmatic disease was incorporated into a 
formalized ‘Asthma Action Plan’18 as part of asthma management policies implemented 
throughout New York State and New York City. As COPD is an obstructive lung disease with a 
similar pathophysiology to asthma, our findings can also support COPD management by 
identifying predictive factors of COPD exacerbation. COPD prevalence is generally higher than 
is recognized by health authorities.19,20 Few population-based prevalence surveys have been 
carried out, and prevalence estimates have often relied on expert opinion or self-reported doctor 
diagnosis, a notoriously unreliable source of information for COPD.21 For example, in the USA 
National Health and Nutrition Examination Survey III, 70% of those with airflow obstruction 
had never received the diagnosis of COPD.22  
 
Incorporating COPD management into this formal action plan across NYC may help reduce 
morbidity rates associated with COPD, especially given this dissertation’s findings suggesting 
patients experiencing a COPD exacerbation episode primarily seek care within the inpatient 
setting as opposed to those experiencing an asthma exacerbation episode. Another way of 
placing the cost of COPD into perspective is to compare it with the cost of asthma. Asthma has 
traditionally received greater investigator attention than COPD; however, the latter is more 
prevalent in the aging adult population and its healthcare load may even be greater due to the 
higher frequency of hospitalizations.21 Although there are a number of resources for patients with 
pre-diagnosed COPD such as online and local support groups organized by organizations such as 
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Freedom From Smoking® and a New York State Smokers’ Quitline organized by the NYS 
Tobacco Control Program and the Roswell Park Cancer Institute, there is no available formal 
‘action plan’ for COPD disease management and education at this time.23  
 
The results from this dissertation also support adaptation measures for disadvantaged individuals 
residing in specific geographical locations that may likely be unable to cope during adverse 
climatic events. Such measures include development of preventative respiratory care measures in 
the outpatient clinical setting within socioeconomically disadvantaged neighborhoods. This may 
include proper medication reconciliation, follow-up on medication adherence, education on 
diagnosis/prognosis including awareness of early warning symptoms, and access to resources to 
better track environmental conditions (e.g., weather, pollutant levels). In addition, the results 
from this study can support the work of environmental justice groups, such as WeACT24, to 
provide awareness and garner community support in maintaining clean and healthy indoor living 
environments, and the promotion of proper respiratory disease management. 
 
5.5 Public Health Relevance 
In Summary, this dissertation research address important problems in the fields of public health, 
environmental health, climate science, health care, and sociology. It advances scientific 
knowledge on refining the general understanding of the associations between climate variability 
and COPD and Asthma as a function over space and time. In particular, this research addresses 
the need for focused studies in major cities such as NYC, where there are diverse 
sociodemographic classes who experience adverse health effects from extreme climate change in 
varying ways. Despite progress in understanding spatial variation in population-based rates of 
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COPD and asthma cases across NYC, there are only a few published studies assessing the 
manner with which these rates change over both space and time and have adjusted for an array of 
sociodemographic and climatic variables. Furthermore, very few studies assessed the future 
burden respiratory disease can pose on human morbidity and the overall healthcare system, 
specifically with regards to cost and length of stay, and the potential association of these 
outcomes with projected temperature and precipitation variables in the context of socioeconomic 
predictive factors. 
 
This study was also able to determine populations most vulnerable to environmental changes. 
The consequences of these changes are either attenuated or amplified by different human and 
environmental conditions and methods that can be implemented to reduce vulnerability to change 
include responses such as coping, adjustments, and adaptations.25 The exposures transcending 
into a system’s sensitivity to climate variability is mitigated by factors such as resilient housing 
and infrastructure as well as emission reduction. Mediating influences and negative moderators 
to how a system can withstand variability in climate include neighborhood-level (e.g., proximity 
to highways, toxic waste sites) and individual-level (socioeconomic, pediatric, elderly, pre-
existing medical condition) variables. Collectively, these influences determine which societies or 
communities are resilient and adaptive to climate variability. Outcomes estimated in this 
dissertation included increased risk of respiratory exacerbation hospitalizations in communities 
that are less resilient. Adaptive capacities to further translate our findings into pragmatic and 
practical measures to alleviate the variation observed in risk factors of respiratory exacerbation 
include the promotion of increased annual primary care physician visits, increased access to 
specialty care within the outpatient setting, and population health informatics tools to easily 
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connect patients to medical resources. These measures can all support a system’s resiliency and 
therefore need to be further assessed.  
 
The findings from this study can be generalizable to other individuals living within NYC that are 
pre-diagnosed with asthma and COPD but were not included in this research, as well as to 
individuals in other urban areas diagnosed with a chronic health condition (e.g., cardiac), that 
may be also experience health inequities. The New York State SPARCS hospital discharge data 
includes outcomes from a representative sample of an urban area (New York City) within the 
NYS population and includes individuals who were discharged from a NYS hospital or article 28 
medical facility, regardless of age, sex, race/ethnicity and socioeconomic status. Therefore, this 
study could also be transportable to other diverse urban populations within the U.S. with a 
similar population structure, where there is a disproportionate burden of chronic health disease 
(e.g., respiratory, cardiac) among disadvantaged populations. Given our findings in NYC, 
research can focus on similar racial and socioeconomic disparities that are expected in other 
large cities with a similar population makeup across the United States.  
 
5.6 Limitations 
The studies in this dissertation have several overlapping limitations. First, the studies in Chapters 
2, 3 and 4 and 3 are based on secondary data. Thus, while they provide insight into various 
associations, they do not imply causality. This limitation translates into the inability of this 
dissertation to determine causal factors which can potentially guide on intervention. For 
example, we were unable to assess underlying clinical components such as early warning 
symptoms and proper adherence to medications, factors that can determine the effectiveness of 
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early interventional measures. Secondly, the collected data about the number of COPD and 
asthma exacerbation episodes were based on hospital discharge codes, so we cannot rule out 
errors inherent in coding or data not collected with the etiology of the exacerbations. However, 
the definition of discharge codes based on ICD-10 is used in all previous studies using this 
methodology and their accuracy has been validated in several studies.26,27 This limitation is 
partially compensated by the large sample size.28  
 
Misclassification of case location could have also occurred, because addresses and geocoded 
coordinates can be subject to errors.29 In addition, cases may spend a majority of their time 
outside of their place of residence such as work and/or school, so the ZCTAs recorded for the 
cases may not represent the locations where they may have highest exposure to predictive factors 
for a respiratory exacerbation. However, respiratory exacerbation is usually an emergency so 
patients are sent to the hospital or article 28 medical facility nearest their current location, which 
may very likely be work or home.  
 
Another limitation is the lack of primary care, pediatrician and pulmonary specialist visits 
captured by SPARCS.30 Many patients go to their Primary Care Physician (PCP) once they 
experience a symptom of COPD/Asthma, prior to heading to their nearest hospital or medical 
facilities certified under Article 28 of the Public Health Law30 where they may fear experiencing 
long waiting periods. Further, these limitations are hypothetical in nature and there is no 
available evidence that these potential location errors are systematic. Therefore, they should be 
minimized by the use of ZCTAs as the unit of analysis, as done in this study, rather than the 
specific geocoded address points.31  
 
176 
Additionally, limitations of the studies in Chapters 3 and 4 was the inability to analyze indoor air 
quality (IAQ) co-variables due to unavailability of data, especially the main drivers of poor IAQ: 
Crowding, second-hand smoke, pests (cockroaches, mice/rats) and pets.32  
 
Further limitations across all three studies in Chapter 2, 3 and 4 include the 3-year time period. 
Traditionally, scientists have defined a ‘Climate Normal’ as an average over a recent 30-year 
period simply because it is the accepted convention.33  However, the results of this study can be 
used to inform future research with the capability of accessing respiratory exacerbation for a 
longer period of time, yielding more consistent findings and improved accuracy of future 
predictions. 
 
Additional limitations across all three studies involve the sociodemographic composition of the 
Summer 2018’ and ‘Spring 2018’ appeared. For example, the population is aging over time 
leading to age, period and cohort (APC) effects as different sources of health-related change: 
change can occur as individuals age throughout their life course, over time due to differences 
between cohort groups where the social and health composition of society as a whole can 
change, and finally as a result of period effects where the passage through time results in a 
change in health, regardless of the age of the individual.34 Prediction about the effects of climate 
variability on health-related air pollution is further hampered by limits including population 
growth, economic development, energy use and production. Current knowledge about weather 
effects on air pollution is still unsatisfactory; there is still a need for better emission inventories 
and observational datasets.35   
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5.7 Future Research Directions 
Future research can begin at the level of the Primary Care Physician (PCP) providing acute 
(outpatient) medical care, given this study’s inability to capture primary care or pediatrician 
visits. Studies could estimate the effect of proximity to one’s PCP and/or a formal pulmonary 
rehabilitation program on reducing respiratory exacerbation. A potential sample population can 
be drawn from patients within specific socioeconomic classes or disadvantaged neighborhoods 
frequenting primary care and/or pulmonology-focused medical practices for their prevention of 
respiratory exacerbations. The study could also entail a longitudinal component spanning a 
longer duration of time, as the three-year time period proved limiting within this dissertation.  
 
Although we cannot use the findings of this dissertation to determine testable interventions, we 
are still able to suggest testable predictive factors that may either increase or decrease the risk of 
respiratory exacerbation. This includes: acknowledgement of early warning symptoms, access to 
medication education using a formalized education tracking system within a medical dashboard, 
adherence to medication, accessible environmental monitoring tracking applications that can be 
easily downloaded unto patients’ cellphones, and availability of improved electronic medical 
record documentation to include sociodemographic variables predictive of respiratory 
exacerbation and/or location of work/school and/or residence. 
 
The data sources and methodologies used in this dissertation are continuously growing and 
improving.  For example, there are many more climate datasets than even a few years ago and 
geospatial software developers continue to add in new features.36  The SPARCS datasets are an 
invaluable resource; however, with recognition of how socioeconomic status affects health, it 
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would be beneficial if information on sociodemographic variables such as race, age group and 
gender could be more adequately collected. 
 
The findings from this dissertation, along with the abundance of literature available37,38, support 
a need for further research on identifying additional predictive risk factors for respiratory 
exacerbation in the context of ambient air pollution. There is a known relationship between 
pulmonary ailments, individuals living within disadvantaged communities, and air emissions 
from sources such as traffic, neighboring highways, factories and warehouse, yet the magnitude 
and the direction of this association is still being extensively studied and analyzed. By 
understanding the strength of this relationship and its contextual nuances, support can be 
garnered towards policy-level provision. 
 
The overall goal is to improve public health response and inform air emissions policies, 
environmental monitoring tools and patient health education efforts. Conclusively, this 
dissertation research will advance scientific knowledge towards reaching these objectives 
through refining the general understanding of the associations between climate variability, 
sociodemographic health disparities, and respiratory exacerbation (as defined by asthma and 
COPD exacerbation) as a function over space and time. 
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